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ABSTRACT 
Previous work has shown that !L-3 is a haemopoietic growth factor 
which stimulates the proliferation of all haemopoetic lineages. 
However, the data presented here show that there is a cons iderable 
strain-dependent variation in the response of murine bone marrow 
cells to IL-3. Bone marrow cells from most strains including 
DBA/2 responded well to IL-3 both in colony assays and liquid 
proliferation assays. In contrast, IL-3 did not support colony 
formation from A/J or AKA bone marrow cells in soft agar culture 
and supported only a low level of proliferation in liquid cultures of 
these cells. Further experiments revealed that the low level of 
proliferation in liquid assays was cell density dependent and was 
most likely due to endogenous growth factor(s) induced by IL-3 
rather than to any direct mitogenic activity cf IL-3. 
The combination of M-CSF and IL-3 supported the production of 
distinctively large colonies from murine bone marrow cells 
regardless of the strain of the donor mouse. In cultures of A/J bone 
marrow cells, the synergistic effect of IL-3 and M-CSF was also 
reflected in an increase in the number and variety of colonies 
produced. A/J bone marrow cells precultured with IL-3 were not 
activated to produce large colonies when subsequently cu ltured 
with M-CSF alone although the presence of IL-3 in these 
precu!tures did maintain M-CSF-reponsive cells which died or lost 
responsiveness in the absence of exogenous growth factors . Pre-
exposure to rv1-CSF did not overcome the defect in the pro li ferative 
response of A/J bone marrow cells to IL-3 . Therefore, the direct 
1n 
mitogenic activity of IL-3 can be separated from its synergistic 
activity with M-CSF. 
Northern analysis revealed that culture with IL-3 enhanced the 
levels of c-fms (M-CSF receptor) RNA transcripts expressed by A/J 
bone marrow cells. Thus, IL-3 may synergise with M-CSF primarily 
by inducing the expression of M-CSF receptors . IL-3 also modulated 
growth factor expression in haemopoietic cells. Culture with IL-3 
elevated the expression of M-CSF RNA transcripts in both A/J and 
DBA/2 bone marrow cells. No G-CSF, GM-CSF or IL-4 RNA 
transcripts were found in these cells before or after culture with 
IL-3. Therefore, endogenous M-CSF induced by IL-3 probably 
accounts for the cell density dependent proliferative response to 
IL-3 detected in liquid cultures of A/J bone marrow cells. 
IL-3 and Epo synergised to enhance erythroid colony formation in 
semi-solid cultures of DBA/2 bone marrow cells. Similarly, IL-4 
enhanced IL-3-dependent colony formation in such cultures. 
However, IL-3 combined with Epo or with IL-4 failed to support 
colony formation from A/J bone marrow cells. Therefore, the 
interactions of IL-3 with Epo and IL-4 may be dependent on the 
mitogenic activity of IL-3. 
Since IL-3 does not induce the proliferation of bone marrow cells 
from some strains, the direct mitogenic activity of IL-3 may not 
be essential for maintaining haemopoiesis. Other actions of IL-3 
including the maintenance of factor respons ive cells, induction of 
growth factors and synergism with M-CSF may nevertheless play 
an important role in blood cell growth and development. 
. 
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Abbreviations commonly used in this thesis 
BFU-E 
-Mk 
Bp 
BPA 
CFC 
CFU 
CFU-S 
CSF 
DEAE 
Epo 
5-FU 
G 
<?BAv1 
Gv1 
HPP-CFC 
Kb 
IL 
PHSC 
r 
20a-SDH 
Burst forming unit -erythroid 
-megakaryocyte 
Base pair 
Bu rs t-p ro m oti ng-activity 
Colony forming cell 
Colony forming unit 
Spleen colony forming unit 
Colony stimulating factor 
Diethylaminoethyl 
Erythropoietin 
5-fluorouracil 
Granulocyte 
Granulocyte, erythrocyte, monocyte, megakaryocte 
Granulocyte/macrophage 
High-pro I iterative-potential co lo ny-fo rm ing-cel i 
Kilobase 
Interleukin 
Pluripotent haemopoietic stem cell 
Recombinant 
20a-hydroxysteroid dehydrogenase 
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Chapter 1 
Literature Review 
INTRODUCTION 
The process of blood cell formation, termed haemopoiesis, 1s one of 
the most complex examples of multilineage differentiation, 
resulting in the production of at least nine functionally and 
morphologically distinct mature cell types. The majority of these 
mature blood elements are short lived and must be continuously 
replenished from a small population of pluripotential stem cells. 
As some indication of the enormity of this process, simply to 
maintain circulating myeloid cells at normal steady state levels, 
an average human must produce about 3.7 x 1011 cells every day of 
adult life (Dexter, 1987). Furthermore, the haemopoietic system 
must retain a degree of flexibil·ity allowing elevated production of 
particular cell types in reponse to stress situations such as blood 
loss or infection. Clearly there must be stringent controls on this 
process to ensure that a stable balance throughout the different 
cell compartments 1s maintained. This chapter will review the 
literature available up until the end of 1986, on mouse 
haemopoietic cell differentiation and the growth factors involved 
1n its regulation. IL-3, the subject of this thesis, will be discussed 
1n some detail including comparisons with IL-3 of other spec ies. 
More recent literature is reviewed in the General Discussion 
(Chapter 8) of this thesis. 
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ORGANISATION OF THE HAEMOPOIETIC SYSTEM 
HAEMOPOIETIC STEM CELLS 
Haemopoietic stem cells arise early in embryogenes is and are first 
found in the yolk sac. Later these cells migrate to the fetal liver 
and then on to the bone marrow - the major site of haemopoiesis 
during adult life. Stem cells are characterised by their extensive 
proliferative potential and their ability to generate daughter cells 
of equivalent potential (self-renewal). As stem cells differentiate 
they give rise to progenitor cells of more restricted 
differentiation and self renewal capacity. The most primitive cell 
in the heirarchy is the pluripotential haemopoietic stem cell 
(PHSC) able to give rise to both myeloid and lymphoid progeny. The 
existence of such cells, capable of long-term engraftment of 
lethally irradiated recipients, was first demonstrated using 
radiation-induced chromosomal markers showing conclusively that 
precursor cells from several lineages (myeloid and lymphoid) 
carried the same karyotype marker (Abramson et al., 1977). More 
recently an elegant experiment, using retroviruses as markers to 
follow the progeny of single stem cells, has defined a predominant 
population of stem cells with both myeloid and lymphoid potential 
(Lemischka et al., 1986). The self renewal and differentiation of 
PHSCs must be tightly regulated since these cells represent the 
ultimate source of haemopoietic cells that must persist throughout 
I ife. 
Pluripotent stem cells have yet to be isolated and defined by 
surface characteristics but functional assays have been described 
which allow quantitation of cells with self-renewal potent ial and 
extensive proliferative capacity. Till and McCulloch (1963) 
transplanted haemopoietic cells into lethally irradiated mice and 
showed that some of the cells lodged in the spleen where they 
formed macroscopic nodules. Subsequent work revealed that these 
nodules arise from single cells (Becker et al.,1963). Since each 
colony may contain upwards of a million cells, this implies an 
extensive proliferative potential of the colony forming cell. 
Furthermore, the nodules, derived from a single cell, contained 
multiple cell lineages (Curry and Trentin, 1967). A small number of 
these spleen colonies contained cells capable of producing more 
spleen colonies when transplanted into secondary irradiated 
recipients indicating that spleen colony forming cells (CFU-S) 
possess some self renewal capacity (Siminovitch et al., 1963, 
Cudkowicz et al., 1964). 
There appear to be 2 subclasses of CFU-S. Spleen colonies 
measured 7 - 8 days after transplantation (CFU-S 7/8) are 
predominantly composed of cells of a single lineage and do not 
contain cells capable of spleen colony formation in secondary 
hosts. In contrast, spleen colonies harvested 12 - 14 days after 
transplantation (CFU-S 12/14) contain multiple cell lineages and 
cells that are capable of secondary spleen colony formation (Magli 
et al., 1982). The self renewal capacity of CFU-S (12/14) together 
with their apparent lack of sensitivity to drugs cytotoxic for 
actively cycling cells (Zant, 1984; Hodgson and Bradley, 1979 ) 
suggests that these cells are the more primitive of the CFU-S 
populations. It is generally agreed however that neither CFU-S 
population comprises truly primitive stem cells but represent a 
heterogenous population including multipotent stem cells and more 
mature cells which have lost much of their capacity for self 
renewal (Hodgson and Bradley, 1979; rv1agli et al., 1982). 
During attempts to assay stem cells in vitro in clonogenic semi-
solid culture systems, a primitive haemopoietic progenitor cell, 
the 'S-cell', has been described The S-cell forms colonies 
containing undifferentiated blast cells. Cells from these colonies 
can generate secondary blast cell colonies or colonies containing 
multiple myeloid lineages when replated (Nakahata and 
Ogawa, 1982). S-cell colonies also contain cells which can give rise 
to spleen colonies indicating that the S-cell may be more primitive 
than the CFU-S population. As with PHSC and CFU-8(12/14), the S-
cell is relatively resistant to drugs cytotoxic for actively cycling 
cells, indicating that it is not actively cycling in vivo, but the 
precise relationship between the PHSC, S-cell and CFU-S is not 
clear. 
COMMITIED CELLS 
Committed progenitor cells are identified by the progeny they 
produce. The multipotential myeloid stem cell [CFU- granulocyte, 
erythrocyte, monocyte, megakaryocyte (CFU-GEMM or CFC-Mix)] 
forms colonies containing multiple myeloid lineages and exhibits 
some self-renewal capacity. There is a significant correlation 
betweeen the number of secondary spleen colonies and the number 
of multilineage colonies obtained from primary spleen colon ies 
indicating that CFU-GEMrv1 and CFU-S may represent overlapping 
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populations (Johnson, 1980). Unlike S-cell colonies, replating of 
primary CFU-GEMM colonies results in no secondary S-cell colonies 
and on!y 10,N frequencies of secondary CFU-GEMM colonies. This 
heterogeneity in self-renewal capacity suggests that CFU-GEMM 
probably represents a continuum of stem and progenitor cells in 
which the capacity for self-renewal is progressively lost as the 
cells become lineage restricted. 
Lineage restricted progenitor cells are committed to one or two 
lineages. Again, these cells are not morphologically recognisable 
and are therefore classified on the basis of functional assays. Two 
classes of erythroid progenitor cells have been identified. The 
erythroid burst forming unit (BFU-E) forms multifocal colonies 
containing proliferating and differentiating erythroid cells in 
semi-solid culture. The erythroid CFU forms single small colonies 
of hemoglobinised red cells and is thought to be the immediate 
progeny of BFU-E (lscove, 1978). Similarly the megakaryocyte BFU 
(BFU-Mk) forms multi-focal colonies and is thought to represent 
the predecessor of the megakaryocyte colony forming unit (CFU-Mk) 
(Long et al., 1985). Other lineage restricted progenitor cells include 
the eosinophil colony forming cell (Eos-CFC), basophil colony 
forming cell (Bas-CFC) , and the granulocyte/macrophage colony 
forming cells (GM-CFC) which generate granulocytes and/or 
macrophages, depending on the growth stimu lus used (see below). 
Sensitivity to drugs cytotoxic for cycling cells reveals that, even 
under steady state conditions, committed progenitor cells are 
predominantly a dividing population (Boswe ll et al.,1984). 
5 
MORPHOLOGICALLY RECCX3N1SABLE PRECURSORS 
Within each cell lineage there is a documented cell sequence by 
which the earliest identifiable precursor cel ls develop into more 
mature progeny. Progression through this differentiati on pathway 
is accompanied by loss of proliferative capacity and acquisition of 
functional properties of the mature cells . 
IN VITRO MODELS OF HAEMOPOIESIS 
Under appropriate conditions, adherant cells derived from the bone 
marrow will support the proliferation and differentiation of CFU-S 
for many months (Dexter et al., 1977). These long term bone marrow 
cultures generate progenitor cells for all the myeloid lineages as 
well as functionally mature myeloid end cells such as granulocytes 
and macrophages. By altering the constituents of the culture 
medium, such cultures can also be induced to form 8-lymphocytes 
(Whitlock and Witte, 1982). The maintenance of haemopoiesis in 
these cultures is absolutely dependent on the intimate contact 
between haemopoietic cells and marrow stromal cells 
(Dexter, 1 982). 
GROWTH FACTORS 
With the advent of semi-solid cu lture systems allowing the 
proliferation and differentiation of progen itor cells 1n vitro, it 
became apparent that growth of these ce lls required the addition of 
6 
certain factors. Such factors were found in media conditioned by 
the growth of various tissues and tumour cell lines. These factors 
vvere originally referred to either as colony stimulating factors 
(CSFs) - to denote the capacity to stimulate precursor cells to 
produce colonies of progeny cells - or by more precise operationai 
terms according to the primary assay by which they were 
characterised. By the early 1980s large numbers of activities had 
been described resulting in a confusing array of names. However, 
improved biochemical analysis of the various complex factor 
sources revealed that many activities were refractory to 
biochemical separation and could probably be attributed to the 
same substance. During the last 5 years, the study of haemopoietic 
growth factors has advanced at a phenomenal pace and the genes 
encoding many of these molecules have been cloned and expressed. 
This has allowed the definitive assignment of particular functions 
to defined molecules and has whittled down the array of 'factors' 
to a more manageable number. 
Table 1 lists seven mouse growth factors active on haemopoietic 
progenitor cells, the other names each factor is knov,n by and the 
investigators responsible for cloning the cDNA for each factor. The 
growth factors are glycoproteins, active at extremely low 
concentrations (10-11 - 10-13M) and exhibit a number of 
activities in addition to their mandatory role in stimulating 
haemopoietic cell proliferation. Thus, they promote the in vitro 
survival and development of the appropriate target cells and , 1n 
some cases, they stimulate important biological functional 
activities of mature cells. 
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Table 1 Mouse haemopoietic growth fact ors 
Growth Factor 
Granulocyte-Macrophage CSF 
(GM-CSF) 
Interleukin 3 (IL-3) 
Granulocyte CSF (G-CSF) 
Macrophage CSF (M-CSF) 
Interleukin 4 (IL-4) 
Interleukin 5 (IL-5) 
Erythropoietin (Epo) 
Othe r acronyms 
MGl-1GM 
Multi-CSF; BPA; 
PSF; MCGF; HCGF; 
E-CSF; MEG-CSF; 
Eo-CSF 
MGl-1G 
MGl-1 M; CSF-1 
BCGF; BSF-1; 
TCGF-11; MCGF-11 
TRF· EDF· Eo-CSF· 
' ' ' 
BCGF-11; IL-4 
cDNAs for these factors were cloned by : 
Ref 
a 
b 
C 
d 
e 
f 
g 
a Gough et al.(1984). b Fung et al. (1984); Yokota et al. (1984) 
c Tsuchiya et al. (1986). d Kawasaki et al., (1985)* 
e Lee et al. (1986). f Kinashi et al. (1986) 
9 McDonald et al. (1986) 
* This report refers to human M-CSF - the cloning of a cDNA 
encoding mouse M-CSF had not been reported at the commencement 
of the work described in this thes is. 
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INTERLEUKIN-3 
Historical perspective 
IL-3 was initially defined by its ab ility to induce the enzyme 20 
alpha-hydroxysteroid dehydrogenase (20a-SDH) in spleen cells 
from athymic nu/nu mice (Ihle et al., 1981). At the time 20a-SDH 
was regarded as a unique marker for T cell maturation so this 
initial characterisation led to the idea that IL-3 may mediate early 
events in T cell differentiation. However, experiments using highly 
specific assays for 20a-SDH have since shown that this enzyme is 
not unique to T-lineage cells (Hape I et al., 1985a). Furthermore, the 
induction of 20a-SDH is not an activity unique to IL-3; both GM-CSF 
and M-CSF maintain high levels of 20a-SDH expression in normal 
macrophages and GM-CSF induces 20a-SDH in nu/nu splenocytes and 
fetal liver cells (Hapel et al. , 1985). Thus , the induction of 20a-
SDH, although a highly sensit ive assay for haemopoietic growth 
factor activity, is not a specific assay for IL-3 and does not imply 
a role for IL-3 in T cell development. 
Based on its 20a-SDH inducing acti vity , IL-3 was purified to 
homogeneity from media cond itioned by WEHl-3 cells (WEHl-3 CM) 
and the amino-term inal sequence of the protein was established 
(Ihle et al., 1983). Using this purif ied preparation it became obvious 
that this factor was active in a variety of assays which were 
thought to detect d ifferent factors . IL-3 not only induced the 
expression of 20a-SDH but also induced increased histamine 
synthesis by bone marrow ce ll s, permitted colony growth from 
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bone marrow ce lls in semi-so lid culture and promoted the 
pro li feration of mast ce lls, pers isting (P) cells and the FDC-P1 cell 
li ne. Thus , IL-3 was demonstrated to have the activities associated 
with histamine-producing cell growth factor (HCGF), colony 
stimu lating factor (CSF), mast ce ll growth factor (MCGF) P cell 
stimulating factor (PSF) and WEHl-3 growth factor, respectively. 
Molecular and biochemical aspects of mouse IL-3 
Clon ing of IL-3 cDNA 
The mouse cDNA for IL-3 was initially cloned by Fung and 
colleagues (1984). Briefly, Poly (A)+ RNA prepared from WEHl-38 
cells was fractionated by sucrose density centrifugation and then 
translated in Xenopus laevis oocytes , The translates were assayed 
for IL-3 activity us ing the IL-3-dependent ce ll line 320 cl-23. RNA 
enriched for IL-3 mRNA was then used to synthesise double 
stranded cDNA. A cDNA clone carrying the entire coding sequence 
for mouse IL-3 was then identified and sequence analysis showed 
that it encoded a polypeptide of 166 am ino acids (Fung et al., 1984). 
At about the same time, Yokota et al. (1984) isolated a cDNA clone 
cod ing for the mouse mast ce ll growth factor (MCGF) activity. The 
MCGF mRNA was isolated from a co ncanavalin A-stimulated mouse 
T ce ll clone and clon ing was ach ieved using the pCD cloning vector 
'Nh ich allows express ion of cDNA inse rts in mammalian cells. The 
nucleotide sequence of MCGF cDNA was identical with that of IL-3 
1 0 
cDNA except for a single nucleotide difference, thus confirming the 
identity of IL-3 and MCGF. 
Based on the assumption that translation begins at the first 
methionine codon, the IL-3 polypeptide includes a hydrophobic 
leader sequence of 27 amino acids. Studies of the mature processed 
IL-3 however, are somewhat confusing. Initially, Ihle (1984) 
reported that the N-terminus commenced at residue 33. Further 
reports have identified a different N-terminus 6 residues ahead of 
the sequence reported by lhle's group (at residue 27) (Clark Lewis 
et al., 1984; Conlon et al., 1985). The shorter form probably results 
from proteolytic cleavage (Clark-Lewis et al., 1984) although it is 
not clear whether this type of processing occurs under 
physiological conditions or is due to adventitious proteolysis 
during purification. Assuming that mature IL-3 begins at residue 
27, it would be 140 amino acids long with an expected Mr of 
15,674. 
Comparison of the predicted amino acid sequence of IL-3 with the 
sequences of GM-CSF (Gough et al., 1984, 1985) , IL-2 (Taniguchi et 
al., 1983) and interferon-y (Gray et al., 1982) has failed to detect 
any significant sequence homology. 
Structure of the IL-3 gene 
The mouse gene has been cloned and sequenced (Campbell et 
al.,1985; Miyatake et al.,1985), revealing a number of features of 
interest. The gene is composed of four intrans and five exons and 
1 1 
the sequence of the exons is in exact agreement with that 
determined for the IL-3 cDNA. lntron 2 contains a tandemly 
repeated sequence made up of 12 similar 14 bp units with a 
consensus sequence AGCTCTCACCTCCC (Campbell et al., 1985). 
These 14 bp repeats share strong homology with a series of 20 bp 
repeats in the human genome which show some enhancer-like 
activity. The mouse IL-3 gene also has a very G-C rich region just 
upstream of the putative TATA box. 
IL-3 genes from other species 
For some time the human gene for IL-3 proved elusive. A number of 
laboratories tried unsuccessfully to isolate the human IL-3 gene by 
cross-hybridisation with its mouse counterpart. This approach did 
however, prove successful for isolating the rat IL-3 gene (Cohen et 
al., 1986). This gene was cloned and sequenced, then expressed in 
monkey COS cells, thus providing recombinant material for study of 
the biological activities of rat IL-3. A comparison of the sequences 
of rat and mouse IL-3 revealed that these genes had evolved 
significantly away from each other resulting in a sequence 
homology of only 54°/o at the protein level. 
Towards the end of 1986, Yang and associates reported the 
identification of the human IL-3 gene. Using expression cloning, 
this group identified an il-3 cDNA from a gibbon T cell line. The 
gibbon cDNA was then used as a hybridisation probe to isolate the 
equivalent human IL-3 gene. As predicted from the difficulties 
encountered with the cross-hybridisation approach, the sequence of 
12 
human IL-3 gene displays unusually low homology with its mouse 
counterpart (29°/o at the amino acid level). 
Notably, whilst there is low homology between the coding regions 
of the mouse, rat and human IL-3 genes, there is a striking 
homology between the exon structures of these genes, suggesting 
that they may have a common evolutionary origin (Cohen et 
al., 1986; Yang et al., 1986) 
Cellular sources of IL-3 
The predominant physiological source of IL-3 appears to be 
antigen- or mitogen- activated T cells, particularly the Lyt2-
L3T 4+ subpopulation which is reponsible for the majority of 
lymphokine production (Miller and Stutman, 1982; Kelso and 
Metcalf, 1985). Mosmann and associates (1986a) have proposed that 
this subpopulation can be further divided into two major groups: 
Type 1 T helper cells produce IL-2, IFN-y, GM-CSF, and IL-3, 
whereas type 2 T helper cells produce GM-CSF, IL-3, IL-4 and IL-5. 
However, the biological significance of these proposed subclasses 
is obscure. Consistent with an activated T cell source for IL-3, an 
IL-3-like activity was found in the serum of mice undergoing 
severe graft versus host disease (Crapper and Schrader, 1986) 
although IL-3 is not detectable in normal serum (Crapper et 
al.,1984). 
The WEHl-38 (D-) myelomonocytic cell line is most notable 
amongst the reported non-T cell sources of IL-3. This cell line 
1 3 
displays constitutive IL-3 production making it an attractive 
source of IL-3 and IL-3 mRNA. Analysis of DNA from WEHl-38 cells 
revealed a genomic rearrangement in the vicinity of the IL-3 gene 
I 
due to the insertion of an intracisternal A type particle upstream 
of the promoter (Ymer et al., 1985). The constitutive synthesis of 
IL-3 by this cell line is thought to be a direct result of this 
rearrangement and therefore does not indicate that IL-3 production 
is a characteristic of normal cells from the myeloid or monocytic 
lineages. 
Other non-T cell sources have been reported to produce an IL-3-like 
activity. Labastie et al. (1984) reported that organ cultures of yolk 
sac require only erythropoietin (Epo) as an external stimulus to 
undergo adult erythropoiesis whereas both Epo and IL-3 must be 
added to cultures of single yolk sac haemiopoietic cells to generate 
adult erythrocytes. This provides indirect evidence that the yolk 
sac itself may produce IL-3, although IL-3 has not yet been purified 
from this source. Epidermal cells produce a factor which induces 
the proliferation of the 'IL-3-dependent' cell lines, 320 and FDC-P 
(Luger et al., 1985). Similarly, astrocytes produce an activity which 
induces the proliferation of 320 cells and the expression of 20a-
SDH in nu/nu splenocytes (Frei et al., 1986). However, the factor(s) 
detected in the latter two studies may not be IL-3 since 'IL-3-
dependent' cell lines will also proliferate in response to other 
growth factors (see below) and numerous factors induce the 
expression of 20a-SDH (as discussed above). Further studies, such 
as Northern analysis to detect specific transcripts for IL-3, are 
required to demonstrate conclusively that yolk sac, epidermal cells 
or astrocytes produce IL-3. 
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Biological activities of IL-3 in vitro 
Action of IL-3 on haemopoietic stem cells 
A direct action of IL-3 on CFU-S has been reported by a number of 
groups. Early experiments by Garland and Crompton (1983), 
revealed that 3 hours culture with IL-3 increased the number of 
CFU-S in S phase as determined by tritiated thymidine killing. 
Later, Spivak and associates (1985) confirmed this action on cell 
cycle and demonstrated that IL-3 maintained the content of CFU-S 
in liquid bone marrow cultures for at least 4 days, whereas in the 
absence of growth factor the number of CFU-S declined to 10 -
15°/o. The effect of IL-3 on S-cells, the progenitors of blast cell 
colonies, has also been investigated. In these studies donor mice 
pretreated with 5 fluoro-uracil (5FU-mice) were used as a source 
of enriched populations of S-cells (Suda et al., 1983). Suda and 
associates found that IL-3 supported the growth of blast cell 
colonies from haemopoietic progenitors in semi-solid cultures of 
spleen cells from 5FU-mice. Serial observations of colony growth 
demonstrated the continuous emergence of blast cell colonies 
suggesting that multipotential progenitors are in a dormant cell-
cycle state for varying times. Delayed addition of IL-3 did not alter 
the proliferative or differentiative characteristics of late 
emerging multipotential blast cell colonies (Suda et al., 1985). 
Together these observations suggest that S-cells do not require IL-
3 for survival and IL-3 does not trigger S-cells into active 
proliferation but is necessary for their continued proliferation. As 
discussed earlier, the relationship of CFU-S to S-cells is not clear 
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although S-cells are believed to be more primitive and perhaps 
representative of the pluripotential stem cell. 
Committed progenitor cells 
In semi-solid bone marrow cell cultures IL-3 supports the 
proliferation and development of CFU-GEMM and committed 
progenitors from the granulocyte/macrophage, eosinophil, 
erythroid and megakaryocyte lineages (Hapel et al., 1985b;Rennick 
et al., 1985). Optimal production of mature erythrocytes requires 
the presence of erythropoietin (Goldwasser, 1975). Similarly, 
although IL-3 supports the early growth of colonies containing 
progenitors of the megakaryocyte lineage, full megakaryocyte 
development to the platelet shedding stage requires thrombopoietin 
(Williams et al., 1984). Although for the most part the activities of 
IL-3 are restricted to myeloid cells, there have been reports that 
IL-3 can maintain precursors of T cells (Ihle et al., 1981) and of B 
cells (Palacios et al., 1984; Palacios and Steinmetz, 1985). However, 
as yet these reports have not been confirmed in other laboratories. 
At the commencement of the work described in this thesis there 
was a paucity of data on the biological activities of rat and gibbon 
IL-3 and as yet no data available concerning the biology of the 
human factor. However, in semi-solid cultures both gibbon IL-3 and 
rat IL-3 were known to support the proliferation of multiple types 
of haemopoietic cells including progenitors of the erythroid lineage 
(Cohen et al., 1986; Yang et al., 1986) suggesting that these factors 
have analogous biological activities to those of mouse IL-3. 
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Mature haemopoietic cells 
IL-3 not only stimulates progenitors for the mast cell lineage but 
is also required for the proliferation and survival of the well-
differentiated functional end cells (Clark-Lewis and 
Schrader, 1981). Moreover, IL-3 opposes the induction of la antigens 
on mucosa! mast cells by interferon y, suggesting that it may 
modulate the function of these cells (Wong et al., 1984). Similarly, 
IL-3 stimulates the functional activation of mature macrophages in 
terms of morphology, phagocytic capacity and prostaglandin E (PGE) 
production, as well as supporting the survival and proliferation of 
these cells in vitro (Crapper et al., 1985). 
Action of IL-3 on haemopoietic cell lines 
A number of cell lines have been generated which are dependent on 
IL-3 for their growth. For example, FDC-P lines were established 
from long-term marrow culture suspension cells by repeated 
subculturing in the presence of IL-3 (Dexter et al., 1980). These 
cells could be maintained as permanently growing cell lines 
provided that IL-3 was continually present in the culture medium. 
When plated in soft agar, the early isolates produced colonies 
containing morphologically recognisable maturing granulocytic 
cells suggesting that FDC-P lines represented granulocytic 
precursor cells. This differentiative capacity has since been lost. 
Indeed, these cell lines have undergone a number of changes since 
their isolation and at least one of these lines, FDC-P1, can now be 
maintained equally well in IL-3 or GM-CSF (Hapel et al., 1984). FDC-
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P1 cells bear the F4/80 antigen suggesting that they may be 
immortalised at some stage of macrophage differentiation. 
The IL-3 dependent 320 cell lines were derived from cultures of 
C3H/HeJ bone marrow using a technique similar to that used to 
derive the FDC-P lines (Greenberger et al., 1983a, 1983b). Cells of 
the 320 cl-23 line are alcian blue positive, placing them in the 
mast cell lineage. These cells can give rise to mast cell/basophil 
colonies in soft agar. Proliferation of 320 cl-23 cells is supported 
by either IL-3 or IL-2 (Hapel et al., 1984). 
Experiments using continuous cell lines have highlighted the 
requirement for IL-3 for the survival of haemopoietic progenitor 
cells. As with normal (freshly isolated) progenitor cells, culture of 
320 or FDC-P cells in the absence of growth factor leads to rapid 
cell death (Whetten and Dexter, 1983; Metcalf, 1985). The 
mechanism by which IL-3 maintains these cells has been 
investigated using FDC-P2 cells as a model. Cells cultured in the 
absence of IL-3 undergo a steady and rapid depletion in ATP levels, 
whereas those in the presence of IL-3 maintain a constant level of 
ATP (Whetten and Dexter, 1983). Furthermore, studies on the rate 
of hexose transport in IL-3 dependent cell lines revealed that 
transport is activated by the addition of IL-3 to the cells (Whetten 
et al.,1984). Thus IL-3 may maintain cell survival via the 
activation of hexose transport, glycolysis and primary n1etabo lism . 
Since IL-3-dependent cell lines repond to IL-3 in a dose dependent 
manner, they provide a useful basis for assays to detect and 
measure biologically active IL-3. Such assays involve either 
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measurements of the incorporation of tritiated thym idine by 
proliferating cells (Hapel et al. , 1984) or spectrophoto metric 
detection of dyes which stain living cells (Mosmann , 1983). The 
availability of these sensitive assays facilitated th e purification 
of IL-3 (Bazil! et al. , 1983) and molecular clon ing of the IL-3 gene 
(Fung et al., 1984). 
Biological activities of IL-3 in vivo 
Whilst there 1s a range of information available on the actions of 
IL-3 in vitro it 1s only recently that enough purified material has 
been available for assessment of its activity in vivo. In one of the 
earliest in vivo studies, osmotic pumps containing recombinant IL-
3 were placed under the skin of normal and sublethally irrad iated 
mice, allowing the continuous infusion of large amounts of IL-3 for 
up to 7 days (Kindler et al., 1986). In mice with progenitor cell 
levels depressed by sublethal irradiation, 7 day treatment with IL-
3 resulted in a return to near normal levels of these cells. In 
normal mice, this treatment resulted in a greater than 2-fold 
increase in numbers of haemopoietic progen itor cells within 3 
days. This enhancement of hematopoiesis occurred primarily 1n the 
spleen and liver, although slight decreases in progenitor levels 1n 
the bone marrow were documented. 
Broadly similar effects on progenitor cells we re observed after a 6 
day regime involving regular intraperitoneal injection of 100,000 
units of IL-3 (Metcalf et al., 1986). In the latter study, up to 100 
fold increases in the levels of mast ce lls were found along with an 
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increased number of morphologically identifiable precursors 
including granulocytes, eosinophils and nucleated erythroid cells. 
The most striking overall population changes were in the peritoneal 
cavity where large increases in numbers of macrophages, 
eosinophils, and neutrophils were observed, probably due at least 1n 
part to an influx of cells from the circulation. In addition, there 
was evidence of increased peritoneal macrophage phagocytic 
activity. 
Exogenous administration of high concentrations of IL-3 also has a 
rapid and profound effect on the cycling status of CFU-S in vivo. 
Lord and associates (1986) reported that administration of IL-3 
resulted in a greater than 2.5 fold increase in the number of CFU-S 
in cycle over a period of 2 - 6 h. In the spleen, both early and late 
appearing CFU-S reached 6 - 8 times control levels after 4 days of 
treatment with IL-3. 
In an attempt to reduce the massive doses of IL-3 required for in 
vivo studies, Broxmeyer and associates (1986) carried out a series 
of experiments using mice pretreated with lactoferrin (LF), a 
material which suppresses release of some hemopoietic growth 
factors and inhibitors in vivo. This pretreatment was designed to 
reduce both the background of normal haemopoiesis and the 
masking effects of growth factor induced release of suppressor 
molecules, thus facilitating the detection of relatively small 
quantities of exogenous~y administered growth factors. Using this 
model, an infusion of 2,000 units of IL-3 was sufficient to enhance 
the cycling status and absolute numbers of all progenitors in the 
bone marrow and to a lesser extent in the spleen. 
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Together these experiments confirm that IL-3 has the ability to act 
on haemopoietic cell populations in vivo. Howevei, considering the 
inherent complexity of in vivo studies it is not possible to 
determine to what extent the reported effects are due to the direct 
action of IL-3 on haemopoietic stem cells and progenitor cells as 
opposed to effects mediated via accessory cells in blood, spleen or 
marrow. 
OTHER HAEMOPOIETIC FACTORS 
This section will briefly review the biology of other haemopoietic 
factors in order to put the activities of IL-3 into a broader 
perspective. 
Growth factors 
In general haemopoietic growth factors are classified either as 
multilineage or lineage-restricted factors. IL-3 is an example of a 
multilineage factor in that it stimulates the proliferation and 
development of cells from all myeloid lineages. Granulocyte-CSF 
(G-CSF), Macrophage-CSF (M-CSF) and erythropoietin (Epo) on the 
other hand are more lineage restricted factors. G-CSF promotes the 
proliferation and development of GM-CFC into neutrophils and 
induces terminal granulocytic differentiation of a subline of the 
myelomonocytic leukemia WEHl-38 [WEHl-3B (D+)] (Nico!a et 
al.,1983). M-CSF acts mainly on the macrophage lineage although it 
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also stimulates a small percentage of granulocyte-containing 
colonies (Burgess et al., 1985) and acts on early progenitor cel ls 1n 
the presence of other factors (see later). Epo promotes the 
proliferation and haemoglobinisation of CFU-E (McDonald et 
al.,1986). 
GM-CSF was initially thought to be restricted in action to GM-CFC. 
However, when assayed at relatively high concentrations, GM-CSF 
can also initiate (but not sustain) cell divisions in multipotential, 
erythroid and megakaryocyte precursors and is an effective 
proliferative stimulus for eosinophils (reviewed in Metcalf, 1986). 
At yet higher concentrations (>800 units/ml), GM-CSF exhibits a 
capacity to stimulate typical megakaryocyte colony formation and 
the formation of mixed erythroid colonies (Metcalf et al., 1986b). 
Thus at high concentrations, GM-CSF apparently mimics many of 
the activities of the multilineage factor, IL-3. 
The activities of IL-3, GM-CSF, G-CSF and M-CSF are apparently 
restricted to stem cells and committed myeloid progenitor cells. 
However, two recently defined growth factors, IL-4 and IL-5, have 
activities on both myeloid and lymphoid cells. IL-4 was first 
characterised as a growth factor for B cells but actually acts on a 
broader range of target cells including some mast cell lines (Lee et 
al., 1986; Mosmann et al., 1986b). Another 8 cell growth factor , IL-5, 
also stimulates differentiation of bone marrow stem cells into 
eosinophils (Sanderson et al., 1986). 
A less well characterised gro'Jvth factor has been isolated from 
long term bone marrow cultures (Lord and Wright, 1980). Th is 
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factor stimulates the proliferation of CFU-S and is produced in 
greater amounts when stem cells are depleted from long term 
cultures (Toksoz et al.,1980). 
Inhibitory factors 
A number of factors apparently have inhibitory rather than 
stimulatory effects on haemopoiesis. For example, the interferons 
(IFN) inhibit growth factor induced mouse myeloid colony formation 
in semi-solid cultures (Kl impel et al., 1982; van't Hull et al., 1978) 
and the E series prostaglandins (PGE) have a potent inhibitory 
effect on monocytopoiesis (Kurland et al., 1978). Since 
macrophages, particularly those stimulated by M-CSF, are a source 
of both PGE and IFN, production of these inhibitors is proposed to 
act as a negative feedback mechanism limiting excessive 
mononuclear phagocyte proliferation (Moore et al., 1984) 
Another inhibitory factor, detected in both normal bone marrow and 
long term bone marrow cell cultures, reversibly suppresses the 
proliferation of CFU-S (Lord et al., 1976; Lord and Wright, 1980) . 
. This factor, together with the CFU-S stimulatory factor described 
in the previous section, may play an important role in the 
regulation of stem cell proliferation in vivo. 
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INTERACTIONS BETWEEN GROWTH FACTORS 
Synergy between growth factors has been demonstrated in a 
number of in vitro systems. In the earliest studies on synergy, 
lscove and colleagues (lscove et al., 1982) reported a requirement 
for both burst promoting activity (BPA, IL-3) and Epo for the 
proliferation and differentiation of primitive red cell precursors 
(BFU-E). BPA also augmented macrophage colony growth in the 
presence of purified M-CSF. lscove proposed that BPA synergises 
with M-CSF and Epo by expanding a population of pluripotent 
haemopoietic precursors and their early committed progeny: M-CSF 
or Epo act on later cells which have acquired the appropriate 
receptors as part of their differentiation programmes. In support 
of this proposal, cells responding synergistically to IL-3 plus M-
CSF are enriched in bone marrow from 5-FU mice, suggesting that 
these cells are early progenitors (Bartelmez et al., 1985; McNiece 
et al., 1984). Recent studies have demonstrated that IL-3 also 
synergises with IL-4 to support the proliferation of mast cell lines 
(Mosmann et al.,1986b). 
Another factor with profound synergistic activities is termed 
hemopoietin-1 (H-1 ). H-1 alone has no effect on haemopoietic cell 
proliferation and is therefore not strictly a haemopoietic growth 
factor. However, H-1 synergises with M-CSF to stimulate 
developmentally early cells to generate M-CSF receptor bearing 
cells. This synergistic activity is apparently restricted to cells 
more primitive than those responsive to M-CSF alone. Stanley and 
associates (1986) demonstrated that H-1 also synergises with IL-
3. In cultures of bone marrow enriched for primitive precursors, a 
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greater total number of colonies and a greater proportion of 
colonies containing blast cells were produced in H-1 plus IL-3 than 
in IL-3 alone. Furthermore, a significant number of the H-1 plus IL-
3 induced colonies could be subcultured 3 times whereas cells from 
IL-3 colonies displayed less proliferative capacity. This suggests 
that H-1 enables IL-3 to act on cells more primitive than those 
stimulated to proliferate and differentiate by IL-3 alone. More 
recent work has shown that H-1 is probably identical with IL-1 
(see Introduction to Chapter 4). 
MEMBRANE RECEPTORS FOR HAEMOPOIETIC GROWTH FACTORS 
Radiolabelled IL-3, GM-CSF, M-CSF, G-CSF and Epo have all been 
shown to bind to specific high affinity cell surface receptors. The 
best characterised of these is the M-CSF receptor which is present 
predominantly on cells of the monocyte/macrophage lineage 
(Guilbert and Stanley, 1980; Byrne et al.,1981; Chen at al.,1984). 
The average number of receptors for M-CSF ranges from 3,000 -
15,000 per cell (Byrne et al., 1986). This receptor is a tyrosine-
specific kinase of Mr 160,000, which autophosphorylates following 
the binding of its ligand (Stanley and Jubinski, 1984). 
Receptors for IL-3 are found on all morpholog ically recognisable 
granulocytic, monocytic and eosinophilic cells and appear to be of 2 
molecular weights - 55,000 and 75,000 (Nicola and Metcalf, 1986; 
Palazynski and Ihle, 1984). The distribution of GM-CSF receptors 1s 
similar to that of the IL-3 receptors (Metcalf, 1986). Walker and 
Burgess (1985) reported the presence of both high and low affinity 
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GM-CSF receptors and determined that the size of at least one of 
these receptors is 51 ,000. However, this data was later challenged 
by Park et al (1986) who found exclusive ly low affinity receptors, 
Mr 130,000, on mouse bone marrow cells. The G-CSF receptor is a 
monomer of Mr 150,000 and is found on mouse granulocytic cells 
and some cells of the monocytic lineage (Nicola and Metcalf, 1985; 
Metcalf, 1986). Epo receptors are apparently restricted to erythroid 
progenitor cells (Krantz and Goldwasser, 1984). 
In contrast to receptors for M-CSF, the average number of IL-3, 
GM-CSF, G-CSF, and Epo receptors on normal cells is in the region 
of only 50-1000 per cell (Metcalf, 1986; Krantz and 
Goldwasser, 1984). Despite these low receptor numbers, half 
maximal proliferative effects can be achieved by G-CSF and GM-
CSF with a receptor occupancy of only 5 - 10°/o (Metcalf, 1985) and 
by Epo with receptor occupation in the region of 1 °/o (Krantz and 
Goldwasser, 1984). Degradation of M-CSF-receptor complexes 
appears to be very rapid (Tushinski et al., 1982) but G-CSF-receptor 
complexes are degraded much more slowly with a half life of at 
least 6 h (Nicola and Metcalf, 1985). This has lead to speculation 
that persistence of growth factor-receptor complexes of the latter 
type may permit sustained response to the factor thus 
compensating for the low absolute number of bound receptors 
(Metcalf, 1985). 
There is no direct competition for receptor binding between IL-3, 
GM-CSF, G-CSF, or M-CSF but a complex set of interactions can 
apparently occur. Walker and associates (1985) found that IL-3 
down-modulated (reduced the number availab le for binding) IL-3, 
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GM-CSF, M-CSF, G-CSF and high affinity GM-CSF receptors but had 
no effect on the low affinity GM-CSF receptors. Similarly , binding 
of GM-CSF to its receptors down-modu lated its o"vn receptor and 
those for G-CSF and M-CSF although it had no effect on the IL-3 
receptor. High concentrations of M-CSF and G-CSF down modulated 
GM-CSF and M-CSF receptors respectively. Since most granulocytes 
and monocytes simultaneously express receptors for at least 3 of 
these factors (Metcalf, 1986), the down-modulation effect 
presumably reflects the responses of individual cells following 
binding of the growth factor to its receptor. However, the 
significance of this phenomena and the apparent hierarchy of 
growth factors remains to be determined. 
BIOLOGICAL ROLE OF IL-3 
The broad range of activities of IL-3 suggests that it plays a 
central role in haemopoiesis. However, since IL-3 is apparently 
produced solely by activated T cells, many investigators have 
proposed that this factor is involved in immunological regulation 
of haemopoietic activity as distinct from constitutive (steady-
state) haemopoiesis. Furthermore, in view of the overlapping 
activities of IL-3 and GM-CSF, IL-3 may be involved principally as 
a mucosa! mast cell factor and as a stimulus to expand the 
precursor pool for cells involved in local antiparasite 
inflammatory responses: GM-CSF, on the other hand, may function 
as a mediator in inflammatory cell hyperplasia involving neutrophil 
and macrophage proliferation and activation following bacterial 
infection. 
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The maJor drawback of these proposals is that IL-3 receptors are 
present on a broad range of haemopoietic progenitor ce !ls vvhich , 1n 
the adult, are restricted mainly to the bone marrow. This is a 
seemingly purposeless situation since these cells are unlikely to 
be exposed to IL-3 produced by activated T cells - IL-3 is detected 
in the serum only under the conditions of widespread T cell 
activation caused by severe graft-versus-host disease. 
An alternative viewpoint stems from studies of in vitro models of 
haemopoiesis. The observation that stromal cells can support 
haemopoiesis in the absence of added growth factors suggests that 
these cells can produce all the growth factor activity required to 
support haemopoietic proliferation and differentiation. 
Significantly however, this range of activities is not detectable 1n 
media conditioned by stromal cells from long term marrow 
cultures. A suggestion which accomodates both these observations 
is that stromal cells produce growth factors such as IL-3 at 
undetectably low levels, perhaps in a membrane bound form which 
1s presented directly to developing haemopoietic cells. This model 
1s supported by the consistent intimate cell associations seen 
between stromal and haemopoietic cells in long term marrow 
cultures. 
AIM OF THIS THESIS 
The biology of IL-3 is obviously complex, involving unique, 
overlapping and synergistic activities and at the present time 
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there are widely differing op1n1ons on the role of this factor 
in vivo. Most of the literature on the biology of IL-3 is based 
on the results of experiments using a few inbred strains of 
mice. However, there is some evidence that the proliferative 
response of bone marrow cells to IL-3, varies according to the 
strain of the donor mice. The initial experiments described 1n 
this thesis were performed to determine the extent of this 
intraspecies variation (Chapter 2). 
Bone marrow cells from two strains of mice, A/J and AKR, 
were found to be particularly unresponsive to IL-3. IL-3 did 
not support colony formation from A/J and AKR cells in soft 
agar cultures but supported a low level of proliferation in 
liquid cultures of these cells. Experiments were then designed 
to test a number of alternative hypotheses which would 
account for these observations (Chapter3). 
These experiments showed that IL-3 had little or no direct 
mitogenic activity on haemopoietic cells from A/J or AKR 
mice. Haemopoietic cells from these strains of mice were then 
used as a novel system to analyse: 
The contribution of the direct mitogenic activity of IL-3 in 
the synergistic response to IL-3 plus M-CSF (Chapter 4); 
The effect of IL-3 on c-fms (M-CSF receptor) RNA expression 
(Chapter 5); 
The synergistic interactions between IL-3 and other 
haemopoietic cytokines, notably erythropoietin , IL-1 and IL-4 
(Chapter 6); and 
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The effect of IL-3 on the synthesis of other haemopoietic 
growth factors in cultures of bone marrow cells. 
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Chapter 2 
Strain-dependent variation in the 
proliferative response to I L-3 
INTRODUCTION 
The biology of mouse IL-3 has been extensively studied 1n 
vitro and it has been shown that IL-3 stimulates the 
proliferation of a broad spectrum of haemopoietic cells 
including pluripotential stem cells and the progenitors of 
granulocytes, macrophages, erythrocytes , megakaryocytes and 
mast cells (reviewed in Chapter 1 ). Most of this experimental 
data has been gleaned from studies using a few inbred strains 
of mice, particulady C57BU6, CSA, and C3H/HeJ. However, at 
least two studies in which the proliferation of bone marrow 
cells from different strains of donor mice was compared, 
indicate that there are variations in IL-3-responsiveness 
(Kincade et al.,1979; Harland et al.,1980.). To determine the 
extent of such intraspecies variation, we compared the 
proliferative activity of IL-3 and other growth factors on 
haemopoietic cells isolated from a range of strains of donor 
mice. The two biological assays we used for this study are 
discussed below. 
Soft agar colony assays 
The first in vitro progenitor cell assays were independently 
reported by Bradley and Metcalf (1966) and Pluznick and Sachs 
(1965). These authors demonstrated that bone marro'N cells 
suspended in semi-solid agar cultures in the presence of 
"feeder cells" or conditioned media proliferated to produce 
discrete colonies. This culture technique now forms the basis 
for in vitro assays used to study the characteristics of colony 
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forming cells and the colony stimulating factors necessary for 
their development. 
The basic soft agar colony assay involves combining equal 
volumes of double strength culture media and liquified O .6°/o 
agar to produce a liquid agar-media mix. The cell suspension to 
be cultured is added to the agar-media and 1 ml aliquots are 
pipetted into 35 mm petri dishes and allowed to set. The 
colony stimulating factors or conditioned media to be tested 
are dispersed in the agar-media before gelling. After the 
required culture period, usually 7-10 days, colonies can be 
scored unstained in situ using a dissecting microscope or can 
be fixed and stained for identification of colony types. The 
colony assays are particularly useful for qualitative 
identification of growth factors since each growth factor 
stimulates the production of a different range of colony types. 
In a modification of the basic technique, we set up our colony 
assays in 12 well leukocyte migration plates rather than 35 
mm petri dishes. This allows us to perform 12 mini assays on 
each plate so that experiments involving large numbers of 
colony assays are more manageable and less costly of 
materials. 
Liquid groliferation assays 
Even with the modification used in our laboratories, co lony 
assays are somewhat cumbersome and time consuming . 
Therefore, for routine detection of growth factor activity, we 
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have developed a 3 day micro-assay based on measurernent of 
[3 H]-thymidine incorporation by proliferating cells in liqu id 
culture. For this assay 1 x1 oS bone marrow cells are incubated 
in 100 µ I cultures in 96 well microtitre plates. After 48 
hours, the cells are pulsed with [3 H]-thymidine overnight (16-
18 hours), subjected to one cycle of freezing and thawing and 
harvested onto glass fibre filters. The incorporated label can 
then be determined by scintillation counting. 
Unlike the soft agar cultures, these assays do not provide data 
on the lineages of the cells stimulated. However, the liquid 
proliferation assays are up to 40 times more sensitive than 
the soft agar colony assays (Hape!, personal communication) 
and allow studies of progenitor cell responsiveness to growth 
factors to be set up both quickly and cheaply. The major 
disadvantage of this technique is the high density of cells 
required which amplifies any effect caused by endogenous 
growth factor or inhibitor production. In addition, because the 
cells are not immobilised in a semi-solid support, results may 
be influenced by direct cell-cell interactions which do not 
occur in the colony assay. 
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rv1ATERIALS AND METHODS 
CHEMICALS AND GRO'NTH FACTORS 
Unless otherwise stated all chemicals were from Sigma 
Chemical Co., St. Louis, Mo., U.S.A. and were of analytical grade. 
Recombinant mouse IL-3 was obtained from Biotechnology 
Australia. The amount of IL-3 stimulating half maximal 
proliferation of FDC-P1 cells in [3 H]-thymidine incorporation 
assays (Hapel et al. 1984) was defined as 1 unit (U). 
Recombinant mouse GM-CSF was obtained from lmmunex Corp. 
Seattle, USA, and affinity purified M-CSF was kindly provided 
by Dr R. Stanley (Albert Einstein College of Medicine, Yeshiva 
University, New York U.S.A.). The amount of GM-CSF or M-CSF 
stimulating half maximal colony numbers from 1 x 1 o4 mouse 
bone marrow cells in 400 µI colony assays (as described 1n 
method 2.3) was defined as 1 U. In some assays media 
conditioned by L929 cells was used as a source of M-CSF. 
Conditioned medium was harvested from 3 day confluent 
cultures of L929 cells in Dulbecco's modified Eagle's medium 
(DMEM; Gibco). All materials used were endotoxin free as 
determined by the Limulus amebocyte lysate assay (ACC Inc., 
MA, USA). 
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METI-ODS 
2.1 Bone marrow cell preparation 
A-TL and A-TH mice were obtained from the Walter and Eliza 
Hall Institute of Medical Research, Melbourne. All other mice 
were obtained from the Animal Breeding Establishment, 
JCSMR, ANU. Age and sex matched mice in the range of 8-15 
weeks were killed and their femurs were removed by 
dissection using alcohol sterilized instruments. RPMl-1640 
(CSL) containing 10°/o fetal calf serum(FCS) (Hybriserum,CSL) 
was forced through femur shafts using a syringe fitted with a 
23 gauge needle. Marrow plugs were collected in a sterile 
plastic tube and converted to a dispersed cell suspension by 
gently aspirating up and down approximately 20 times using a 
5 or 10 ml pipette. Viable nucleated cell counts were 
determined on the basis of trypan blue exclusion using a 
hemocytometer. Cells were then pelleted at 200 x g for 1 O 
mins and resuspended to the required cell density in RPMI 
containing 1 Oo/o FCS (RPMl-10°/o FCS). 
2.2 Foetal liver cell preparation 
Foetal livers were removed from AKR, A/J and DBA/2 mice at 
14 days gestation using alcohol sterilised dissecting 
instruments. Livers were disaggregated in RPMl-1 Oo/oFCS by 
gently aspirating them up and do\vn using a pasteur pipette. 
Cells were then counted and resuspended to the required cell 
density as in method 2.1. 
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2.3 Bone marrow colony assays 
Colony assays were performed using 12 well leukocyte 
migration plates (Sterilin). Each plate was placed in a petri 
dish and the required growth factors were pipetted into each 
well. Saturating doses of all growth factors (determined by 
titration) were used except where otherwise stated. Total 
volume of growth factors used for each well was usually 
between 1 O and 80 µI. For each plate (12 wells), 6 mis of 
0.33°/o agar medium and cell suspension was prepared as 
follows. 1.32°/o agar (Difeo Laboratories Inc.) was melted by 
heating in a microwave oven and allowed to cool to 400C in a 
water bath for 1-3 hours before use. Double strength RPMl-
1640 (1 .5 mis) was mixed with 1 .5 mis of melted 1 .32°/o . 
agar, 1.8 mis of FCS and 0.6 mis of 10°/o BSA in RPMl-1640 
supplemented with 0.04 volumes of 25 µm 2-mercaptoethanol 
(BDH Chemicals Ltd.) in So/o NaHC03. This mixture was then held 
at 370 C until the addition of 0.6 mis of bone marrow cell 
suspension at 2.5 x 1 as cells/ml. Aliquots (0.4 mis, containing 
1 x 1 o4 cells) of the cell suspension in agar medium were 
pipetted into each well using a gentle stirring action to mix 1n 
the growth factors. To prevent the cultures from drying out, a 
small volume of water - sufficient to cover the base of the 
dish but not to wet the cultures - was added to the petri dish. 
The cultures were allowed to gel at room tempeiature, then 
incubated at 370c in a humidified 5°/o CO2 · atmosphere. Colonies 
(>50 cells) were scored after 7 days using a stereo dissecting 
microscope. 
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2.4. Bone marrow cell liquid proliferation assays 
In liquid culture bone marrow cell assays, incorporation of 
[3 H]-thymidine was used as a measure of cell proliferation. 
Serial two-fold dilutions of the sample to be tested were 
incubated with 1 x1 as freshly isolated bone marrow cells 1n 
100 µI of RPMl-10°/o FCS in 96 well microtitre plates 
(Nunclon). The starting concentrations (concentrations of 
factors in the first wells) of the growth factors used were as 
follows: IL-3, 250 U/ml; GM-CSF, 50 U/ml; M-CSF, 200 U/ml. 
Assays were incubated for 48 hours in a humidified, 5°/o CO2 
atmosphere. Cultures were pulsed for 18 hours using 0.5 µCi 
[3H]-thymidine and subjected to one cycle of freezing and 
thawing before harvesting onto glass fibre filters (Titerteck) 
using a Titerteck cell harvester. Incorporated label was 
determined by scintillation counting. 
2.5 Foetal liver cell liquid proliferation assays 
Assays were carried out essentially as described in method 
2.4 except that foetal liver cell assays were incubated for 72 
hours prior to pulsing _ and harvesting. 
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RESULTS 
Strain·dependent differences in the response of bone 
marrow cells to IL-3 
A. COLONY ASSAYS 
Freshly isolated mouse bone marrow cells (method 2.1) from a 
range of strains were plated in soft agar cultures with IL-3 or 
M-CSF (method 2.3) and the number of colonies produced was 
scored 7 days later. The number of colonies supported by M-
CSF was similar regardless of the strain of the donor mouse 
(table 2.1 ). However, there was considerable strain-dependent 
variation in the proliferative response of bone marrow cells to 
IL-3. Bone marrow cells from AKR and the A-derived strain, 
A/J, did not produce colonies in response to IL-3 although they 
responded normally to M-CSF. In occasional assays, numerous 
small clusters, usually consisting of <20 cells, were produced 
by A/J and AKR bone marrow cells in the presence of IL-3 
Search for linkage between IL-3 responsiveness and genes 
within the H-2 complex 
This experiment was designed to analyse whether the low IL-3 
response detected in A/J and AKR mice is controlled by a 
gene(s) within or linked to the H-2 complex. The response to 
IL-3 of bone marrow cells from strains with identical 
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Table 2.1 Effect of IL-3 and M-CSF on colony formation by 
bone marrow cells from different mouse strains 
MOUSE STRAIN 
C5781/6 
BALB/c 
C3H/HeJ 
A/ J 
AKA 
NUMBER OF COLONIES 
IL-3 
23 ±4 
11 ± 1 
31 ± 8 
· O 
0 
M-CSF 
23 ± 6 
18 ± 2 
NT 
18::.4 
18 ±. 4 
Bone marrow cells were plated on colony assays with IL-3 
(200U/ml) or M-CSF (200U/ml). Data represents the mean+ SD 
of the number of colonies in triplicate cultures each containing 
1 x 104 cells. NT, not tested. 
haplotypes to those of A/J or AKR was assayed. Congenic 
strains were also tested to allow more accurate localisation 
of any linkage found. Bone marrow cells from each strain were 
cultured in soft agar (method 2.3) with IL-3 and the number of 
colonies produced was scored 7 days later. Cultures with M-
CSF were set up in parallel as controls. Bone marrow cells 
from AKA, A/J and the congenic strains A.TH and A.TL failed to 
produce colonies in response to IL-3. In contrast, IL-3 
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supported colony formation from CBA (same H-2 haplotype and 
Tia type as AKR) and from 81 O.A (same H-2 haplotype and Tia 
type as A/J) bone marrow cells (Table 2.2). Therefore, H-2 and 
H-2-linked loci are not apparently involved in IL-3-
responsiveness. Since both A/J and AKA mice are C5 deficient, 
the possibility that CS deficiency is linked with low IL-3 
responsiveness was also tested. Bone marrow cells from 
DBA/1, another CS deficient strain, were assayed for response 
to IL-3 in colony assays as above. In contrast to A/J and AKR 
bone marrow cells, DBA/1 cells produced colonies in response 
to IL-3 indicating that CS deficiency is not correlated with IL-
3 response. 
B. LIQUID PROLIFERATION ASSAYS 
Freshly isolated mouse bone marrow cells (method 2.1) from a 
range of strains were plated in liquid proliferation assays 
with serial dilutions of IL-3 (method 2.4). The results of these 
assays reveal the same general pattern of strain-dependent 
IL-3-responsiveness observed in the colony assays (Fig 2.1 ). 
However, in this assay system bone marrow cells from A/J and 
AKA proliferated to a limited extent in the presence of IL-3. 
Further liquid proliferation assays were set up using DBA/2, 
BALB/c, and A/J bone marrow cells in the presence of IL-3, 
GM-CSF, or M-CSF. A/J and BALB/c bone marro~, cells were 
indistinguishable in their response to both M-CSF and GM-CSF 
(Table 2.3). However, IL-3 induced a much greater response 1n 
BALB/c than in A/J bone marrow cells . The maximum [3H]-
39 
Table 2.2 Effect of H-2 haplotype and Tia type on the 
respo nse of bone marrow ce ll s to IL-3 
STRAIN 
08A/1 
C8A 
810.A 
81 O.A(2R) 
81 O.A(SR) 
81 O.T(6R) 
A/J 
A.TH 
A.TL 
AKA 
H-2 
Haplotype 
q 
k 
a 
h2 
jS 
y2 
a 
t1 
t2 
k 
Origin of 
H-2 Reg ions Tia 
K D type 
q q q b 
k k k b 
k k.d d a 
k k.d b b 
k b.k.d d a 
q q d a 
k k.d d a 
s s d a 
s k d C 
k k k b 
Colony Number 
IL-3 M-CSF 
37 20 
28 NT 
1 9 9 
30 1 5 
26 1 6 
29 27 
0 20 
0 22 
0 21 
0 1 6 
Bone marrow cells were plated in colony assays with saturating 
doses of IL-3 (200U/ml). Assays containing M-CSF (200U/ml) 
were set up in parallel. Data represents the mean of the number 
of colonies in triplicate cultures each containing lx 1 o4 cells. 
NT, not tested 
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Fig 2.1 Effect of IL-3 on the oroliferation of bone marrow 
cells from different mouse strains 
Bone marrow cells from a range of mouse strains were 
cultured in serial two-fold dilutions of IL-3 (starting 
concentration, 250U/ml) for 2 days (method 2.4) and then 
pulsed for 18 h with [3 H]-thymidine. Results represent the 
mean uptake of [3 H]-thymidine in triplicate assays. 
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thymidine incorporation by bone marrow cells from these two 
strains in IL-3 was significantly different (p < 0.001) 
according to the Students t test. Similarly, the proliferative 
response induced by IL-3 was significantly greater in DBA/2 
than BALB/c bone marrow cells (p < 0.001) whereas there was 
no significant difference between these strains in response to 
GM-CSF or M-CSF. 
Table 2.3 Effect of IL-3, GM-CSF and M-CSF on the 
proliferation of bone marrow cells from different mouse 
strains 
Tritiated Thymidine Incorporation 
FACTOR DBA/2 BALB/c A/ J 
IL-3 117.8 ± 10.2 53.7 ± 6.3 18.3 ± 8.8 
GM-CSF 65.1 ± 6.9 57.4 ± 8.7 46.6 ± 3.0 
M-CSF 14.4 ± 4.2 11.6 ± 1.4 13.6±1.2 
None 5.7 ± 0.8 3.6 ± 0.5 4.0 ± 0.5 
Bone marrow cells were cultured at 1 x 106 cells/ml for 2 days 
in IL-3 (200 U/ml), GM-CSF (40 U/ml) or M-CSF (200 U/ml). 
Cultures were pulsed with [3H]-thymidine, harvested and 
counted as described in method 2.5. Data represents the mean + 
SD of [3H]-thymidine incorporation (cpm x 1 o3) in 6 replicate 
wells. 
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Strain-dependent differences in the response of 
foetal liver cells to IL-3 
Liquid proliferation assays (method 2.5) were also carried out 
using cells isolated from 14 day DBA/2, A/J, and AKA foetal 
livers (method 2.2) in the presence of IL-3 or GM-CSF. A/J 
cells responded well to GM-CSF but were relatively poor 
responders to IL-3 (Fig 2.2). Similar results were obtained 
with AKR cells (data not presented). DBA/2 cells however, 
responded well to both IL-3 and GM-CSF. 
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Fig 2.2 Effect of IL-3 and GM-CSF on the proliferation of A/J 
and DBA/2 foetal liver cells 
(A) , A/J and (B), DBA/2 foetal liver cells were cultured in 
serial two-fold dilutions of IL-3 (filled circles) or GM-CSF 
(open circles). Starting concentration of IL-3 was 250 U/ml. 
Starting concentration of GM-CSF was 50 U/ml. Assays were 
incubated for 72 h prior to an 18 h pulse with [3H]-thymidine. 
Results represent the mean uptake of [3H]-thymidine in 
triplicate assays. 
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DISCUSSION 
The results of in vitro assays revealed that the response of 
bone marrow cells to IL-3 varied according to the strain of the 
donor mouse, such that donor strains can be arbitrarily 
classified as low, middle, or high responders. C3H, CBA, and 
C57BU6, the strains commonly used in studies characterising 
the biological activities of IL-3, were middle to high 
responders to IL-3 in soft agar cultures. In contrast, AKR and 
the A-derived strains rarely produced any colonies in response 
to IL-3 although a few cell clusters were sometimes observed 
1n these assays. The results from liquid proliferation assays 
revealed the same pattern of IL-3 responsiveness; using this 
assay system however, a low level of proliferation was 
detected in A/J and AKR bone marrow cells cultured in the 
presence of IL-3 (The apparent discrepancy between the 
results from these two assay systems is discussed and 
investigated in Chapter 3). In both assay systems A/J and AKR 
bone marrow cells responded well to other growth factors. 
The variation in response to IL-3 suggests that bone marrow 
cells from different strains may express quantitatively or 
qualitatively different IL-3 receptors. In a proposal to explain 
the rapid evolution of the IL-3 gene between species, Cohen 
(1986) suggested that the IL-3 receptor may function as a 
histocompatibility antigen and as such would be evolving quite 
rapidly in line with other such antigens. This proposal would 
also explain the differences in response to IL-3 between 
mouse strains. The IL-3 receptor is unlikely to be a classical 
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H-2 antigen because these antigens are present on all ce ll 
types (reviewed in Mellor, 1986) whereas expression of the IL-
3 receptor is probably restricted to haemopoietic cells (N ico la 
and Metcalf, 1986). In contrast, the related Class 1 
polypeptides encoded by genes in the Qa and Tia regions of the 
H-2 complex have been detected primarily on cells of 
hemopoietic lineage (Mellor, 1986). Therefore, the gene for the 
IL-3 receptor may be one of a number of genes in these regions 
which are actively transcribed but whose polypeptide products 
have not yet been identified. However, the data reported in this 
chapter indicate that the level of response to IL-3 is not 
correlated with H-2 haplotype or Tia type, strongly suggesting 
that IL-3-responsiveness is not controlled by gene(s) within 
the H-2 complex. 
Other groups (Kincade et al., 1979; Harland et al., 1980) have 
reported that bone marrow cells from NZB and RF mice produce 
an abnormally low number of colonies in soft agar cu ltures 
containing WEHl-38 CM (a source of IL-3). In common with AKR 
mice, both NZB and RF mice have a high incidence of 
spontaneous leukaemias. Harland et al.(1980) suggested that 
this propensity for the development of leukaemias is linked 
with the low proliferative response to IL-3. Consistent with 
this proposal, Chevalier and co-workers (1974) showed that 
bone marrow cells from leukaemic AKR mice have a reduced 
response to a crude CSF preparation compared with age-
matched non-leukaemic AKR mice. However, the abnormal IL-3 
response reported here is obvious even in haemopoietic cel ls 
isolated from 14 day AKR foetal livers, whereas the onset of 
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leukaemias in this strain usually occurs at > 6 months of age 
suggesting that this disease is not directly responsible for the 
low IL-3 response observed. AKR and the A-derived strains are 
CS deficient but this is also unlikely to be a direct cause of 
their low IL-3 response since another CS deficient strain, 
DBA/2, is highly responsive to IL-3. 
Finally, a number of studies have documented a defect in 
macrophages from mice of the A/J strain . For example, such 
macrophages do not acquire tumoricidal competence as do 
macrophages from other mouse strains (e.g. CS7BU6) after 
treatment with recombinant interferon-y (Hamilton et 
al., 1986). However, further work is required to determine 
whether the abnormalities in IFN-y and IL-3 responses in this 
strain are related. 
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Chapter 3 
Analysis of the mitogenic activity of IL-3 
on A/J and AKR bone marrow cells. 
INTRODUCTION 
The low levels of IL-3-induced proliferation in liquid assays of 
A/J and AKR cells suggested that bone marrow from these strains 
does contain IL-3-responsive cells. Why then were IL-3-responsive 
colony-forming-cells (CFCs) not detectable in soft agar assays? On 
the basis of the known biology of IL-3, together with the 
observations on the behaviour of A/J and AKR cells in liquid and 
soft agar cultures, the following explanations were proposed: 
1. A/J and AKR bone marrow contains an unusually small 
population of IL-3-responsive cells: These cells 
nevertheless proliferate normally in response to IL-3. The 
relatively large number of cells used for each well of the liquid 
assay would explain why it was possible to detect the 
proliferation of cells comprising this proposed rare population in 
liquid culture but not in soft agar cultures. 
2. A/J and AKR IL-3 receptors recognise autologous IL-3 
but not the BALB/c derived IL-3 used routinely in our 
assays. In support of this proposal, IL-3 has evolved suprisingly 
rapidly between species; for example, the amino acid homology 
between rat and mouse IL-3 is only 54°/o (Cohen et al., i 986.). This 
low homology is reflected in low cross-species reactivity in 
biological assays, indicating that IL-3 and its receptor have 
evolved in concert. There is also evidence of strain-specific 
differences in the amino acid sequence of mouse IL-3 (Campbell et 
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al., 1987.). Therefore the IL-3 produced by A/J and AKA may have 
evolved significantly away from the BALB/c derived recombinant 
IL-3, resulting in such low cross-strain reactivity that the 
proliferative response is detectable only in the more sensitive 
liquid culture assay. 
3. A/J and AKR bone marrow cells do not possess IL-3 
receptors. If this is the case, the small proliferative response 
apparently induced by IL-3 in liquid cultures of A/J and AKA bone 
marrow cells must be an artefact caused by some mechanism other 
than the interaction of IL-3 with its receptor. 
4. A/J and AKR bone marrow cells do not proliferate in 
response to IL-3 _ the low level of proliferation observed 
in liquid cultures is indirectly induced perhaps via 
stimulation of endogenous growth factor production. This 
would explain the disparity between liquid and soft agar cultures 
as the . indirect effects would be cell density dependent and 
therefore most likely to be detected in the liquid proliferation 
assays. 
5. A/J and AKR bone marrow cells produce excessive 
levels of factors which inhibit haemopoietic 
proliferation. Since A/J and AKA cells responded normally to GM-
CSF and M-CSF, it follows that the proposed inhibitor is induced by 
IL-3 but not by other growth factors and/or that the inhibitor 
specifically antagonises IL-3-induced proliferation. Possibly, the 3 
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day culture period used for the liquid assays allows detection of 
IL-3-induced proliferation before the optimal concentration of 
inhibitor has been reached. The small necrotic co!onies often 
detected in 7 day soft agar cultures of A/J and AKR cells may 
reflect this early proliferation prior to complete inhibition of the 
response to IL-3. 
The experiments described in this chapter were designed to 
investigate each of these five possibilities. In addition, the 
inheritance pattern of the IL-3 responsive trait was investigated 
in an attempt to determine the relationship between the defects in 
A/J and AKR mice. 
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MATERIALS AND METHODS 
CHEMICALS AND GROVVTH FACTORS 
Chemicals and growth factors used were as described in Chapter 2 
unless otherwise stated. WEHl-38 cond itioned medium (CM) was 
prepared by cu lturing WEHl-38 cells in RPMl-5°/oFCS at an initial 
density of 1 o6cells/ml for 48 h. Radioiodinated IL-3, specific 
radioactivity 60,000 cpm/ng, was kindly provided by N.Nicola (The 
Walter and Eliza Hall Institute of Medical Research, Victoria) 
MEll-lODS 
3.1 Bone marrow cell preculture 
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Freshly isolated bone marrow cells (method 2.1) were plated at 
1x106/ml in 5 ml RPMl-10°/oFCS in the presence of IL-3 (200U/ml) 
in 35 mm diameter wells (Costar). Bone marrow cells were plated 
without added growth factors as a control. Cultures were incubated 
at 370c in a humidified 5°/o CO2 atmosphere. After 48hrs, non-
adherent cells were harvested and then washed extensively by 
pelleting and resuspending 3 times in 50ml RPMl-10°/oFCS. 
3.2 Production of AKA spleen cell cond itioned medium 
Spleens were removed from 3 AKR mice, flushed with .10 mis of 
RPMl-5°/oFCS and minced using curved scissors. Single cell 
suspensions were prepared by repeated pipetting and the majority 
of the debris were removed by passing the resulting cell 
suspension through a fine mesh sieve. Cells were incubated at 
1x106/ml in 2µg/ml concanavalin A (Pharmacia) in RPMl-5°/oFCS at 
370c in a humidified 5°/o CO2 atmosphere; after 48 hours the 
conditioned medium (CM) was harvested and centrifuged at 400 x g 
for 15 mins to remove cells and debris. The CM was then 
concentrated 5 times using an Amicon stirred cell concentrator 
(Molecular weight cut-off, 10 kd; Am icon Corp.) and dialysed 
against 0.01 M phosphate buffer pH 7 .2 (starting buffer). 
3.3 Partial purification of AKA IL-3 
IL-3 was partially purified from the CM on the basis that in low 
salt buffer at neutral pH, IL-3 does not bind to DEAE-Sephacel and 
can thus be rapidly separated from the bulk of the protein including 
GM-CSF (Ihle et al.,1981). The concentrated and dialysed CM was 
loaded onto a DEAE-Sephacel (Pharmacia ) column which had been 
equilibrated with starting buffer. The unbound proteins were then 
eluted in the run through fractions with starting buffer. The 
remaining material was eluted with 0.01 M phosphate buffer + 
0.03M NaCl. 2ml fractions were collected, dialysed and assayed for 
growth promoting activity on the IL-3-responsive cell lines, 320 
cl-23 and FDC-P1 (method 3.4). Peak IL-3 containing fractions 
were combined, concentrated 5 times using an Amicon B15 
concentrator, dialysed against PBS and stored at 40c prior to 
assay. 
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3.4 320 cl-23 and FOC-P1 proliferation assay 
The factor dependent cell lines 320 cl-23 and FDC-P1 were 
maintained in RPMl-5°/oFCS supplemented with 30°/o WEHl-38 CM. 
Immediately before use, the cells were washed 3 times by 
pelleting at 200 x g for 10 min and resuspending in 50 ml fresh 
RPMl-5°/oFCS. Assays were performed by incubating serial two-fold 
dilutions of the sample to be tested with 2 x 1 o4 washed cells 1n 
100 µI of RPMl-10°/oFCS in 96 well microtitre plates (Nunclon) 
(Hapel et al., 1984.) After overnight incubation at 370c, cultures 
were pulsed with 0.5 µCi [3 H]-thymidine for 6 hours before 
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harvesting cells onto glass fibre filters. Incorporated label, 
determined by scintillation counting, was used as a measure of cell 
proliferation. Proliferation of 320 cl-23 cells indicates the 
presence of IL-3 or IL-2; proliferation of FDC-P1 cells indicates 
the presence of IL-3 or GM-CSF (Hapel et al., 1984). 
3.5 Binding of radioiodinated IL-3 to bone marrow cells 
For single time point analysis of binding of [1 251]-IL-3 to bone 
marrow cells, cells were prepared from A/J, BALB/c and C57BI 
mice (method 2.1). 1 x 107 bone marrow cells were incubated in a 
total volume of 65 µI of RPMl-1 Oo/oFCS in 20 mM Hepes pH 7.4 with 
90,000 cpm [1251]-IL-3 with or without 750ng/ml unlabelled IL-3 
for 20 min at 370c. The cell suspensions were layered over 200 µI 
FCS in small flexible centrifuge tubes (0.5 ml) on ice and 
centrifuged at 700 x g for 5 min at 40c. The supernatant \Vas 
removed by aspiration and discarded. The tips of the tubes 
containing the pelleted cells were then cut with a scalpel blade 
and the pellet was counted in a gamma counter. Specific binding 
was calculated as total binding minus that in the presence of 
excess unlabelled IL-3. 
Analysis of binding of [1251]-IL-3 to bone marrow cells at various 
time points was performed using A/J and DBA/2 bone marrow 
cells. 1.6 x 1 o7 bone marrow cells in 400 µI of RPMl-10°/oFCS were 
incubated with approximately 150,000 cpm [1 251]-IL-3 with or 
without 750 ng/ml unlabelled IL-3 at 370c. At the indicated times, 
50 µI samples of the cell suspension were taken. The cells in these 
samples were pelleted and counted as above. 
3.6 Time course of tritiated thymidine incorporation ,n liquid bone 
marrow cell proliferation assays 
These assays are a modification of the single time point liquid 
proliferation a~says described in method 2.4. For the time course, 
1 x 1 oS or 1 x 1 o4 freshly isolated bone marrow cells were 
incubated in 100 µI of RPMl-10°/oFCS in the presence or absence of 
200 U/ml IL-3 for 2, 4, or 6 days, then pulsed , harvested and 
counted as described in method 2.4. 
3. 7 Production of A/J and DBA/2 bone marro'N cell conditioned 
media 
A/J and DBA/2 bone marrow cells were cultured at 1x106/ml in 
the presence of IL-3 (200U/ml) in RPMl-5°/oFCS at 370c in a 
humidified 5°/o CO2 atmosphere. After 48 hours the CM were 
harvested and centrifuged at 400 x g for 15 min to remove cells 
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and debris. The CMs were then concentrated 5 times using an 
amicon stirred cell concentrator, dialysed overnight against PBS 
(pH 7.4) and filtered through Amicon 0.2µm filters. Samples were 
stored at 40c prior to assay. 
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RESULTS 
In vitro selection of IL-3-responsive cells 
This experiment was designed to determine whether a rare 
population of IL-3-responsive colony-forming-cells (CFCs) could 
be expanded from A/J or AKR bone marrow by preculture with IL-3. 
For comparison, the effect of such preculture on the population of 
IL-3-responsive CFCs present in DBA/2 bone marrow was also 
assessed. Freshly isolated cells from each strain were plated in 
colony assays with IL-3 (method 2.3). The remaining cells were 
precultured (method 3.1) for 6 days in IL-3 before plating in the 
colony assays. The mean number of colonies produced from 1 x 1 o4 
fresh DBA/2 cells in triplicate assays was 27. After 6 days 
preculture with IL-3 however, the mean number of colonies 
produced per 1 o4 DBA/2 bone marrow cells increased to 173. In 
contrast, even after preculture, A/J and AKR bone marrow cells did 
not produce colonies in response to IL-3 suggesting that bone 
marrow from these strains does not contain cells which 
proliferate normally ,n response to IL-3. 
Partial purification and assay of AKA IL-3 
A. Partial purification of AKR IL-3 
AKR spleen cell CM (method 3.2) was fractionated by ion exchange 
chromatography using DEAE-Sephacel (method 3.3). A total of 36 
fractions were collected from the column, dialysed against PBS (pH 
7.4) and assayed on 320 cl-23 and FDC-P1 cells (method 3.4). The 
resulting column profile revealed two peaks of FDC-P1 
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proliferative activity (Fig 3.1 ). The first peak has the 
characteristics of IL-3 since it was eluted using low salt buffer 
and had activity on both FDC-P1 and 320 cl-23 cells. The majority 
of the second peak of FDC-P1 activity is probably GM-CSF although 
a small 'blip' of activity on 320 cl-23 cells indicates that some 
residual IL-3 may also be present. 
Column fractions with peak IL-3 activity were pooled and tl1is 
pooled material was concentrated 5 times and dialysed against PBS 
(pH 7.4) before testing in bone marrow liquid proliferation assays. 
B. Assay of AKR IL-3 
Next the proliferative activity of the AKA derived IL-3 was 
assayed on AKR and DBA/2 bone marrow cells in liquid cultures 
(method 2.3). BALB/c derived rll-3 was assayed in parallel. As 
shown in Fig 3.2, AKR IL-3 had little activity on AKR bone marrow 
cells. The activity of AKR IL-3 on both DBA/2 and AKR bone marrow 
cells was equivalent to approx 125 U of rll-3. 
Binding of radioiodinated IL-3 to A/J bone marrow cells 
Single time point analysis of the binding of [1 251]-IL-3 to A/J bone 
marrow cells was performed (method 3.5) to determine whether 
these cells possess receptors for IL-3. The binding of [1251]-IL-3 
to BALB/c and C57BI bone marrow cells was also analysed for 
comparison. A/J, BALB/c and C5781 cells bound [1251]-IL-3 (Table 
3.1) although the level of [1251]-IL-3 bound differed between the 
strains: C5781 cells bound the most [1 251]-IL-3 whereas A/J cells 
bound the least. 
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Fig 3.1 Separation of AKR conditioned media (CM) by DEAE-
Sephacel chromatography 
CM from concanavalin A stimulated AKA spleen cells was 
concentrated 5 times and dialysed against 0.01 M phosphate 
buffer (PB). Five millilitres of this concentrated CM was 
applied to a DEAE-Sephacel column which had been equilibrated 
with starting buffer. Unbound material was eluted with PB. 
Fractions were collected at a rate of 20ml/h with 
2ml/fraction. After 22 fractions had been collected the column 
buffer was changed to PB + 0.3M NaCl and a further 12 
fractions were collected. 
The column fractions were dialysed and assayed for growth 
promoting activity on the IL-3-responsive cell lines, 320 cl-
23 and FDC-P1 (method 3.4). 320 cl-23 (open circles) and FDC-
P1 (closed circles) growth promoting activity is represented 
as the tritiated thymidine incorporation (cpm x 1 o-3) 
stimulated by a 1 in 8 dilution of the dialysed fraction. 
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Fig 3.2 Proliferative activity of IL-3 isolated from AKR 
spleen cell conditioned medium 
Dose response curves for two-fold serial dilutions of AKR IL-3 
( ) and BALB/c derived rll-3 (------) assayed against AKR 
(circles) and DBA/2 (diamonds) bone marrow cells (method 
2.4). Preparation of AKR ll-3 is described in the text. 
Concentration of BALB/c derived rll-3 was 125 U/ml. Results 
represent the mean uptake of tritiated thymidine in triplicate 
assays. 
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Table 3.1 Single time point analysis of binding of radio iodinated 
IL-3 to bone marrow cells 
Bone Marrow Cells 
A/ J 
BALB/c 
C57BI 
Specific Binding 
2010±.23 
4834 ± 273 
7225 ± 137 
1 x 107 cells were incubated with [125r]-IL-3 (90,000 cpm) with or 
without unlabelled IL-3 (750 ng/ml) at 370c for 20 min. Mean 
specific binding (total binding minus that in competed samples) and 
the range in duplicate tubes is shown. This data was generated in 
collaboration with Dr N. Nicola, The Walter and Eliza Hall Institute of 
Medical Research, Victoria. 
The binding of [1 251]-IL-3 to A/J bone marrow cells was also 
analysed at various time points (method 3.5). DBA/2 bone marrow 
cells were used for comparison. The maximum counts bound by 
DBA/2 cells was greater than the maximum counts bound by A/J 
cells (Fig 3.3) 
Analysis of cell density dependent effects in A/J cultures 
This experiment was designed to examine in more detail the small 
IL-3-induced proliferation observed in liquid cultures of A/J bone 
marrow cells and to analyse whether this response is directly or 
Fig 3.3 Analysis of binding of radioiodinated IL-3 to bone 
marrow cells at various time points 
A/J (open circles) or DBA/2(closed circles) bone marrow cells 
were incubated at 4 x 10 7 /ml in volumes of 400µ1 with [1 251]-
IL-3 (150,000cpm) with or without unlabelled IL-3 (750 
ng/ml) at 370 C. Approximately 2 x 106 cells were sampled for 
each time point. 
• 
16 DBA/2 
~· ~ N 
I e 
/ 0 .... )( 
E 12 -/ a. 
0 
'-" 
'l:J 
C 
:::, 
0 
.c 
~ A/J 
-
- 8 C o_,,.,,,,-o 0 0 0 
·-'t-
·- I 0 Cl) a. 
0) 0 
t'") 
I 
...J 
-I 4 ,--, 
-LO 
N 
.... 
.__, 
32 64 96 128 
Incubation time (min) 
indirectly induced by IL-3. A time course liquid proliferation assay 
was set up (method 3.6) using DBA/2, BALB/c, and A/J bone 
marrow cells at normal cell density (1x106/ml) or lovv cell density 
( 1 x 1 oS/ml) in IL-3. The level of proliferation of DBA/2 and BALB/c 
cells, both at normal and low cell density, increased over the time 
course (Fig 3.4a and 3.4b) suggesting that the IL-3-responsive cell 
populations from both these strains were expanded during culture 
in IL-3. In contrast, the proliferation of A/J bone marrow cells, at 
normal cell density fell slightly over the time course (Fig 3.4a). 
This observation supports the conclusion drawn earlier in this 
Chapter, that A/J bone marrow does not contain IL-3-responsive 
cells which can be expanded by in vitro culture in IL-3. Most 
significantly, when A/J bone marrow cells were plated at low cell 
density, no more than background proliferation was observed (Fig 
3.4b). The results from this experiment are thus consistent with 
the hypothesis that IL-3 has no direct proliferative effect on A/J 
cells and that the low level of proliferation observed in liquid 
culture assays performed at normal cell density is most likely due 
to endogenous growth factor(s) production induced by IL-3. 
Analysis of A/J bone marrow cell conditioned media 
A. Inhibitory activity 
Media conditioned by A/J bone marrow cells, cultured in the 
presence of IL-3 was assayed for inhibitory effect on the IL-3-
induced proliferation of DBA/2 bone marrow cells. Media 
conditioned by DBA/2 cells was assayed in parallel. DBA/2 cells 
were cultured (method 2.3) in the presence of IL-3 alone or IL-3 
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Fig 3.4 Time course of IL-3-induced groliferation in cultures 
of DBA/2, BALB/c and A/J bone marrow cells glated at two 
cell densities 
Bone marrow cells from DBA/2 (open circles), BALB/c (filled 
diamonds) and A/J (filled circles) mice were cultured at (A) 1 
x 1 o6cells/ml or (B) 1 x 1 oScells/ml in 200 U/ml IL-3. After 
2, 4, or 6 days the cultures were pulsed for 18 h with [3H]-
thymidine.- Data represents the mean uptake of [3H]-thymidine 
minus the background cpm (from cultures without added IL-3) 
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plus one of the bone marrow conditioned media (prepared using 
method 3.7). Both DBA/2 and A/J conditioned media marginally 
reduced the colony numbers produced from DBA/2 cells in the 
presence of IL-3 indicating that they contained some inhibitory 
activity (table 3.2a). However, A/J conditioned media was no more 
inhibitory than media conditioned by DBA/2 cells. 
B. Colony stimulating activity 
The activity of these conditioned media was also tested in colony 
assays using A/J bone marrow cells. A few colonies were produced 
in response to each of the conditioned media indicating the 
presence of a non-lL-3 colony stimulating activity (table 3.2b). 
Therefore, both A/J and DBA/2 cells produce low levels of 
endogenous growth factor in the presence of IL-3. 
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Table 3.2 Colony stimulating and inhibiting activities produced by 
A/J and OBA bone marrow cells in culture 
SOURCEOF 
CONDITIONED MEDIA 
COLONY NUMBERS 
A/J 
DBA/2 
Control 
a) DBA/2 
44 ± 8 
41 ± 1 
53 ± 0 
b) A/J 
2±1 
2±0 
0±0 
DBA/2 or A/J cells were plated in colony assays with 200 U of IL-3 
and 50 µl of the concentrated and dialysed conditioned media 
prepared as described in the text. The control was RPMI-5°/oFCS 
concentrated and dialysed in the same way as the conditioned media. 
Colony numbers are the mean + SD of the colony counts from 
triplicate cultures each containing 1 x 104 cells. 
Inheritance of A/J and AKR abnormalities 
We studied the relationship between the A/J and AKR defects by 
following the inheritance pattern of the IL-3 responsive traits. 
Soft agar cultures (method 2.3) of bone marrow cells from (DBA/2 
x AKR)F1, (C3H/HeJ x A/J)F1, and the various parental strains 
were set up in the presence of IL-3. Bone marrow cells from 3 
progeny of each cross were pooled. Control GM-CSF assays on each 
F 1 and parental strain were cultured in parallel. Bone marrow cells 
from (DBA/2 x AKR) and (C3H/HeJ x A/J) F1 mice produced colonies 
in response to IL-3 (Table 3.3). Further crosses between responsive 
and non-responsive parents consistently produced responsive 
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progeny (data not presented). Therefore, the responsive trait is 
dominant and as a corollary A/J and AKR are homozygous for the 
defective allelle(s) they carry. 
Table 3.3 Colony stimulatina activity of IL-3 and GM-CSF on F1 
mouse bone marrow cells 
STRAIN 
DBA/2 
C3H/HeJ 
A/J 
AKA 
C3H/HeJ x A/J 
DBA/2 x AKA 
A/J x AKR 
NUMBER OF COLONIES 
I L-3 GM-CSF 
34 
30 
0 
0 
29 
33 
0 
14 
1 3 
1 7 
20 
21 
1 6 
1 9 
Bone marrow cells from parental and Fl strains ~Nere cultured in soft 
agar on the presence of IL-3 (200 U/ml). Cultures containing GM-
CSF (50 U/ml) were set up in parallel. Data represents the mean of 
the number of colonies in triplicate cultures each containing 1 x 1 o4 
cells. 
In an attempt to assess whether the same gene(s) are defective 1n 
A/J and AKR mice the progeny of a cross between A/J and AKR 
were tested for their response to IL-3. If the same recessive 
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gene(s) are defective in AJJ and AKR mice, all the progeny of a 
cross between these strains would be expected to be non-
responsive to IL-3. However, if different genes are defective 1n 
A/J and AKR strains, the possible outcomes of a cross between 
these two strains is more complex. The various possible 
combinations of parental genotypes, together with the F1 
genotypes and phenotypes expected in each situation, assuming 
that the genes are not linked and follow normal Mendelian 
inheritance, are presented 1n Table 3.4. For simplification, the 
recessive allelles defective in A/J and AKR are referred to as 'x' 
and 'y' respectively. and the corresponding dominant allelles 
conferring IL-3-responsiveness are referred to as 'x+' and 'y+'. If 
the parents are homozygous for both al le lies (Table 3.4A), it would 
be expected that all progeny would be heterozygous for both 
allelles and would be responsive to IL-3. However, if the A/J 
parent is heterozygous for y, or the AKR parent is heterozygous for 
x, only 50°/o of the offspring would be expected to be heterozygous 
for both allelles and therefore responsive to IL-3 (Table 3.48). 
Similarly, if both parents are heterozygous for one allelle, 25°/o of 
the F'1 progeny would be expected to be responsive to IL-3 (Table 
3.4C). 
Bone marrow cells from the (AKR x A/J) F1 did not produce 
colonies in response to IL-3 (Table 3.3). Similarly a further cross 
between A/J and AKR mice yielded non-responsive progeny (data 
not presented). Therefore, it is likely that the same gene or genes 
are defective in AKR and A/J mice. However, it is also possible 
that responsive phenotypes are produced from the NJ x AKR cross 
but were not detected due to the small samples of F1 progeny 
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sampled, or that the doubly heterozygous genotype wh ich gives the 
responsive phenotype is fatal (or otherwise se lected against) and 
was therefore not detected. 
Table 3.3 Possible outcomes of A/J x AKR cross assuming that 
A/J and AKR are defective at different, un linked loci 
A. Parental Genotypes 
F1 Genotypes 
F1 Phenotypes (0/o total) 
B. Parental Genotypes 
F1 Genotypes 
F1 Phenotypes 
C. Parental Genotypes 
F1 Genotypes 
(A/J) 
X y+ 
X y+ 
(AKR) 
x+ y 
x + y 
X y+ 
x+y 
R (100°/o) 
(A/ J) 
X y+ 
X y 
X y+ 
x+y 
R (50°/o) 
(A/ J) 
X y+ 
X y 
X y+ X y 
X y X y 
X 
(AKR) 
x+ y 
x+ y 
y 
x+y 
N (50°/o) 
(AKR) 
x+ y 
X 
X y 
x+y 
y 
X y+ 
x+y 
F1 Phenotypes N (25°/o) N (25°/o) N (25o/o) R (25°/o) 
R, responsive to IL-3. N, non-responsive to IL-3. 
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DISCUSSION 
The analysis of the strain-dependent variation in the response of 
mouse bone marrow cells to various growth factors revealed that 
A/J and AKA mice are very poor responders to IL-3 (Chapter 2). 
However, although bone marrow cells from these 2 strains do not 
produce colonies with IL-3 in soft agar cultures, IL-3 does induce a 
low level of proliferation in liquid cultures of these cells. In the 
present Chapter, 5 alternative hypotheses were proposed which 
would account for these observations and explain the disparity 
between the soft agar and liquid culture assays. The results and 
conclusions from experiments designed to investigate each of 
these hypotheses are summarised below: 
1. In vitro culture with IL-3 failed to expand an IL-3-responsive 
cell population from A/J bone marrow cells _ a method which 
dramatically expands such a population from DBA/2 or BALB/c bone 
marrow cells. Therefore it seems unlikely that there are any IL-3-
responsive CFCs in A/J bone marrow. 
2. AKA bone marrow cells proved unresponsive to autologous IL-3. 
Furthermore, the activities of AKA IL-3 and rll-3 on DBA/2 and 
AKA bone marrow cells were comparable indicating that there is no 
biologically significant difference between AKR IL-3 and BALB/c 
derived rll-3. 
3. A/J bone marrow cells bound [1251]-IL-3 specifically, indicating 
that these cells do possess receptors for IL-3. The binding data 
suggests that IL-3 receptors may be present in lower numbers in 
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A/J bone marrow than in BALB/c, C5781 or DBA/2 bone marrow. A 
Scatchard analysis would provide more conclusive data on IL-3 
receptor numbers on bone marrow cells from each strain and would 
allow a comparison of the affinities of these receptors. However, 
further binding analyses were not performed due to limited 
availability of radioiodinated and biologically active IL-3. 
4. The proliferation of A/J bone marrow cells in IL-3 was cell 
density dependent indicating that this response may not be directly 
induced by IL-3. Further analysis revealed a low level of non-lL-3 
colony-stimulating-activity in media conditioned by A/J cells 
cultured in IL-3. Therefore, the proliferation observed in liquid 
cultures of A/J cells probably reflects a response to endogenous 
growth factors induced by IL-3 . 
5. A/J cells cultured in IL-3 produce an activity which partially 
inhibits the IL-3 induced proliferation of cells from a normal IL-3 
responder strain. This inhibitory activity may be prostaglandin E 
(PGE) which is induced by IL-3 in a number of macrophage and 
macrophage-like populations (Kurland et al.1977)and inhibits IL-3 
induced proliferation (Kurland and Moore 1977; Moore, 1982). 
Because the levels of inhibitory activity found in A/J conditioned 
media are not significantly greater than those found in media 
conditioned by DBA/2 cells, the defect in A/J mice is probably not 
caused by excessive endogenous inhibitor production. However, the 
data does not eliminate the possibility that the defect in A/J mice 
is caused by excessive sensitivity to the endogenous inhibitor. 
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Finally, the results from F1 experiments suggest that the same 
abherrant gene or genes result in the poor IL-3 response of A/J and 
AKA mice and, as a corollary, the same fundamental defect is 
involved. This would justify the somewhat interchangeable use of 
the two strains which was necessary due to unpredictable supplies 
of these mice during the early work reported in this thesis. 
However further analyses, using larger samples of F1 mice, are 
required to thoroughly investigate the genetics of the defective 
A/J and AKA response. 
The results presented in this Chapter lead to the conclusion that 
IL-3 has no direct mitogenic activity on A/J cells although it is 
not clear why this is so. Perhaps a subpopulation of stem cells 
from which IL-3-responsive CFCs derive is absent in the A/J 
strain. Alternatively, there may be a defect in the IL-3 receptor 1n 
A/J mice. It seems unlikely that the IL-3 receptor is completely 
defective or absent in A/J bone marrow, since there is an indirect 
response to IL-3 in cultures of A/J cells. However, the defect may 
lie in abnormal function of the IL-3 receptor or in reduced 
generation of second messengers. Indeed, such a defect has been 
proposed as the major cause of the reduced response of A/J 
macrophages to interferon-y. Specifically, Hamilton et al. (1986) 
found that the binding of interferon-y to its receptor on A/J 
macrophages did not induce either enhanced protein kinase C 
activity or elevation of intracellular calcium - biochemical 
changes previously shown to be associated with macrophage 
priming induced by interferon-y. Therefore, it is tempting to 
speculate that perhaps the deficiency in the response of A/J bone 
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I 
marrow cells lies in a signal transduction pathway 1n common with 
th at of i nterferon-y 
In the light of the assumed importance of IL-3 1n haemopoiesis, it 
seems suprising that the haemopoietic systems of AKR and A/J 
mice are apparently normal. There is mounting evidence however, 
that GM-CSF, initially considered to be specific for the 
proliferation of granulocyte/macrophage progenitors, also exhibits 
many of the activities attributed to IL-3. Purified recombinant 
human GM-CSF supports the formation of various types of single 
and multilineage colonies and augments erythroid colony 
formation, suggesting that the targets of GM-CSF include 
multipotential progenitors (Emerson et al., 1985, Sieff et al., 1985, 
Donahue et al., 1985). Furthermore, at high concentrations 
recombinant mouse GM-CSF appears to support the production of 
eosinophil, megakaryocyte and mixed-erythroid colonies (Metcalf 
et al., 1986b). Most recently, Koike and associates (1987) reported 
that GM-CSF supports multipotential colony formation from spleen 
cells of 5-FU treated mice. Therefore, it is conceivable that an 
adequate complement of haemopoietic cells can be produced via a 
predominantly GM-CSF controlled pathway. An alternative 
viewpoint, supported by the results presented in the following 
Chapter, is that although the direct proliferative activity of IL-3 
is somewhat redundant, its synergistic activities with other 
factors such as M-CSF may be essential for the development of the 
haemopoietic system. 
, 
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Chapter 4 
Synergistic effect of IL-3 plus M-CSF on 
A/J bone marrow cel ls 
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INTRODUCTION 
M-CSF stimulates the production of haemopoietic colonies 'Nhich 
consist almost exclusively of macrophages, suggesting that the 
action of M-CSF is restricted to relatively late progenitors already 
committed to the macrophage lineage. However, early haemopoietic 
progenitors respond synergistically to M-CSF in combination with 
other haemopoietic factors. 
Bradley and Hodgson ("1979) originally described a population of 
CFCs, termed high-proliferative-potential CFCs (HPP-CFCs), which 
produce large colonies (> 0.5mm) in the presence of a source of M-
CSF and a synergistic factor (SF). These HPP-CFCs are found in 
normal bone marrow and are enriched in bone marrow harvested 
from mouse donors four days post 5-FU treatment, suggesting that 
this cell population comprises relatively primitive haemopoietic 
precursors (as discussed in Chapter 1 ). Bradley and Hodgson found a 
number of sources of SF including human spleen, human placental 
and mouse spleen conditioned media (CM). Later, burst promoting 
activity (BPA), partially purified from WEHl-3B CM, was also 
shown to exhibit SF activity (lscove et al., 1982). In retrospect, the 
SF present in WEHl-3 CM (and probably also in mouse sp leen cell 
CM) is clearly IL-3 (McNiece et al., 1984), whereas the SF detected 
in the human CMs is similar if not identical to IL-1 (previously 
termed haemopoietin-1: Mochizuki et al., 1987; Zsebo et al., 1988) . 
Using clonal replating techniques, McNiece et al. (1986) 
demonstrated the existence of two popu lations of HPP-CFC which 
they termed HPP-CFC 1 and HPP-CFC 2. The HPP-CFC 1 population 
l 
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is stimulated by the combination of M-CSF plus IL-1 and probably 
represents the most primitive haemopoietic cell population yet 
shown to proliferate and differentiate in cultuie. The HPP-CFC 2 
population is actively generated by HPP-CFC 1 (McNiece et 
al., 1987), is stimulated by M-CSF plus IL-3 and generates 
macrophage-CFC (M-CFC) that differentiate to form mature 
macrophages. 
In a model designed to explain the synergistic activity of IL-3, 
lscove (lscove et al., 1982) proposed that IL-3 is a lineage 
indifferent factor needed to expand a population of pluripotent 
haemopoietic precursors and their early comitted progeny whereas 
lineage specific factors such as M-CSF act only on later cells 
which have acquired the appropriate receptors as part of their 
differentiation programme. To delineate further the roles of IL-3 
and M-CSF in macrophage colony formation in culture, Koike and 
associates (1986) investigated what effect delaying the addition 
of one factor had on the large colony response to IL-3 plus M-CSF. 
In soft agar bone marrow cell cultures where IL-3 was present 
from the initiation of the culture, the sizes of colonies produced 
were similar regardless of whether the addition of M-CSF was 
delayed for 5 days or not. However, when M-CSF wa_s present from 
the initiation of the culture but the addition of IL-3 was delayed, 
only small colonies resulted. Consistent with the model proposed 
by lscove (lscove et al., 1982), these results suggest that M-CSF 
promotes cell proliferation during later stages of macrophage 
colony development that has been initiated by IL-3. 
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As a corollary of lscove's model, the synergistic activity of IL-3 1s 
dependent on its proliferative activity on early haemopoietic 
precursors. In other words, the synergistic response of bone 
marrow cells to IL-3 and M-CSF should follow the same strain-
dependent profile as the response to IL-3 alone. To test this 
proposal, the synergistic large colony response to IL-3 and M-CSF 
was assayed in a range of strains including the IL-3 non-
responders, A/J and AKA (Chapter 3). The results of these 
experiments are described in the following section along with 
further work to ascertain the contribution of the direct mitogenic 
activity of IL-3 in the synergistic response to IL-3 and M-CSF. 
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I 
MATERIALS AND METHODS 
CHEMICALS AND GROWTH FACTORS 
Chemicals and growth factors used were as described 1n Chapter 2 
unless otherwise stated. 
METI-ODS 
4.1 Assay for synergistic colony response 
Colony assays were performed as described in method 2.3. The 
growth factors added were IL-3 (200U/ml), M-CSF (200U/ml), or . 
IL-3 plus M-CSF. Control assays contained no added growth factors. 
Colonies > 0.5mm diameter were scored as large colonies. For 
identification of colony types, gels were fixed and stained as 
follows. Gels were placed on microscope slides, fixed in methanol 
for 30 seconds, rinsed with distilled water and air dried. Gels were 
then stained with a-naphthyl acetate esterase and naphthol AS-D 
chloroacetate (using Sigma kit) to allow identification of 
granulocytes and macrophages. 
4.2 Bone marrow cell preculture 
Precultures were performed as described in method 3.1 except that 
additional cultures containing M-CSF (200U/ml) were set up in 
parallel. 
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4.3 Sequent ial addition co lony assays 
Colony assays were performed as described in method 2.3 with the 
following modifications. Colony assays initiated (day 1) in the 
presence of IL-3 (200U/ml) were overlaid 2 days later (day 3) with 
either M-CSF (to give a final concentration of 200U/ml) or an 
equivalent volume of RPMI. Similarly, assays initiated in the 
presence of M-CS F (200U/ml) were overlaid 2 days later with 
either IL-3 (final concentration 200U/ml) or an equivalent volume 
of RPMI. Control assays without added growth factor or containing 
IL-3 plus M-CSF throughout the culture period were set up in 
parallel. Assays were incubated for 12 days before fixing and 
staining as in method 4.1. Colonies > 0.5mm diameter were scored 
as large colonies. 
7 1 
RESULTS 
Synergistic effect of M-CSF and IL-3 
To determine whether or not the synergistic response follows the 
same strain-dependent pattern as the response to IL-3 alone, the 
combination of IL-3 and M-CSF was tested in colony assays 
(method 4.1) on the same panel of mouse strains used in Chapter 2. 
In soft agar cultures of bone marrow cells (isolated using method 
2.1) from all strains tested including AKR and A/J, the presence of 
IL-3 plus M-CSF resulted in much larger colonies than were 
produced in M-CSF or IL-3 alone (Figs 4.1 and 4.2). In some assays a 
few large colonies (> 0.5 mm diameter) were produced in M-CSF 
alone, but these never exceeded 10°/o of the total colony number. In 
comparison, in IL-3 plus M-CSF the percentage of large colonies 
ranged from 25°/o to 40°/o of the total colony number. In assays using 
bone marrow cells from IL-3 responsive strains, the number of 
colonies supported by the combination of IL-3 and M-CSF was less 
than or equal to the sum of the colonies supported by the factors 
individually (colony scores from DBA/2 bone marrow cells are 
presented in Table 4.1 ). In A/J and AKR assays however, the 
synergistic response to IL-3 plus M-CSF was also reflected 1n a 
significant increase in colony numbers (Table 4.1 ). 
We next examined the effect of IL-3 on the type of colonies 
produced from A/J bone marrow cells in soft agar cultures. At high 
concentration, M-CSF alone supported exclusively macrophage 
colonies, whereas at lower concentrations some granulocyte (G) 
and granulocyte/macrophage (GM) colonies were produced. The 
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Fig 4.1 Synergistic effect of IL-3 plus M-CSF on the size of 
colonies produced from DBA/2 bone marrow cells 
Colonies grown from 1 x 1 o4 DBA/2 bone marrow cells with 
(A) IL-3, (8) M-CSF or (C) IL-3 + M-CSF. Photographs are of 
whole agar preparation (16 mm diameter) stained with a-
naphthyl acetate esterase and naphthol AS-0. 
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Fig 4.2 Synerg istic effect of IL-3 plus M-CSF on the size of 
colonies produced from A/J bone marrow cells 
Colonies grown from 1 x 1 o4 A/J bone marrow cells with (A) 
M-CSF or (B) IL-3 + M-CSF. No colonies were produced in 
response to IL-3 alone. Photographs are of whole agar 
preparation (16 mm diameter) stained with a-naphthyl acetate 
esterase and naphtha! AS-0 
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presence of IL-3 increased the percentage of G and GM colonies 
produced at all M-CSF concentrations (Table 4.2). 
Table 4.1. Colony formation from bone marrow cells stimulated by 
IL-3 and/or M-CSF 
Factor 
IL-3 
M-CSF 
IL-3 + M-CSF 
A/J 
0 0 
25±3 10±1 
34±3 22±5 
Number of Colonies 
AKR 
0 0 
14+5 15+2 
27±4 24+1 
DBA/2 
44±3 48±.3 
22+2 19±2 
52±4 53±.3 
Data represents the mean + SD or the number of colonies in 
triplicate cultures each containing 1 x 1 o4 cells. Two independent 
experiments on each strain are tabulated. The numbers of colonies 
produced from A/J and AKR bone marrow cells plated in IL-3 + M-
CSF are significantly different from the number produced in M-CSF 
alone (P < 0.01) according to the Students t test. 
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Table 4.2 Types of colony produced by A/J bone marrow ce lls 
stimulated with M-CSF in the presence or absence of IL-3 
Factors 
100U M-CSF 
1 OOU M-CSF + IL-3 
200U M-CSF 
200U M-CSF + IL-3 
400U M-CSF 
400U M-CSF + IL-3 
Colony number 
10 ± 4 
12 + 1 
10 + 1 
22 ± 2 
12 + 2 
23 + 3 
Colony type (0/o) 
M G Gv1 
84 
75 
93 
77 
100 
92 
1 3 
14 
7 
1 7 
0 
4 
3 
1 1 
0 
6 
0 
4 
M-CSF concentrations shown are the final concentration in the 
culture (U/ml), fmal concentration of IL-3 was 200U/ml in all assays, 
Colony numbers are the mean + SD of the colony counts from 
triplicate cultures each containing 1 x 104 cells. M, macrophage; G, 
granulocyte; GM, granulocyte-macrophage 
Effect of M-CSF on response of A/J bone marrow cells to 
IL-3 
The increased number and variety of colonies are produced from 
A/J bone marrow cells in IL-3 plus M-CSF compared with M-CSF 
alone, suggested that exposure to M-CSF primes a population of A/J 
CFCs to become IL-3 responsive. To investigate th is poss ibil ity 
A/J bone marrow cells were precultured in M-CSF (method 4.2), and 
the non-adherent cells were then harvested. The yield of non-
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adherent cells was not significantly different from the original 
number of bone marrow cells plated but large numbers of adherent 
cells (not harvested for colony assays) were also observed in all 
these cultures. Even after this pre-exposure to M-CSF, A/J bone 
marrow cells did not produce colonies when cultured in soft agar 
(method 2.3) in the presence of IL-3 alone (Table 4.3a). Subsequent 
experiments in which A/J bone marrow cells were precultured 
with M-CSF for various lengths of time (1 day, 4 days, and 6 days) 
also failed to produce IL-3 responsive CFCs (data not presented). 
Effect of IL-3 on A/J bone marrow cell response to M-CSF 
Preculture experiments (method 4.2) were also performed to 
determine whether exposure to IL-3 affected the response of A/J 
bone marrow cells to M-CSF. As expected, IL-3 preculture did not 
result in a significant increase in overall numbers of non-adherent 
A/J bone marrow cells. We plated precultured and fresh bone 
marrow cells in soft agar culture with M-CSF (method 2.3) and 
scored the number and size of the colonies produced 7 days later. 
The number of large colonies produced by the precultured cell 
population was not significantly greater than the number produced 
by fresh bone marrow (Table 4.3b) indicating that IL-3 precultured 
cells were not preactivated to produce large colonies in response 
to M-CSF. In addition IL-3 preculture did not expand the population 
of M-CSF-responsive CFCs compared with fresh bone marrow. 
However, A/J bone marrow precultured with IL-3 contained more 
non-adherent M-CSF responsive CFCs than parallel cultures with M-
CSF or without added growth factor (Table 4.3a,b).This experiment 
was repeated twice with similar results (data not represented). 
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Table 4.3. Colony formation by A/J bone marrow cells precu ltured 
with M-CSF or IL-3 
Number of Colonies 
Factor 1n Preculture IL-3 M-CSF IL-3+M-CSF 
(a) M-CSF 0 8±4 (Oo/o) 17±3 (12%) 
(b) IL-3 0 24±4 (0°/o) 32±3 (16o/o) 
No factor 0 4±1 (0°/o) 9±1 (14%) 
Control (fresh bm cells) 0 16±4 (0°/o) 33±8 (27%) 
Colony numbers are the mean + SD of the colony counts from 
triplicate cultures each containing 1 x 104cells. Numbers in 
parentheses represent the large (> 0.5 mm diameter) colony count 
expressed as a percentage of the total colony counts. Bm, bone 
marrow. 
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Effect of sequential additions of CSFs on colony size and 
number 
Finally, experiments were carried out to determine what effect 
delaying the addition of one of the growth factors would have on 
the IL-3 plus M-CSF induced synergistic large colony response by 
A/J bone marrow cells. Bone marrow cells from A/J mice were 
plated in colony assays (method 4.3) in the presence of either IL-3 
or M-CSF at the beginning of the culture period (day 1 ). On day 3, 
the second factor was added. Control assays contained IL-3 plus M-
CSF from day 1 of the culture. The results of these experiments 
were variable but the overall pattern was consistent in that 
delaying the addition of either factor reduced the percentage of 
large colonies produced (Table 4.4) but had no effect on the overall 
number of colonies produced. 
Table 4.4. Effect of sequential addition of IL-3 and M-CSF on 
colony size 
Growth Factor Added 0/oLARGE COLONIES 
DAY 1 DAY3 
IL-3 + M-CSF 30 1 5 26 
IL-3 M-CSF 9 4 1 8 
M-CSF IL-3 1 6 1 2 24 
M-CSF 9 0 1 
Results of 3 independent experiments are tabulated. Large colonies 
are> 0.5 mm diameter. 
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DISCUSSION 
Previous reports have documented that a population of 
haemopoietic progenitor cells produces distinctively large colonies 
in the presence of IL-3 plus M-CSF (lscove et al., 1982; McNiece et 
al., 1984; Koike et al., 1986). The effect of this combination of 
growth factors on bone marrow cells from a range of mouse strains 
is presented here. As expected, bone marrow cells from IL-3-
responsive strains produced larger colonies 1n IL-3 plus M-CSF 
than in either factor alone. In these assays the number of colonies 
produced in the combination of IL-3 plus M-CSF was no more than 
additive. Similarly, Williams and associates (1987a) reported that 
the synergism between IL-3 and M-CSF at optimal concentrations, 
enhanced the size but not the number of colonies produced from 
granulocyte/macrophage progenitors. In contrast, in A/J bone 
marrow cell cultures, IL-3 and M-CSF acted synergistically to 
increase both the size and the number of colonies produced 
compared with those produced in M-CSF alone. Furthermore, A/J 
bone marrow cells cultured in IL-3 plus M-CSF generated G, GM, and 
M colonies whereas in M-CSF alone only M colonies were found. 
A hypothesis consistent with these observations is that M-CSF is 
required to prime haemopoietic progenitor cells to respond to IL-3. 
As a corollary, in IL-3 responsive strains this priming event must 
----------
occur before the cells are isolated for in vitro experimentation. 
The experimental evidence presented here does not support this 
hypothesis however, since exposure to M-CSF does not preactivate 
A/J cells to produce colonies in response to IL-3. This does not 
rule out the possibility that continuous exposure to low levels of 
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endogenously produced M-CSF is required to prime an IL-3 
responsive population and that this endogenous production of M-
CSF is lacking in A/J mice. This too is unlikely however, firstly 
because single bone marrow cells isolated from CBA mice 
proliferate in response to IL-3, indicating that the action of IL-3 
on these cells does not require mediation by a second factor 
released by another cell type (Clark Lewis and Schrader, 1988) and 
secondly because there is no apparent difference in the endogenous 
growth factor production by A/J bone marrow cells and bone 
marrow cells from the IL-3 responder strain DBA/2 (Chapter 3). 
An alternative hypothesis to explain the increased number of 
colonies in IL-3 plus M-CSF is that IL-3 primes an A/J 
haemopoietic stem cell population to respond to M-CSF. In support 
of this hypothesis, Bartelmez and associates demonstrated that in 
C3H/HeJ bone marrow cell cultures, IL-3 stimulates the de nova 
appearance of blast cells possessing the ~"1-CSF receptor 
(Bartelmez et al., 1985). It is not clear from the present study 
whether the observed synergistic increase in colony numbers 
produced from A/J bone marrow cells in IL-3 plus M-CSF is due to 
stimulation of the de nova appearance of M-CSF responsive CFCs by 
IL-3. No significant increase in the number of M-CSF responsive 
CFCs ,n A/J bone marrow was found after IL-3 preculture but this 
effect may be obscured by the differentiation and subsequent 
adherance of a proportion of the macrophage progenitors during 
culture. In favour of this interpretation, a synergistic increase in 
colony numbers was observed in colony assays in which IL-3 was 
present from the initiation of the culture but the addition of M-CSF 
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was delayed, whereas a corresponding increase in IL-3 plus M-CSF 
responsive CFCs was not observed after IL-3 preculture. 
Another possible explanation for the observed synergistic increase 
in colony numbers however, is that coincident exposure to IL-3 and 
M-CSF is required to prime a population of A/J CFCs to proliferate. 
The synergism between IL-1 and M-CSF is apparently an example of 
such an interaction: Using a highly purified multipotent stem cell 
population, Lord and Spooncer (1986) demonstrated that coincident 
exposure to IL-1 and M-CSF is required to commit these early cells 
to an M-CSF-responsive state. However, further work with purified 
early progenitor populations from the A/J strain is required to 
clarify whether there is a population of cells requiring coincident 
exposure to IL-3 and M-CSF for proliferation. 
Apart from increasing the numbers of colonies produced from A/J 
bone marrow cells, the presence of IL-3 and M-CSF increased the 
size and variety of colonies produced compared with those 
produced in M-CSF alone. The increase in colony size appears to 
require coincident exposure to both IL-3 and M-CSF since exposure 
to IL-3 did not preactivate a population of A/J haemopoietic 
progenitor cells to produce large colonies when plated 
subsequently in M-CSF alone. The increase in variety of colony 
types may be accounted for partly by the stimulation of earlier 
less committed progenitor cells by the comb ination of growth 
factors. However, since M-CSF has a strong differentiative activity 
- such that exposure of bipotential GM-CFC to M-CSF through 2 or 3 
cell divisions irreversibly commits the cells to form macrophage 
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colonies (Metcalf and Burgess 1982) - it appears that IL-3 must 
also antagonise this M-CSF driven differentiation. 
The sequential additions experiments reported here revealed that 
both IL-3 and M-CSF must be present from the initiation of the 
culture to achieve the optimum large colony response from A/J 
bone marrow cells. In contrast, Koike et al. (1986) found that 
delaying the addition of M-CSF had no effect on the large colony 
response of bone marrow cells from the IL-3-responsive strain 
BDF1. Taken together, these observations suggest that the 
production of synergistic large colonies requires both a synergistic 
activity and a proliferative stimulus. Since bone marrow cells 
from BDF1 mice produce relatively lar.ge colonies in culture with 
IL-3, both the synergistic activity and the proliferative stimulus 
can be provided by IL-3 in the early stages of large colony 
development from these bone marrow cells. In the A/J cultures 
however, IL-3 provides the synergistic activity but M-CSF is 
required for the proliferative response throughout the culture 
period. 
In conclusion, the data presented in this Chapter indicate that IL-3 
and M-CSF synergise on A/J bone marrow cells in the absence of 
direct IL-3-induced proliferation. This is obviously inconsistent 
with lscove's model which proposes that the synergistic activity 
of IL-3 is entirely due to its proliferative action on early 
haemopoietic progenitor populations . However, the separation of 
the synergistic from the mitogenic effects of IL-3 in the A/J 
system provides an ideal model for studying what mechanisms a re 
actually involved in the synergistic activities of IL-3. 
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Chapter 5 
Effect of IL-3 on expression of c-fms 
transcripts by A/J bone marrow cells 
INTRODUCTION 
As discussed in Chapter 4, in soft agar cultures of haemopoietic 
' 
progenitor cells, IL-3 acts synergistically with M-CSF to produce 
very large colonies. The mechanism previously suggested for this 
synergism is that IL-3 initiates the colonies by amplifying 
immature early macrophage progenitors which subsequently 
develop sensitivity to M-CSF (Koike et al., 1986). However, since 
IL-3 synergises with M-CSF even in the A/J system, in which IL-3 
has no direct proliferative activity (Chapter 4), the proliferative 
activity of IL-3 is apparently not essential to its role in enhancing 
the response to M-CSF. 
The development of M-CSF sensitivity by haemopoietic progenitor 
cells has been correlated to an increase in M-CSF receptor 
expression (Bartelmez et al., 1985, Bicknell et al., 1988). The mouse 
M-CSF receptor is a 165 kd glycoprotein which has tyrosine-
specific protein kinase activity (Morgan and Stanley, 1984; Yeung et 
al., 1987) and is similar in its properties to the product of a feline 
proto-oncogene c-fms (Rettenmier et al., 1985). Indeed a rabbit 
antiserum prepared using a transmembrane glycoprotein encoded by 
the viral oncogene (v-f ms) has been shown to have specific cross-
reaction with the mouse M-CSF receptor (Sherr et al., 1985). 
Moreover, v-fms transformed fibroblasts express high affinity 
binding sites for M-CSF (Sacca et al., 1986). These results 
implicate the M-CSF receptor as a similar if not identical mo lecu le 
to the product of the c-fms proto-oncogene. 
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The aim of the experiments reported in this chapter was to 
investigate whether the effect of IL-3 on M-CSF-responsiveness 
could be linked with an increase in c-fms RNA express ion. 
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MATERIALS AND METHODS 
CHEMICALS, GROWTH FACTORS AND PLASMIDS 
The chemicals and growth factors used were as described in 
Chapter 3 unless othe-rwise stated. The 0.4 kb Pst1 fragment of v-
fms cDNA inserted into pBR322 was kindly donated by T.Robbins 
(NCI-FCRF, Maryland, USA)). The plasmid pUB8 which contains 2.8 
human ubiquitin coding units inserted into the plasmid pUC18 
(Baker and Board, 1987) was kindly donated by A.Baker, Department 
of Human Genetics, JCSMR, ANU, Canberra) 
METHODS 
5.1 Culture of freshly isolated bone marrow cells and bone 
marrow-derived macrophages 
Bone marrow cells (isolated using method 2.1) were cultured at 1 x 
106/ml in 75 ml RPMl-10°/o FCS in the presence of IL-3 (200U/ml), 
M-CSF (200U/ml), IL-3 plus M-CSF in 75 cm2 plastic tissue culture 
flasks (Falcon Labware). Cultures were incubated at 370c in a 
humidified 5°/o CO2 atmosphere. After the time specified in the 
text, cells were harvested and lysed as described in method 5.4. 
5.2 Production of bone marrow derived macrophages 
Bone marrow-derived macrophages were produced from liquid 
cultures of mouse bone marrow cells in the presence of L-cell 
conditioned medium (LCM) as described by Hume and Gordon (1983). 
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Briefly, bone marrow cells were harvested from mouse femurs 
(method 2.1) and cultivated in a medium containing 20~~ LCM. After 
5 days, the non-adherent cells were discarded and the adherent 
cells were washed in situ with RPM 1-10°/o FCS before use. 
5.3 Maintenance of cell lines 
Mouse L929 cells, which constitutively produce M-CSF, were grown 
in DMEM (Gibco) plus 5°/o FCS. Cells were harvested with trypsin 
(1.25°/o w/v)-EDTA (1 .5 mM) in PBS every 7 days and replated at 
one-tenth density. WEHl-38 cells, which constitutively produce IL-
3, -were grown in RPMl-5o/o FCS. Non-adherent and adherent cells 
were harvested by agitation and replated at one-tenth density 
every 7 days. The mouse cell line PUS which constitutively 
expresses GM-CSF RNA was cultured as described for L929 cells. 
5.4 Isolation of total RNA by ultracentrifugation 
This method is based on that of Muller et al. (1983). To avoid 
contaminating the samples with RNase, gloves were worn 
throughout the procedure. Solutions and buffers which did not 
contain RNase inhibitors were incubated with diethyl 
pyrocarbonate (DEPC) at room temperature for at least 12 h and 
autoclaved (Maniatis et al., 1982). Sterile disposable plasticware 
was used for the preparation and storage of RNA without 
pretreatment. General laboratory glassware was treated by baking 
at 2500c for at least 4 h. 
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Cultured cells or cells prepared by tissue disaggregation, were 
pelleted by centrifugation and resuspended in a minimum volume of 
PBS and the resulting cell suspension was added dropwise into 
lysis buffer with vigorous vortexing. Approximately 1 O ml of lysis 
buffer was used per 108 cells or gram of tissue. Cells grown in 
monolayer or adherent cell populations from bone marrow cell 
cultures were lysed directly in the tissue culture dish or flask by 
addition of lysis buffer (4 ml of lysis buffer for 75 cm2 flask). The 
lysis buffer contained 4 M guanidine thiocyanate, 0.4o/o lauroyl 
sarcosine, 0.025 M sodium citrate (pH7.0), 0.1 °/o Antifoam A and0.1 
M 2-mercaptoethanol (added just before use; BDH Chemicals Ltd.) 
Tissue or cell lysate was then forced through a 21 guage needle 
several times to shear the DNA and either processed immediately, 
following the protocol below, or stored at -7QOC until required. 
The lysate, made up to 30 ml with lysis buffer, was underlayered 
with 5 ml of 5.7 M caesium chloride in 0.025 M sodium acetate (pH 
5.0) in an SW27 polyallomer tube (Beckmann) and centrifuged at 23 
K rpm at 150c for 24 h in a Beckmann SW27 rotor. After carefully 
withdrawing the guanidine isothiocyanate layer, the caesium 
chloride cushion was decanted and the tubes were left to drain for 
about 10 min. Each tube was then cut below the interphase level 
and the bottom part of the tube containing the RNA pellet was 
rinsed with cold ethanol and allowed to drain. The RNA pellet was 
resuspended in 0.4 ml water. A 2.6 ml aliquot of 7.5 M guanidine 
hydrochloride buffer containing 0.025M sodium citrate (pH7.0) and 
0.005 M dithiothreitol (OTT) was added to the RNA solution and the 
pH was lowered by addition of 75 µI of 1 M acetic acid. Cold ethanol 
(1.5 ml) was then added and the mixture was vortexed briefly and 
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stored at -2ooc for at least 4 h. The resulting RNA precipitate was 
recovered by centrifugation at 10,000 x g for 15 min and the pellet 
was resuspended in 1.5 ml water and repeatedly drawn up and down 
a pasteur pipette until dissolved. The RNA was then reprecipitated 
by addition of 100 µI of 3M sodium acetate and 4 ml cold ethanol. 
After overnight precipitation at -2ooc the RNA was recovered by 
centrifugation at 10,000 x g for 15 min and dissolved in 1 ml or 
other appropriate volume of water. The concentration of RNA was 
determined spectrophotometrically based on an optical density at 
260 nm (00260) of 24 for 1 mg of RNA per ml. RNA was stored at -
700C until required. For long term storage (> 3 months) RNA was 
reprecipitated with ethanol, centrifuged and the pellet was stored 
under ethanol at -7QOC. 
5.5 Isolation of total RNA by single-step method 
Th is method is essentially as described by Chomczynski and Sacchi 
(1987). Cells were lysed as in method 5.4. Lysate (3 ml) was placed 
in a 10 ml disposable plastic centrifuge tube. 0.3 ml of 2 M sodium 
acetate (pH 4), 3 ml of water saturated phenol (BDH Chemicals Ltd; 
prepared as described in Maniatis et al.,1982), and 0.6 ml of 
chloroform-isoamyl alcohol mixture (49:1) were added sequentially 
to the lysate with thorough mixing by inversion after the addition 
of each reagent. The final suspension was shaken vigorously for 1 O 
seconds and cooled on ice for 15 min at 40c. Samples were then 
centrifuged at 10,000 x g for 20 min at 40c. The aqueous upper 
phase which contained RNA was transferred to a fresh tube and the 
interphase and phenol phase were discarded. The aqueous phase was 
mixed with 6 ml of ethanol by vortexing and then placed at -20°c 
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for at least 1 h to precipitate RNA. Samples were centrifuged at 
10,000 x g for 20 min at 40c to sediment the RNA precipitate. The 
resulting RNA pellet was then dissolved in 0.3 ml of lysis buffer, 
transferred to a 1.5 ml Eppendorf tube and reprecipitated with 0.6 
ml of ethanol at -2ooc for at least 1 h. After centrifugation 1n an 
Eppendorf centrifuge for 1 O min at 40c, the RNA pellet was 
resuspended in 75°/o ethanol, sedimented, vacuum dried (15 min) and 
dissolved in an appropriate volume (usually 50 or 100 ml) of water 
at 650C for 10 min. Concentration of RNA was determined as in 
method 5.4. 
5.6. Isolation of messenger RNA from total RNA 
Poly (A)+ RNA (mRNA) was separated from total RNA by 
chromatography on oligo (dT)-cellulose (Aviv and Leder, 1972). 0.5 -
1 .0 g oligo (dT)-cellulose was equilibrated in loading buffer (1 O 
mM Tris-HCI pH 7.5, 1 mM EDTA, 0.5 M NaCl) and poured into a 
sterile polypropylene column (Bio-rad) to give a final bed volume 
of 3 - 4 ml. Up to 3 mg of RNA was heated at 600C for 5 min, 
rapidly chilled ·in ice water and adjusted to 0.5 M NaCl. The sample 
was then loaded onto the column and washed through with loading 
buffer until the 00260 of the column effluent was less than 0.005 
(usually approx. 5 column volumes of buffer). At that point, the 
buffer was replaced with elution buffer (10 mM Tris-HCI pH 7.5, 1 
mM EDTA ) and 0.5 ml fractions were collected in Eppendorf tubes. 
Elution of mRNA was monitored by absorbance at 260 nm. The 
mRNA was ethanol precipitated overnight at -2ooc, pelleted for 15 
min in an Eppendorf centrifuge and resuspended in an appropriate 
volume of water. 
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5.7. Preparation of probe templates 
The v-fms insert was excised from PBR322 using Psti and isolated 
by low melting point agarose gel electrophoresis and phenol 
extraction as described in method 5.8. The entire plasmid PUB8 
was used as a template for the ubiquitin probes. 
5.8 Isolation of DNA from low melting point agarose gels 
Low gelling temperature agarose was dissolved by heating in 
electrophoresis buffer to 700c. The agarose was allowed to cool to 
370c prior to pouring. Ethidium bromide was added to a final 
concentration of 0.5 µg/ml and the gel was poured in a cold room 
(40C). Electrophoresis of DNA samples was carried out at 40c at 
100 mA constant current. Electrophoresis buffer was 40 mM Tris-
acetate (pH 7.8), 1 mM EDTA and contained ethidium bromide at 0.5 
µg/ml. Following electrophoresis, the gel was viewed under UV 
illumination and the region of the gel containing the fragment of 
interest was cut out using a scalpel blade. Approximately 0.5 ml 
gel slices were placed into separate Eppendorf tubes and incubated 
at 650C for 5 min. At room temperature, 0.5 - 1 volume of phenol 
was added quickly to each tube and the tube was vortexed 
vigorously for 2 min. The phases were separated by centrifugation 
and the aqueous phase \Vas then re-extracted twice with 1 volume 
of phenol then twice with 1 - 2 volumes of ether (water saturated). 
The resulting aqueous phase was heated for 2 min at 650C to 
remove any remaining traces of ether and the DNA was recovered 
by ethanol precipitation. 
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5.9. Preparation of labelled DNA markers 
A mixture of stock plasmid DNA was used which gave fragments of 
appropriate sizes when digested with EcoR1. Plasmid DNA (3 
µg)was incubated with 3 units of EcoR1 in 45 ml restriction digest 
buffer (100 mM NaCl, 50 mM Tris-HCI pH 7.5, 10 mM MgCl2, 1 mM 
OTT) at 370c. After 1 h, 20 nmol dTTP, 3.3 pmol [a- 32P]-dATP 
(Amersham) and 5 units Escherichia coli DNA polymerase 1 (Kienow 
fragment, BRESA) were added to the digest in a total volume of 3 
µI. The mixture was incubated at room temperature for 30 min and 
then made up to 300 µI with 100 mM Tris-HCI (pH 7.5), 1 mM EDTA. 
The resulting end labelled DNA fragments were stored at -20 C 
until they were used as size markers on Northern gels. 
5.1 O RNA slot blots 
RNA slot blots were performed using a modification of the method 
of White and Bancroft (1982). RNA was dissolved in v,ater to a 
concentration of 1 mg/ml. 15 µI of formaldehyde (37°/o w/w, Merck 
A.R.) and 30 µI of 20 x SSC (3 M NaCl, 0.3 M Na citrate) were added 
to 15 µI (15 µg ) RNA in an Eppendorf tube. The mixture was 
vortexed, incubated at 600C for 15 min and kept on ice. 60 µI of 20 
x SSC \vas then added to each sample giving a final concentration 
of 15 x SSC. Serial three-fold dilutions of the denatured RNA were 
prepared in 15 x SSC to give final RNA concentrations of 10, 3.3, 
and 1 µg / 80µ1. RNA was applied to nitrocellulose (NC, Schleicher 
and Schuell) using a slot blot apparatus (Minifold 11, Schleicher 
and Schuell) as follows. 2 layers of Whatman 3MM paper were 
placed in the apparatus and a piece of NC, prewetted with 15 x SSC 
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was placed on top of the paper. The apparatus was assembled and 
100 µI of 15 x SSC was pipetted into each of the sample wells to 
keep the NC wet until samples were loaded. The vacuum source was 
connected and 80 µI aliquots of RNA solution were pipetted into the 
appropriate wells. Once the samples had run through, each well was 
rinsed with 100 µI of 15 x SSC under vacuum. The vacuum source 
was then turned off and the minifold was dismantled, gently 
removing the NC filter with 'soft' forceps (Amicon Corp.). After air 
drying on 3MM paper, the filter was baked in a vacuum oven for 2 
hr. 
5.11 Northern blots 
RNA was separated according to size on formaldehyde/agarose gels 
using a modification of the method described by Gurney (1984). A 
mini-gel apparatus (Pharmacia Biotechnology) kept free from 
RNase was used for all Northern gels. The gel buffer in the gel, in 
the sample and in the buffer reservoirs was: 20 mM 
triethanolamine (pH7.4), 2.5 mM EDTA, and 2.2 M formaldehyde. 
-
Sample preparation buffer was prepared just before use by mixing 
10 volumes of deionised formamide (prepared as described in 
Maniatis et al., 1982) with 4 volumes of 5 x gel buffer. RNA solution 
(4 µI usually at 5 mg/ml) was added to 9 µI of sample preparation 
buffer in an Eppendorf tube and mixed thoroughly by vortexing the 
capped tube vigorously. The samples were then incubated at ssoc 
for 15 min and kept on ice. Labelled DNA size markers were 
denatured using identical conditions. Loading buffer (1 µI) 
containing 50°/o glycerol, 1 mM EDTA, 0.4o/o bromophenol blue and 
0.4% xylene cyanol \Vas added to each of the samples which were 
9 1 
then dry-loaded into wells of a 30 ml formaldehyde/agarose gel. 
The samples were run into the gel at 70 mA for 15 min and the gel 
was submerged with gel buffer. Electrophores is was continued for 
3 - 5 h at 35 - 45 mA (usually until the first dye fro nt had 
migrated 50 - 70 o/o of the length of the gel). The gel was blotted to 
NC without pretreatment using established methods (Man iatis et 
al. , 1982) with the following modifications. The transfer was left 
for 18 - 24 h at room temperature, after which the NC was 
removed and air dried on fresh 3MM filters. At this po int the 2 
major ribosomal (r) RNA bands could be detected by holding the NC 
up to the light and the positions of these bands were marked fo r 
future reference. The rRNA bands in each lane were compared to 
check that roughly equivalent amounts of each sample of RNA had 
been transferred. 
5.12 Hybridisation of Northern and dot blots 
A. Prehybridisation 
Blots were prehybridized in 15 - 20 ml of 50% freshly deionised 
formamide, 5 x SSC, 0.1 °/o sodium dodecyl su lphate (SOS), 5 x 
Denhardt's so lution (Denhardt, 1966) and 200 µg/ml sonicated 
salmon sperm DNA (prepared as described in Maniatis et al., 1982) 
at sooc for > 3 h. Prehybridisations and hybridisations were both 
carried out in small flat-bottomed plastic boxes with sealab le lids 
in a gently shaking water bath. 
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B.Probe preparation by random primer synthesis 
This method is based upon the procedure described by Feinberg and 
Vogelstein ('1983, '1984) and can be used for labelling DNA from any 
source without the need for specific vectors or subcloning. 
A typical probe synthesis reaction was as follows. 100 ng of the 
template DNA fragment or plasmid was mixed with a 20-fold 
(w/w) excess of a universal decamer primer (synthesized by the 
phosphoramidite method, using an equimolar mixture of all four 
bases at each position) in a volume of 10 µI. The mixture was 
sealed inside a drawn-out glass capillary and heated to 1 oooc for 
5 min, followed by rapid chilling in ice water. The contents of the 
capillary were then added to an Eppendorf tube containing a final 
reaction mixture of 50 mm K phosphate (pH 6.8), 1 O mM Mg acetate. 
10 mM OTT, 1 mM each of dCTP, dGTP, dTTP (Boehringer Mannheim 
Biochemicals), 33 pmol [a - 32P]dATP (Amersham) and 1 O units of 
DNA polymerase (Kienow fragment) in 90µ1. The reaction was 
incubated at 370c for 60 min. 
Probes were also prepared by the standard Multiprime DNA 
labelling protocol (Amersham). Using this protocol 50 ng of DNA 
was labelled with 10 µI (33 pmol) of [a - 32P]dCTP (Amersham) . 
To monitor the progress of the reaction, the incorporation of label 
into trichloroacetic acid (TCA) precipitable counts was determined 
by the following method. A 1.5 µI aliquot was taken from the 
reaction mixture and added to 28.5 µI of 0.5 M EDTA (pH 8.0) in an 
Eppendorf tube. After vortexing the mixture, 10 µI was removed and 
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set aside for determination of the total radioactivity in the 
reaction mixture. Another 10 µI was added to 90 ml of 500 µg/ml 
calf thymus DNA in 10 mM Tris HCI (pH 7.5) and 10 mM EDTA. To 
this mixture, 2 ml of ice cold 10°/o TCA solution was added and the 
DNA was left to precipitate in an ice-bath for 10-15 min. 
Precipitated DNA was then collected by vacuum filtration on a 
glass fibre disc (Whatman). After washing the filter disc several 
times with cold 10°/o TCA solution and then with ethanol, the disc 
was placed in a scintillation vial with 10 ml ethanol and 
incorporated radioactivity was determined by Cherenkov counting. 
The sample set aside for determination of total radioactivity v,as 
counted under the same conditions as the filter disc. The 0/o label 
incorporated could then be calculated. 
The synthesized probe was separated from unincorporated label by 
chromatography on a Sephadex G-50 fine (Pharmacia Biotechnology) 
column (prepared in a 5 ml disposable pipette). The specific 
activity of probes produced was approx. 1-1 .8 x1 o9 dpm/µg 
C. Hybridisation 
Just prior to use, the probe was denatured in 15 - 20 ml of 
prehybridisation buffer at 700c. Solution used for prehybridisation 
was discarded and replaced with prehybridisation buffer containing 
the denatured probe. Blots were hybridised overnight (18 h) at 
500c. 
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D. Washing 
Filters were removed from hybridisation buffer and immediately 
submerged in a so lution of 2 x SSC at room temperature. Filters 
were then incubated sequentially in 2 x SSC plus 0.1°/o SOS, 0.5 x 
SSC plus 0.1 °/o SOS, 0.1 x SSC plus 0.1 °/o SOS, for 30 min each, with 
gentle shaking at room temperature. If background counts on the 
filters were still high after this washing regime , further washes 
in 0.1 x SSC and 0.1 - 0.5°/o SOS at room temperature were 
performed. Where necessary, the stringency of the washing 
conditions was increased by raising the washing temperature to 
5QOC. Excess washing buffer was blotted from the filters which 
were then covered with Saran Wrap (to keep them damp). The 
wrapped filters were exposed to X-ray film (Kodak XAR-5) with 
intensifying screens (Dupont Lightning Plus) at -700C . 
Densitometric scanning of the X-ray films was performed with an 
LKB Ultroscan XL scanning densitometer. 
5.13 Repeated hybridisation of Northern blots 
After autoradiography, filters were stripped of probe by washing 1n 
stripping buffer (5 mM Tris-HCI pH 8, 0.2 mM EOTA, 0.05o/o 
pyrophosphate, 0.1 % Oenhardts) at 650C for 1 - 2 h. Filters were 
stored dry between Whatman filter paper until required for further 
hybridisations. 
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RESULTS 
IL-3 enhances c-fms transcriot expression in mo use bone 
marrow cells 
Bone marrow cells were prepared from DBA/2 and A/J mice 
(method 2.1) and either lysed immediately for subsequent RNA 
extraction (method 5.4) or cultured at 1 x 106/ml in 100 U/ml IL-
3. After 48 h culture, RNA was extracted from the non-adherent 
cells. WEHl-38 cells, which have previously been shown to express 
c-fms transcripts, were used as a positive control and L929 cells 
were used as a negative control. The yield of RNA from both fresh 
and cultured bone marrow cells was very low in comparison with 
that recovered from cell lines (Table 5.1 ). 
20 µg of each RNA sample were run on a 1 °/o agarose-formaldehyde 
gel (method 5.11 ). After overnight transfer to nitrocellulose, the 
filter was hybridised to a 32P-labelled v-fms probe (method 5.12). 
The blot was later washed and rehybridised with a ubiquitin probe 
to control for RNA loading. WEHl-38 ce lls expressed c-fms 
transcripts of approx 3.8 kb but no specific message was detected 
in L929 cells (Fig 5.1 ). Both the fresh bone marrow samples 
contained c-fms RNA (approx. 3.8 kb) although the level of these 
transcripts was slightly higher in A/J than in DBA/2 bone marrow 
cells. In both strains, 48 h treatment with IL-3 greatly enhanced c-
fms message levels (Fig 5.1). 
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Fig. 5.1 Effect of IL-3 on c-fms transcript levels in bone 
marrow cells 
Nothern analysis of RNA (20 µg per lane)from A/J and DBA/2 
bone marrow cells using a v-fms probe. RNA was pepared by 
ultracentrifugation through caesium chloride (method 5.4). 
Lanes: (1) L929 cells, (2) WEHl-38 cells,(3) freshly isolated 
A/J bone marrow cells, (4) A/J bone marrow cells cultured 
with IL-3 for 48h, (5) freshly isolated DBA/2 bone marrow 
cells, (6) DBA/2 bone marrow cells cultured with IL-3 for 48h. 
Rehybridisation with a ubiquitin probe showed equivalent 
amounts of RNA in each lane (data not shown). 
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Table 5.1 Yield of RNA from bone marrow cells and cell lines 
SAMPLE 
DBA/2 Bm (freshly isolated) 
DBA/2 Bm ( cultured with IL-3)* 
A/J Bm (freshly isolated) 
A/J Bm (cultured with IL-3)* 
L929 
WEHl-38 
RNA YIELD 
(µg/108 cells) 
40. 
45 
25 
28 
1100 
780 
RNA isolated by ultracentrifugation through caesium chloride 
(method 5.4). *Culture conditions as described in text. 
Bm., bone marrow. 
Time course of IL-3 induced c-fm s expression in A/J and 
DBA/2 bone marrow cells 
In an attempt to improve the RNA yields from bone marrow cells, a 
single step RNA isolation procedure was used to prepare RNA for 
this time course. The limited handling involved in this technique is 
claimed to minimize degradation and loss of RNA (Chomczynski and 
Saachi, 1987). 
Freshly isolated bone marrow cells from A/J and DBA/2 mice were 
either lysed immediately for subsequent RNA extraction (method 
5.5) or cultured at 1 x 106/ml in 100 U/ml IL-3. After 2, 6, 12, 24, 
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or 48 h culture, total RNA was extracted from the non-adherent 
cell population (method 5.5). Polyadenylated RNA was prepared 
(method 5.6) from the macrophage-like cell line PUS, to serve as a 
positive · control. L929 RNA was used as a negative control. The 
yields of RNA from 1 x 108 bone marrow cells ranged from 80-150 
µg using this single step method. 20 µg total RNA from each bone 
marrow sample was analysed by Northern blotting (method 5.11) 
and hybridisation with the v-fms probe (method 5.12) The blots 
were later washed and rehybridised with the ubiquitin probe to 
control for RNA loading. 
Hybridisation with the ubiquitin probe revealed that the amounts of 
A/J bone marrow cell RNA loaded for each time point were not 
equal. However,the low levels of c-fms RNA expression detected 1n 
freshly isolated A/J bone marrow cells, was obviously enhanced 
after 24 h exposure to IL-3 (Fig 5.2). Exposure to IL-3 for a total of 
48 h did not further enhance c-fms transcript levels (data not 
presented), suggesting that the maximal effect had occurred. A 
similar result was obtained with DBA/2 bone marrow cells 
although some enhancement of c-fms message levels was observed 
after only 12 h culture with IL-3 (Fig 5.3). A/J and DBA/2 cells 
cultured in the absence of IL-3 for 24 h did not show enhanced c-
fms message levels (data not presented). PUS mRNA contained high 
levels of c-fms transcripts of a similar size to those present in 
bone marrow. The sharp bands of c-fms message detected on these 
Northern blots indicates the integrity of the samples prepared 
using the single step method. Therefore, this method was used 
routinely for future RNA preparations. 
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Fig 5.2 Time course of IL-3-induced c-fms exgression in A/J 
bone marrow cells 
Northern analysis of RNA (20 µg per lane) from A/J bone 
marrow cells after culture with IL-3 for O h (lane 1), 2 h (lane 
2), 6 h (lane 3), 12 h (lane 4), or 24 h (lane 5). 5 µg poly (A)+ 
RNA from PUS cells (lane 6) and 20 µg RNA from L929 cells 
(lane 7) were used as controls. RNA was isolated from bone 
marrow cells by a single step procedure (method 5.5). Blot was 
hybridised first with a v-fms probe (A) and then with a 
ubiquitin probe to control for RNA loading (B). 
A. 1 2 3 4 s a 1 
1111 3.8 kb 
B. 1 2 3 4 s a 1 
1111 1.4 kb 
Fig 5.3 Time course of IL-3-induced c-fms expression ,n 
DBA/2 bone marrow cells 
Northern analysis of RNA (20 µg per lane) from DBA/2 bone 
marrow cells after culture with IL-3 for O h (lane 1), 2 h (lane 
2), 6 h (lane 3), 12 h (lane 4), or 24 h (lane 5). 5 µg poly (A)+ 
RNA from PUS cells (lane 6) and 20 µg RNA from L929 cells 
(lane 7) were used as controls. RNA was isolated from bone 
marrow cells by a single step procedure (method 5.5). Blot was 
hybridised first with a v-fms probe (A) and then with a 
ubiquitin probe to control for RNA loading (8). 
A. 1 2 3 4 s 6 1 
ti 3.8 kb 
B. 1 2 3 4 s 6 1 
ti 1.4 kb 
Effect of IL-3 on c-f ms expression in bone marrow-
derived macrophages 
Macrophages produced from A/J and DBA/2 bone marro\v cells 
(method 5.2) were either lysed immediately for subsequent RNA 
extraction (method 5.5) or were rinsed with fresh media and 
cultured for 12 or 24 h with 200 U/ml IL-3 before lysis. 20 µg of 
total RNA from each macrophage sample was analysed by Northern 
blotting (method 5.11) and hybridisation with the v-fms probe 
(method 5.12). PUS mRNA and L929 total RNA were used as positive 
and negative controls respectively. 
A high level of c-fms message was found in all macrophage 
samples, equivalent to approximately half the message expressed 
in 5 µg of PUS mRNA (Fig 5.4a). Assuming that selection of 
polyadenylated RNA enriches message levels at least 20 times, the 
expression of c-fms RNA by the macrophage samples is 
approximately 2.5 times that expressed by the PUS cell line. 
Incubation with IL-3 for 12 or 24 h did not result in a detectable 
enhancement in the level of c-fms message expressed by bone 
marrow-derived macrophages (Fig 5.4a). 
Effect of IL-3 plus M-CSF on c-fms expression 
Freshly isolated A/J bone marrow cells were either lysed 
immediately for subsequent RNA extraction (met.hod 5.5) or 
cultured at 1 x 106/ml in IL-3 (200U/ml), M-CSF (200U/ml) or IL-3 
plus tv-1-CSF for 72 h (method 5.1 ). After culture, RNA was extracted 
from both non-adherent and adherent cells (method 5.5). Bone 
99 
Fig 5.4a C-fms transcript levels in bone marrow-derived 
macrophages before and after culture with IL-3 
Northern analysis of RNA (20 µg per lane) from A/J (lanes 1 -
3) and DBA/2 (lanes 4 - 6) bone marrow-derived macrophages 
using a v-fms cDNA probe. RNA was extracted from bone 
marrow-derived macrophages after culture in IL-3 for O h 
(lanes 1 and 4), 12 h (lanes 2 and 5) or 24 h (lanes 3 and 6). 5 µg 
poly (A)+ RNA from PUS cells (lane 7) and 20 µg RNA from L929 
cells (lane 8) were used as controls. Rehybridisation with a 
ubiquitin probe showed equivalent amounts of RNA in each of 
lanes 1 - 6 (data not shown). 
Fig.5.4b Effect of IL-3, M-CSF. and IL-3 plus M-CSF on c-fms 
transcript levels in A/J bone marrow cells. 
Slot blot analysis of RNA from A/J bone marrow cells after 48 
h culture with M-CSF (lane 2), IL-3 (lane 3) or IL-3 plus M-CSF 
(lane 4). RNA samples from freshly isolated A/J bone marrow 
cells (lane 1 ), L929 cells (lane 5), and WEHl-38 cells (lane 6) 
were used as control. RNA was blotted in serial triplicate 
dilutions giving equivalents of 1 O µg, 3.3 µg and 1 µg and 
hybridised with a v-fms cDNA probe. 
A. 1 2 a 4 s a 1 a 
B. Increasing dilution 
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marrow RNA was applied to a slot blot (method 5.10) along with 
positive and negative control RNA from WEHl-38 and L929 cells 
respectively. The slot blot was then hybridised with the v-f ms 
probe (method 5.12). 
A/J bone marrow cells cultured in either IL-3 or M-CSF expressed 
somewhat higher levels of c-fms transcripts than did fresh A/J 
bone marrow. Furthermore, c-fms RNA expression was strikingly 
enhanced by culture in the combination of factors (Fig 5.4b). 
Densitometer analysis revealed that IL-3 plus M-CSF increased c-
fms transcript levels synergistically (Table 5.2). 
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Table 5.2 Expression of c-fms transcripts in A/J bone marrow 
cells after treatment with IL-3, M-CSF or IL-3 + M-CSF 
GROWTH FACTOR(S) 
M-CSF 
IL-3 
IL-3 + M-CSF 
Control 
Relative Levels of 
C-fms Transcripts 
1 .8 
1.5 
4.1 
1 .0 
Values were determined by densitometric scanning of the 
autoradiogram represented in Fig 5.4b. The values are expressed as 
the signal density relative to the control (RNA isolated from freshly 
isolated A/J bone marrow cells) 
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DISCUSSION 
These results demonstrate the presence of c-fms transcripts at 
high levels in bone marrow-derived macrophages. C-fms 
transcripts are also easily detectable in freshly isolated bone 
marrow cells. This was not unexpected because transcripts of c-
fms RNA have previously been detected in the myelomonocytic cell 
line, WEHl-3B (Gonda and Metcalf, 1984), purified mouse 
granulocyte-macrophage progenitor cells (Bicknell et al., 1988), and 
in human bone marrow, peripheral blood mononuclear cells and 
haemopoietic cell lines induced along the monocyte differentiation 
pathway (Nienhuis et al.,1985; Sariban et al.,1985). 
The present study also reveals that exposure to IL-3 enhances the 
expression of c-fms RNA transcripts in non-adherent bone marrow 
cells. Although this increase in mRNA transcript levels is not 
necessarily correlated with an elevation in levels of functional M-
CSF receptors, this interpretation would be consistent with a 
previous study in which IL-3 was shown to increase the binding of 
[1251]-M-CSF to non-adherent b·one marrow cells (Bartelmez et 
al.,1985). In the latter study, IL-3 was shown to induce the de novo 
appearance of blast cells bearing low levels of M-CSF receptor and 
the authors suggested that this effect was most like ly due to the 
proliferation of IL-3 responsive cells which already bear M-CSF 
receptors. However, the magnitude of enhancement of c-fms RNA 
levels was similar in A/J and DBA/2 cells even though IL-3-
induced proliferation occurs only in the DBA/2 cultures. Together, 
these results suggest that IL-3 induces the appearance of M-CSF 
receptors on M-CSF receptor negative cells. 
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An elevated expression of M-CSF receptors has been correlated 
with increased proliferative activity in M-CSF (Chen and 
Clark, 1986). In contrast, in functionally mature macrophages, M-
CSF receptor expression is suppressed and there is a concommitant 
reduction in the proliferative activity of these cells. Thus, the 
increase in receptor expression in non-adherent cells could account 
for the enhanced M-CSF responsiveness observed in the A/J system 
in the presence of IL-3. Elevated expression of M-CSF receptors has 
also been correlated with commitment to the macrophage lineage 
(Bartelmez et al., 1985). However, the increased range of colony 
types produced by lower M-CSF concentrations (Chapter 4) 
suggests that lineage definition may also be influenced by the rate 
of occupancy or turnover of M-CSF receptors. 
In the present study, culture with IL-3 did not enhance the levels 
of c-fms RNA expression in bone marrow-derived macrophages. 
However, in a report by Chen and Clark (1986), IL-3 was shown to 
increase the binding of [1251]-M-CSF to peritoneal exudate 
macrophages. The most likely explanation for this apparent 
contradiction in results is the difference between the macrophage 
populations studied. The macrophages in the present study had been 
derived by culture for 7 days in a source of M-CSF. Such conditions 
have been shown to enhance the expression of M-CSF receptors not 
only by expansion of M-CSF receptor bearing cells but also by 
increasing receptor levels on individual cells (Bartelmez et 
al., 1985). Possibly then, c-fms expression was already maximally 
induced in the bone marrow-derived macrophages before exposure 
to IL-3. Indeed, Northern analysis revealed that the level of c-fms 
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transcripts in these macrophages was approximately 2.5 times the 
level present in the macrophage cell line PUS. 
Both M-CSF and IL-3 enhanced the expression of c-fms RNA in 3 day 
A/J bone marrow cell cultures. The greater than additive effect of 
the combination of factors on c-fms transcript levels suggests 
that the induction of c-fms RNA by IL-3 results in the recruitment 
of more A/J bone marrow cells into an M-CSF responsive pool. This 
is in agreement with the previous observation that the presence of 
IL-3 increases the number of colonies produced by A/J bone 
marrow cells in soft agar culture with M-CSF (Chapter 4). The 
proposed antagonistic effect of IL-3 on M-CSF driven 
differentiation (see discussion Chapter 4), may also contribute to 
high c-fms expression in the presence of both factors by delaying 
the appearance of functionally mature macrophages. 
The results presented in this and the previous chapter suggest that 
IL-3 synergises with M-CSF primarily by enhancing the expression 
of M-CSF receptors. An alternative hypothesis was put forward by 
Walker and associates (1985) in their report demonstrating that 
the binding of IL-3 to its receptor temporarily down-modulates M-
CSF receptor expression by BALB/c bone marrow cells. The authors 
proposed that the ability of IL-3 to stimulate the proliferation and 
differentiation of cells of the macrophage lineage and to synergise 
with M-CSF might be explained by this down-modulation and thus 
activation of M-CSF receptors. However, since the down modulation 
of M-CSF receptors is proposed to evoke cellular proliferation, it 
is unlikely that such a response occurs after the binding of IL-3 to 
its receptors on A/J cells. Thus the relevance of IL-3-induced 
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receptor down-modulation for the synergistic activity of IL-3 ,s 
questionable. 
I 
The Northern analyses reported in this chapter revealed that the 
size of the c-fms RNA transcript in mouse bone marrow cells, bone 
marrow-derived macrophages, WEHl-38 and PUS cells is 
approximately 3.8 kb and is therefore similar in size to the 
transcripts found in mouse placental tissue (Muller et al., 1983). An 
analysis of a variant of the WEHl-38 cell line, WEHl-3B (D+), which 
has retained an ability to differentiate to macrophages or 
granulocytes in the presence of granulocyte (G)-CSF, revealed 2 c-
fms transcripts of 8.4 kb and 4.1 kb (Gonda and Metcalf., 1984). The 
smaller of these transcripts probably corresponds to the transcript 
we observed in WEHl-3B (D-) cells. Although the evidence 1s 
circumstantial, it 1s tempting to speculate that the absence of the 
larger transcript 1s correlated with the absence of differentiative 
capacity in the WEHl-3B (D-) subline. 
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Chapter 6 
Study of the interactions of IL-3 with IL-4, 
IL-1, and Erythropoietin 
... 
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INTRODUCTION 
As discussed in Chapter 1, IL-3 interacts with erythropoietin (Epo) 
to enhance erythroid burst formation in vitro. In 1978, lscove 
observed that early erythroid progenitors BFU-E, could be 
maintained for several days in the absence of exogenously added 
Epo but maximal erythroid burst formation required both IL-3 and 
Epo during later stages of culture. In addition, the more mature 
erythroid progenitors produced small erythroid colonies in the 
presence of Epo alone. These observations led to the 2-stage model 
of humeral regulation of erythropoiesis in which early progenitors 
(BFU-E) possess receptors for IL-3 but not Epo whereas cells later 
in the maturation progression (CFU-E) have lost IL-3 receptors and 
acquired receptors for Epo. 
The results of subsequent studies however, suggest that this model 
may be oversimplified. For example, Epo apparently acts directly on 
early progenitor cells since this factor is required for the 
generation of CFU-E in long term bone marrow cultures (Eliason et 
al., 1979) and the presence of Epo during pre incubation of total bone 
marrow increases the ratio between BFU-E and GM progenitors (Van 
Zant and Goldwasser, 1979). Furthermore, under certain 
circumstances, IL-3 can apparently drive the complete sequence of 
events leading to the mature red cell (Goodman et al., 1985) 
although the failure to detect IL-3 receptors on nucleated 
erythroid cells suggests that IL-3 does not act directly on these 
cells (Nicola and Metcalf, 1986). Thus there is some controversy 
regarding the relative importance of IL-3 and Epo and the 
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synergistic interaction between these factors for the maintenance 
of erythropoiesis. 
IL-3 displays a different kind of interaction with IL-1 and IL-4. 
Although the latter 2 factors have little or no capacity to 
stimulate haemopoietic colony formation, they both enhance the 
effects of other factors. In combination with M-CSF, IL-1 enhances 
the development of primitive haemopoietic cells apparently by 
inducing the expression of M-CSF receptors normally expressed 
only on more mature cells (Bartelmez and Stanley, 1985). IL-1 also 
enhances the response of early haemopoietic progenitors to IL-3 
(Stanley et al., 1986). IL-4 enhances the effects of IL-3, Epo, G-
CSF, and M-CSF (Rennick et al., 1987). In combination with IL-3, IL-
4 enhances the growth of mast cell lines and enhances mast cell 
colony formation (Smith and Rennick, 1986; Rennick et al., 1987). 
To further investigate the synergistic interactions between IL-3 
plus Epo, IL-3 plus IL-1 and IL-3 plus IL-4, the effect of these 
combinations of factors was assayed in cultures of IL-3-
responsive (DBA/2) and IL-3-hyporesponsive (A/J) bone marrow 
cells. 
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MATERIALS AND METHODS 
CHEMICALS AND GROWTH FACTORS 
Chemicals and growth factors used were as described in Chapter 2 
unless otherwise stated. IL-1 (lot 14993-74/102) was donated by 
Hofman La Roche, Nutley, New Jersey, USA. Epo was obtained from 
Snow Brand Milk Products Co. Ltd., Tochigi, Japan. IL-4 was 
obtained from lmmunex Corp., Seattle, USA. 
METHODS 
6.1 Soft agar colony assays 
Colony assays were performed as described in method 2.3. The 
factors added were IL-3 (200 U/ml), IL-4 (50 U/ml), and IL-1 (25 
U/ml). Control assays contained GM-CSF (50 U/ml). Assays were 
incubated for 7 days before scoring colony numbers. 
6.2 Methylcellulose colony assays 
Methylcellulose assays were set up essentially as described for 
soft agar colony assays (method 6.1) except that the cu lture 
medium consisted of 0.8°/o methylcellulose (Fluka) / 1 o-4 M 2-
mercaptoethanol / 1 °/o BSA / 30°/o FCS in lscove's Modified 
Dulbecco's Essential Medium (Flow Laboratories). The factors added 
were IL-3 (200 U/ml), IL-1 (25 U/ml), Epo (2 U/ml) or 
combinations of these factors. Control assays contained GM-CSF 
(50 U/ml). After 12 days incubation, gels were placed on 
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microscope slides, then fixed in 5°/o glutaraldehyde in PBS (6 
minutes), rinsed in distilled water (6 minutes)and dried at 370c 
(approximately 30 minutes). Fixed gels were stained with 1 °/o 
benzidine in methanol (2 minutes) then drained and placed in 2.5°/o 
H202 in 70°/o ethanol (1 minute). Slides were then washed in water 
dried, counterstained with Mayer's haematoxylin (5 minutes) and 
finally washed again with water. 
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RESULTS 
Synergism between IL-3 and IL-4 
To investigate the synergistic interaction between IL-3 and IL-4, 
the effect of this combination of growth factors was assayed in 
soft agar cultures of A/J and DBA/2 bone marrow cells (method 
6.1). IL-4 alone failed to stimulate colony formation by A/J or 
DBA/2 bone marrow cells. However, when assayed in combination 
with IL-3, the presence of IL-4 significantly (p<0.001 according to 
the Students t test) enhanced the total number of colonies 
produced by DBA/2 cells (Table 6. i ). A synergistic interaction 
between IL-3 and IL-4 was not seen in A/J bone marrow cell 
cultures. 
Table 6.1 Strain-dependent synergism between IL-4 and IL-3. 
COLONY NUMBER 
STRAIN IL-3 IL-4 IL-3 + IL-4 GM-CSF 
DBA/2 26 ± 6 0 37 + 4 11 + 2 
A/J 0 0 0 13 + 2 
DBA/2 and A/J cells _were plated in colony assays with IL-3 (200 
U/ml), IL-4 (50U/ml) or IL-3 plus IL-4. Cultures containing GM-CSF 
were set up in parallel. Data represents the mean + SD of the 
number of colonies in triplicate cultures. 
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Synergistic interactions between IL-3, Epo and IL-1. 
The effect of IL-3, Epo and IL-1 on erythroid cell production was 
examined using methylcellulose cultures (method 6.2). These 
growth factors were assayed alone and in all combinations on A/J 
and DBA/2 bone marrow cells. In DBA/2 bone marrow cell cultures, 
IL-1 did not significantly enhance the number of colonies produced 
in response to I L-3 or I L-3 p I us E po (Tab I e 6. 2) . Furthermore, I L-1 
and Epo, alone or in combination, failed to support colony 
formation in these cultures. Erythroid cells were produced only in 
the presence of both IL-3 and Epo (Table 6.2). IL-3, IL-1 and Epo, 
alone or in combination, failed to support colony formation by A/J 
bone marrow cells in methylcellulose cultures. Similarly in soft 
agar cultures (method 6.1), IL-3, IL-1, and IL-3 plus IL-1 failed to 
stimulate colony production by A/J bone marrow cells (data not 
shown). 
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Table 6.2 Effect of IL-3, Epo, and IL-1 on erythroid co lony 
format ion 
COLONY NUMBER 
FACTOR DBA/2 A/J 
IL-3 15 + 2 ( - ) 0 
I L-1 0 ( - ) 0 
Epo 0 ( - ) 0 
IL-3 + IL-1 18 ± 2 ( - ) 0 
IL-3 + Epo 17 ± 3 (18°/o) 0 
IL-1 + Epo 0 ( - ) 0 
IL-3 + IL-1 + Epo 21 ± 3 (24°/o) 0 
GM-CSF 11 ± 3 ( - ) 12 ± 5 
( - ) 
( - ) 
( - ) 
( - ) 
( - ) 
( - ) 
( - ) 
( - ) 
A/J and DBA/2 bone marrow cells were plated in methylcellulose 
colony assays with IL-3 (200 U/mlL IL-1 (25 U/ml) or Epo (2 U/ml) 
or combinations of these factors. Control assays contained GM-CSF 
(50 U/ml). Data represents the mean+ SD of the number of colonies 
in triplicate cultures. In parentheses are the number of colonies 
containing erythroid cells (as determined by benzidine staining) 
expressed as a percentage of the total colony count. 
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DISCUSSION 
In soft agar cu ltures , IL-4 enhanced IL-3-dependent colony 
formatio·n by DBA/2 bone marrow cells. This is consisten t with 
previous studies revealing that IL-3 and IL-4 act syn erg isti ca lly to 
support mast cell proliferation (Smith and Rennick, 1986). In a 
recent report, Rennick and col leagues reported that IL-4 
suppresses IL-3-dependent colony formation by a purified 
population of multipotential progenitor cells (Thy lo+). The results 
presented here do not necessarily contradict th is observation 
because Thy lo+ cells represent a relatively smal l proportion of 
the colony forming cells present in total bone marrow. 
IL-3 did not act synergistically with IL-4 or Epo to produce 
colonies in A/J bone marrow cell cultures. Thus , th ese synergistic 
interactions are apparently inseparable from the mitogenic 
activity of IL-3. Assuming that IL-3 and Epo do not synergise in 
vivo in A/J mice, an alternative pathway must ex ist to allow 
production of erythroid cells in this strain. In this regard, lscove 
and associates (1988) recently identified a so luble synergistic 
activity which cooperates with IL-3 and Epo in stimulating the 
growth of mixed erythro id colonies from primitive precursors. In 
addition, the direct surface-surface interacti ons observed between 
macrophages and erythroblasts in long term marrow cultures 
(Lichtman, 1981) may be important for the maintenance of 
erythropoiesis in vivo. 
No synergistic interaction between IL-1 and IL-3 was detected 1n 
semi-solid cultures of either A/J or OBA/2 bone marrow cells. In 
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contrast, previous work has shown that the combination of IL-1 
and IL-3 stimulates a population of high proliferative potential 
colony forming cells (Stanley et al., 1986, McNiece et al., 1987). 
However, the latter studies used bone marrow cells from mice 
treated with 5-FU to enrich for non-cycling early progenitor cells. 
Possibly then, the cell population responsive to IL-1 plus IL-3 is 
too small to be detected in colony assays using normal bone 
marrow cells. 
In conclusion, the data presented in this Chapter suggest that IL-3 
does not interact with IL-4 or Epo in the A/J system. Therefore 
these interactions are probably not crucial for the development and 
maintenance of the haemopoietic system Further experiments, 
using purified early haemopoietic progenitors, are required to 
assess whether IL-1 interacts normally with IL-3 in the A/J 
system. 
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Chapter 7 
Effect of IL-3 on the expression of growth 
factor message by haemopoietic cells 
INTRODUCTION 
In addition to its direct proliferative and synergistic effects, IL-3 
may influence haemopoiesis indirectly by inducing the synthesis of 
other haemopoietic factors. In support of this proposal, there are 
numerous examples of the induction of one haemopoietic factor by 
another. In both man and mouse, M-CSF stimulates the release of G-
CSF and/or GM-CSF from macrophages (Metcalf and Nicola, 1985; 
Warren and Ralph, 1986). IL-1 stimulates G-CSF and GM-CSF from 
several different cell types in vitro including cultured human 
fibroblasts (Zucali et al., 1986) and endothelial cells (Broudy et 
al., 1987). Furthermore, GM-CSF stimulates expression of message 
for M-CSF by human monocytes (Horiguchi et al., 1987). 
The experiments discussed in Chapter 3 revealed that media 
conditioned by A/J and DBA/2 bone marrow cells cultured in the 
presence of IL-3, contained a non-lL-3 colony stimulating activity. 
Therefore, IL-3 apparently induces endogenous growth factor 
production by mouse haemopoietic cells. The aim of the 
experiments discussed in the present chapter was to investigate 
this phenomenon further by analysing the effect of IL-3 on the 
expression of growth factor message by mouse haemopoietic cell 
lines, bone marrow-derived macrophages, and freshly isolated bone 
marrow cells. The effects of IL-3 on growth factor message levels 
in A/J and DBA/2 bone marrow cells were compared to assess 
whether this activity is linked to the proliferat ive activity of IL-3. 
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MATERIALS AND METHODS 
CHEMICALS, GROWTH FACTORS AND PLASMIDS 
Chemicals, growth factors and plasmids were as described in 
Chapter 5 unless otherwise stated. Plasm ids containing full length 
or partial cONAs for M-CSF, GM-CSF, G-CSF, and IL-4 were ki ndly 
donated by T. Rajavashisth (UCLA School of Medicine,USA), N. Gough 
and A. Dunn (Ludwig Cancer Institute for Cancer Research, 
Victoria), S. Nagata (Institute of Medical Science, University of 
Tokyo, Japan), and F. Lee (DNAX Institute of Molecular and Cellular 
Biology, CA, USA) respectively. 
METHODS 
7.1 Culture of 320 cl-23 cel ls 
320 cl-23 cells were maintained in RPMl-5o/o FCS supplemented 
with 30°/o WEHl-3B CM (method 3.4). Immediate ly before use, the 
cells were washed three times by pelleting at 200 x g for 10 mins 
and resuspending in 50 ml fresh RPMl-5°/o FCS with either 50 U/ml 
IL-3 or 50 U/ml IL-2 (Jansenn , Belgium). After 3 days culture at 
370c in a humidified CO2 atmosphere , ce lls we re harvested and 
lysed as described in method 5.4 
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7.2 Preparation of control RNA 
PUS mRNA, WEHl-38 total RNA, and L929 total RNA were prepared 
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as described in Chapter 5. In addition, total RNA was prepared 
(method 5.4) from a human bladder carcinoma cell line, 5637, 
which constitutively produces G-CSF (Welte et al., 1985) and from 
COS-1 monkey cells 3 days after transfection with the mouse IL-4 
gene [COS (IL-4)]. 5637 cells were maintained in RPMl-10°/oFCS. 
COS-1 cells were maintained in DMEM-10°/oFCS. PUS mRNA, and 
total RNA from L929 and COS(IL-4) cells were applied together as 
a mixed marker. 20 µg of this mixed marker contained 12.5 µg PUS 
mRNA, 6 µg L929 RNA, and 1.5 µg COS(IL-4) RNA. 
7.3 Probe preparation 
The following restriction enzyme fragments were isolated (method 
5.8) for use as probe templates; M-CSF, a 170 bp Pst1 -Eco R1 
fragment of the mouse M-CSF cDNA (Rajavashisth et al., 1987) 
inserted into the multiple cloning site of the pGEM-2 vector; GM-
CSF, a 700bp Hind111-EcoR1 fragment of the mouse GM-CSF cDNA 
derived from plasmid PGM38 (Gough et al., 1984); G-CSF, a 600 bp 
EcoR 1-Sau3A fragment of plasmid pHCS-1 containing 308 bp of 
human G-CSF cDNA (Nagata et al., 1986); IL-4, a 373 bp RsaO 
fragment of the mouse IL-4 cDNA inserted into a modified pcDV1 
vector (Lee et al.1986); IL-3, a 588 bp Hinc11-Nco1 fragment of 
the mouse IL-3 cDNA (Fung et al., 1985) derived from plLM 21 
(Campbell et al., 1988). 32P-labelled probes were prepared from 
isolated fragments as described in method 5.12. Ubiquitin probes 
were prepared as described in method 5.7. 
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7.4 Repeated hybridisation of Northern blots 
Northerns were prepared, prehybridised, hybridised and washed as 
described in methods 5.11 and 5.12. Hybridisation with the G-CSF 
probe was carried out at 370c to allow cross hybridisation 
between the human probe and mouse RNA (Tsuchiya et al., 1986) 
After auto radiography, filters were stripped of probe as described 
in method 5.13. 
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RESULTS 
Expression of growth factor message by 32D cl-23 cells 
20 µg total RNA (prepared using method 5.4)from 320 cl-23 cells 
cultured in IL-3 or IL-2 (method 7.1) was analysed by Nothern 
blotting (method 7.4). 5 µg PUS mRNA, 1 µg COS(IL-4) RNA and 1 µg 
WEHl-38 RNA were used as positive controls for GM-CSF, IL-4, and 
IL-3 respectively. The blot was hybridised sequentially with 
labelled cDNA probes (prepared using method 7.3) for GM-CSF, IL-3, 
and IL-4. 
IL-4 transcripts of approximately 0.6 kb were just d~tectable in 
RNA from 320 cells maintained in IL-3 but not in RNA from 320 
cells which had been transferred to IL-2 (data not shown). No GM-
CSF or IL-3 transcripts were detected in these cells irrespective 
of the culture conditions. 
The experiment was repeated using 20 µg poly (A)+ RNA (prepared 
using method 5.6) from 320 cells cultured in IL-3 or IL-2. IL-4 
transcripts were easily detectable in RNA from 320 cells 
maintained in IL-3 and were just detectable in RNA from 320 ce lls 
which had been transferred to IL-2 (Fig 7.1). Again no GM-CSF or 
IL-3 transripts were detected in 320 cells irrespective of the 
culture conditions. 
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Fig. 7. 1 Expression of growth factor transcripts by 320 cl-23 
cells cultured in IL-3 or IL-2 
Northern analysis was performed with 20 µg of poly (A)+ RNA 
isolated from 320 cl-23 cells cultured in either IL-3 (lane 1) 
or IL-2 (lane 2). 1 mg WEHl-38 total RNA (lane 3), 5 µg PUS 
poly (A)+ RNA (lane 4) and 1 mg COS(IL-4) total RNA (lane 5) 
were used for controls. The blot was hybridised with cDNA 
probes for (A) IL-4 (0.6 kb message), (8) GM-CSF (1.2 kb 
message), and (C) IL-3 (1.2 kb message). Rehybrisation with a 
ubiquitin probe showed equivalent amounts of RNA in lanes 1 
and 2 (data not shown) 
A. 1 2 3 4 s 
• 0.6 kb 
B. 1 2 3 4 s 
• 1.2 kb 
C. 1 2 a 4 s 
• 1.2 kb 
Expression of growth factor message bv bone marrow-
derived macrophages 
The preparation of RNA from bone marrow-derived macrophages 
was described in Chapter 5. RNA (20 µg) from A/J and DBA/2 bone 
marrow-derived macrophages after 0, 12, or 24 h culture in IL-3 
was analysed by Northern blotting. 5637 RNA (20 µg) was used as a 
positive control for G-CSF. Mixed control (10 µg) containing RNA 
from PUS, L929, and COS(IL-4) cells (method 7.2) was used as a 
positive control for IL-4, GM-CSF and M-CSF. The blots were 
hybridised sequentially (method 7.4) with labelled cDNA probes 
(Prepared using method 7.3) for GM-CSF, G-CSF, and IL-4. 
A/J bone marrow-derived macrophages contained M-CSF 
transcripts prior to culture in IL-3 and the level of these 
transcripts was augmented by 24 h culture in IL-3. DBA/2 bone 
marrow-derived macrophages prior to culture in IL-3 expressed M-
CSF transcripts at higher levels than were detected in the 
corresponding A/J sample (Fig 7.2). In DBA/2 macrophages, M-CSF 
message levels were enhanced after only 12 h culture in IL-3 and 
had returned to control levels by 24 h. A repeat of this experiment 
confirmed the difference in the kinetics and magnitude of M-CSF 
transcript expression between A/J and OBA bone marrow-derived 
macrophages (data not shown). In both strains, the most abundant 
form of M-CSF mRNA is approximately 3.8 kb in size but another 
transcript of approximately 2.5 kb was also found. 
Transcripts for G-CSF, GM-CSF, or IL-4 were not detected in bone 
marrow-derived macrophages either before or after culture with 
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Fig 7.2 Induction of M-CSF message in bone marrow-derived 
macrophages by culture with IL-3 
Northern analysis of RNA (20 µg per lane) extracted from A/J 
(lanes 1 - 3) and DBA/2 (lanes 4 - 6) bone marrow-derived 
macrophages after culture in IL-3 for O h (lanes1 and 4 ), 12 h 
(lanes 2 and 5), or 24 h (lanes 3 and 6). Mixed marker RNA [6µg 
L929 RNA , 12.5 µg PUS poly (A+) RNA and 1.5 µg COS (IL-4) 
RNA] and 5637 RNA (lane 8) were used as controls. The blot 
was hybridised with cDNA probes for (A) M-CSF (3.8 kb and 2.5 
kb message), (B) GM-CSF (1.2 kb message), (C) G-CSF (1.6 kb 
message)and (D) IL-4 (0.6 kb message). Rehybridisation with a 
ubiquitin probe showed equivalent amounts of RNA in lanes 1 -
6 (data not shown). 
A. 1 2 a 4 s s 1 a 
• 
B. 1 2 a 4 s s 1 a 
c. 1 2 3 4 5 6 7 8 
D. 1 2 a 4 s s 1 a 
111 3.8 kb 
111 2.5 kb 
111 1.2 kb 
1.6 kb 
Ill 0.6 kb 
IL-3 (Fig 7.2). Similarly, previous experiments failed to detect IL-
3 message in such macrophages (data not presented). 
Expression of growth factor transcripts in bone marrow 
cells 
The preparation of bone marrow cell RNA samples used for these 
Northern analyses was described in Chapter 5. RNA (20 µg) from 
DBA/2 and A/J bone marrow cells cultured in IL-3 for 0, 2, 6, 12, 
or 24 h was analysed by Northern blotting (method 5.11). Control 
RNA samples were the same as those used for the analysis of 
growth factor transcript production by bone marrow-derived 
macrophages. The blots were hybridised sequentially (method 7.4) 
with cDNA probes for G-CSF, M-CSF, GM-CSF and IL-4 (probes 
prepared using method 7.3). 
Low levels of M-CSF transcripts of 3.8 kb were detectable in all 
bone marrow samples. Following 6 h exposure to IL-3, the level of 
M-CSF message was transiently augmented, returning to control 
levels after 12 h of culture (fig 7.3) Transcripts for G-CSF, GM-
CSF, and IL-4 were not detected in any of the bone marrow cell 
samples (data not shown). Similarly, in previous experiments , IL-3 
transcripts have not been detected in bone marrow ce lls before or 
after exposure to IL-3 (data not shown). 
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Fig 7.3 Induction of M-CSF message in bone marrow cells 
cultured with IL-3 
Northern analysis of RNA (20 µg per lane) extracted from (A) 
A/J and (8) DBA/2 bone marrow cells cultured in IL-3 for O h 
(lane "1 ), 2 h (lane 2), 6 h (lane 3), "12 h (lane 4) or 24 h (lane 5). 
Mixed marker RNA [6 µg L929 RNA, "12.5 µg PUS poly (A)+ RNA 
and "1 .5 µg COS (I L-4) RNA] (lane 7) and 5637 RNA (lane 8) were 
used as controls. The blots were hybridised with a cDNA probe 
for M-CSF (3.8 kb message). Rehybridisation with a ubiquitin 
probe showed equivalent amounts of RNA in each of lanes "1 - 5 
(data not shown). 
A. 1 2 3 4 s a 1 
t1 3.8 kb 
B. 1 2 3 4 s a 1 
ti 3.8 kb 
DISCUSSION 
Although a number of haemopoietic growth factor cascades have 
been identified, the effect of IL-3 on growth factor production by 
haemopoietic cells has not been extensively examined. The results 
presented here however, clearly demonstrate that IL-3 modulates 
growth factor expression in haemopoietic cells. 
320 cl-23 cells share many of the characteristics of mast cells; 
they proliferate in response to IL-3, are alcian blue positive and 
form basophil colonies in agar. However, 320 cl-23 cells also 
proliferate in response to IL-2 and are lyt1 +, suggesting that these 
cells may represent a branch point in haemopoiesis between the 
mast cell and lymphoid lineage. The observation that 320 cl-23 
cells grown in IL-3 express IL-4 transcripts is consistent with a 
recent report demonstrating that various mast cell lines contain 
IL-4 message (Brown et al.,1987). The present study further 
demonstrates that when 320 cl-23 cells are transferred to medium 
supplemented with IL-2, the expression of IL-4 transcripts is 
considerably reduced. Therefore, IL-3 apparently induces IL-4 
expression in these cells. 
M-CSF transcripts were readily detectable in all bone marrow-
derived macrophage RNA samples. The predominant transcript size 
was 3.8 kb but a low level of 2.5 kb transcripts were also present. 
These transcripts probably correspond to the· 3.8 kb and 2.3 kb 
transcripts reported by Rajavashisth et al.(1987) . In addition, 
Rajavashisth's group found 4.5 kb and 1.4 kb M-CSF transcripts. 
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The presence of M-CSF RNA in bone marrow-derived macrophages 
prior to exposure to IL-3 may indicate that M-CSF is constitutively 
produced by cells of the monocyte/macrophage lineage. Two 
studies of the human system support this notion: Horiguchi et 
al.(1986) detected low levels of M-CSF in human monocytes and 
Vellenga et al.(1988) observed that adherence of monocytes 
elevated the level of M-CSF transcripts expressed by these cells. 
Both these groups however, found that M-CSF transcript levels 
expressed in monocytes were barely detectable. In contrast, in the 
present study bone marrow-derived macrophages contained 
relatively high levels of M-CSF message, suggesting that the 
culture conditions used to produce these macrophages may have 
enhanced the expression of M-CSF RNA. Indeed, numerous studies 
indicate that M-CSF stimulates macrophages to release increased 
amounts of secretory factors. Furthermore, one of the secretory 
factors induced, interferon-y (Moore et al., 1981 ), will itself induce 
synthesis of M-CSF by macrophages (Cosman, 1987; Rambaldi et 
al., 1987). Therefore, M-CSF message expression in bone marrow-
derived macrophages may be enhanced by an autostimulatory 
pathway. In support of this proposal, A/J bone marrow-derived 
macrophages, which respond poorly to interferon-y (Hamilton et 
al., "I 986), express considerably lower levels of M-CSF transcripts 
than do their counterparts derived from DBA/2 mice. 
Exposure to IL-3 elevates the expression of M-CSF message by bone 
marrow-derived macrophages. This is in agreement with a report 
by Vellenga et al.(1988) who demonstrated an enhancement in M-
CSF transcript levels in human monocytes exposed to IL-3. 
Although IL-3 elevated M-CSF RNA levels in both A/J and DBA/2 
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macrophages, the A/J cells required a longer exposure to IL-3 than 
did the DBA/2 cells. This may reflect either a strain-dependent 
difference in responsiveness to IL-3 or a difference in the 
interferon-induced activation state of the cells as discussed 
above. 
In the present report, no evidence was found that IL-3 induced G-
CSF, GM-CSF, or IL-4 production by bone marrow-derived 
macrophages. Similarly, Vellenga et al.(1988) found no 
enhancement of G-CSF or GM-CSF transcript levels in human 
monocytes exposed to IL-3. In contrast, Metcalf and Nicola (1985) 
reported that peritoneal exudate macrophages stimulated by IL-3, 
produced G-CSF. The apparent disparity between these results may 
be caused by the use of macrophages from different sources or by 
the relatively low sensitivity of Northern analysis compared with 
biological assays. Alternatively, the response of peritoneal 
macrophages, apparently elicited by IL-3, may have been caused at 
least in part by the high levels of endotoxin found in media used for 
that study (Metcalf and Nicola, 1985). 
M-CSF transcripts are present in a number of mouse tissues 
including adult lung and heart (Rajavashisth et al., 1987) and fetal 
membranes and placenta (Azoulay et al., 1987). The detection of M-
CSF transcripts in freshly isolated adult bone marrow further 
extends this list of tissues and is consistent with a report by 
Shadduck et al.(1983) demonstrating that M-CSF is produced in long 
term bone marrow cultures. Stromal cells are prime candidates as 
the cellular source of M-CSF and M-CSF RNA detected in bone 
marrow cultures. A fibroblast cell line, L929, expresses M-CSF 
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RNA and produces M-CSF consti tutive ly (Stan ley and 
Heard ,1977. ,Rajavash isth et al. ,1987). M-CSF is present in th e Cl\1 
of 'adipocyte' ce ll lines (Lanette et al. , 1982) and , as discussed 
above, low levels of M-CSF RNA are detected in human monocytes . 
However, further work, perhaps using in situ hybr idisati on , is 
required to determine which types of bone marrow ce ll produce M-
CSF in vivo. 
IL-3 elevates the level of M-CSF message expressed in A/J and 
DBA/2 bone marrow cultures. This increase in message levels may 
be due either to the elevation of M-CSF express ion by the 
constitutive producer cells or to induction of M-CSF RNA 
expression in another population of cells. Since . IL-3 induces M-CSF 
RNA expression in cells of the monocyte/macrophage lineage, it is 
likely that these cells are the source of at least some of the 
induced transcripts observed in whole bone marrow. In this regard, 
the apparently transient nature of the response by non-adherant 
bone marrow cel ls may be due to adherence of the responsive 
macrophage popu lation. 
Irrespective of the nature of the producer cell , the presence of RNA 
transcripts for M-CSF but not G-CSF, GM-CSF or IL-4 in A/J and 
DBA/2 bone marrow cells cultured in IL-3 ind icates that M-CSF 
probably accounts for the non-lL-3 endogenous colony stimulating 
activity found in the media cond itioned by these cells. There is no 
apparent d ifference between A/J and DBA/2 cells in the magnitude 
of the induction of M-CSF RNA by IL-3. Therefore, the M-CSF-
inducing activity is apparently separable fro m the proliferative 
activity of I L-3. 
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Chapter 8 
General Discussion 
Introduction 
A review of the literature available up until 1986 on haemopoiesis 
1 
and the growth factors believed to regulate this process is 
presented in Chapter 1. To bring this review up to date, more recent 
information on the biological activities and the molecular biology 
of the haemopoietic growth factors is discussed in this section. 
The availability of quantities of the purified recombinant gibbon 
and human IL-3 has facilitated the study of the biological 
activities of IL-3 in primates. To date, the biolog ical activities of 
gibbon and human IL-3 appear to be largely similar to those of 
mouse IL-3. Thus, human and gibbon IL-3 support the formation of 
G, GM, M, mixed and erythroid colonies in semi-sol id culture 
(Kobayashi et al., 1988; Lopez et al., 1987). In humans, as in mice, 
there is a broad overlap in the activities of IL-3 and GM-CSF 
(Kobayashi et al., 1988; Migliaccio et al., 1988) However, at 
saturating levels of each factor, human IL-3 is superior to GM-CSF 
in promoting megakaryocyte-containing colonies (Kobayashi et 
al., 1988). Further differences between the two growth factors 1s 
evident in serum-free cultures in which IL-3 is 2-3 fold more 
active than GM-CSF in promoting erythroid burst growth in the 
presence of Epo, whereas GM-CSF is 2-3 fold more active than IL-3 
in inducing GM colonies (Migliaccio et al., 1988). 
In parallel with the mouse system, human Epo and G-CSF appear to 
be considerably more lineage-restricted than IL-3. Human Epo 
primarily stimulates the proliferation and terminal maturation of 
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CFU-E (Sonada et al., 1988). Human G-CSF supports the proliferation 
of colonies consisting primarily of neutrophils (Souza et al., 1986). 
The biology of M-CSF has become something of an enigma over 
recent years. The synthesis of both human and mouse M-CSF is 
complex. In both species the gene for M-CSF transcribes multiple 
RNA species that range in size from approximately 1 .5 to 4.4 kb 
(Kawasaki et al.,1985; Wong et al.,1987; Rajavashisth et al.,1987) 
As yet only one cDNA encoding mouse M-CSF has been isolated 
(Rajavashisth et al., 1987) but there are now three different human 
cDNAs described that encode biologically active M-CSF (Kawasaki 
et al.,1985; Wong et al.,1987; Ceretti et al.,1988). The human M-CSF 
cDNAs, referred to as M-CSFa, M-CSF~ and M-CSFy, are probably the 
result of alternative RNA splicing within the coding region of the 
gene and encode proteins of 256 (Kawasaki et al., 1985), 554 (Wong 
et al., 1987) and 438 (Ceretti et al., 1988) amino acids. The two 
predominant proteins synthesised from these cDNAs are 44 kd (M-
CSF~, M-CSFy) and 28 kd (M-CSFa). Each of the M-CSF molecules is 
represented by a form anchored to the plasma membrane and 
soluble M-CSF is processed from the membrane bound precursor 
(Rettenmier et al.,1987; Ceretti et al.,1988). 
The functional significance of these different forms of M-CSF 
remains to be determined although Ceretti et al. (1988) have 
speculated that the three membrane bound precursors may present 
different proteolytic cleavage sites that are cleaved by different 
proteases located at different sites in the body. On the other hand, 
one or more of the membrane bound forms may be functionally 
active requiring direct cell-to-cell contact for binding to M-CSF 
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receptors on adjacent ce lls to init iate a biolog ical respo nse . Th e 
distance between cells requ ired for this in teracti on may be critical 
and would vary according to the form of M-CSF expressed. 
I 
Mouse M-CSF stimulates colonies consist ing pr imaril y of 
macrophages. However, at low concentrations, M-CSF also 
stimulates granulocyte and granulocyte/macrophag e co lon ies 
(Chapter 4). Furthermore, in the presence of IL-1, M-CSF generates 
CFC for the megakaryocyte and granulocyte lineages in addition to 
M-CFC (McNiece et al., 1987). Therefore, the activity of M-CSF is not 
restricted to cells committed to the macrophage lineage. 
Recombinant human M-CSFs also stimulate macrophage colony 
growth although paradoxically the human factors have much less 
biological activity on human bone marrow cells than on co mparable 
populations of mouse bone marrow cells (Wong et al., 1987; Ceretti 
et al.,1988). In view of the synergism of mouse M-CSF with IL-1 
and IL-3 (reviewed in Chapter 1 and below) , it is possible that 
human M-CSF requires the presence of another factor(s) for optimal 
stimulation of human target cells . 
As reviewed in Chapter 1, recomb inant mouse IL-4 and IL-5 support 
the proliferation of mast cells and eosinoph ils respectively. Human 
IL-5 has been shown to have identical biological activities to those 
of the mouse factor (Campbell et al., 1987) but the activity of IL-4 
on human mast ce lls has yet to be demonstrated. Recently, IL-6 was 
added to the list of myeloid growth factors . Human IL-6, first 
identified in the bas is of its ant iviral activity, supports the 
proliferation of some but not all mouse granulocyte/macrophage 
progenitors although it has litt le pro li fe rative activity on human 
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target cells (Wong et al., 1988). As yet no data is available on the 
activity of mouse IL-6 on myeloid cells. The interactions of the 
haemopoietic growth factors with the various cell lineages 1s 
summarised in Fig 8.1. 
In situ hybridisation studies have localised the human genes for IL-
3 (Le Beau et al.,1987), GM-CSF (Huebner et al.,1985), IL-5 
(Sutherland et al., 1988), IL-4 (van Leeuwen et al., 1989), M-CSF 
Pettenati et al., 1987), and the proto-oncogene fms (Le Beau et 
al., 1986), which is believed to be the M-CSF receptor, to the 
segment of chromosone 5 between bands 5q23 and 5q33. The IL-3 
and GM-CSF genes are only 9 kb apart (Yang et al.,1988) and the IL-
4 and IL-5 genes are 90 - 240 kb apart (van Leeuwen et al., 1989). 
The close physical linkage between these genes is also found in the 
mouse where IL-3 and GM-CSF are only 14 kb apart (Lee and Young, 
1989) and IL-4 and IL-5 are 110 - 180 kb apart (Lee et al., 1989). 
The proximity of the four related genes suggests that these genes 
may have evolved by ancient gene duplication. Furthermore, since 
the relatively close IL-3/GM-CSF and IL-4/IL-5 linkages are 
conserved in mouse and human, these relationships may be 
important for the regulation of expression of these genes. 
The remainder of this Chapter reviews the proliferative and 
synergistic activities of IL-3 in the light of recent developments 
including those presented in this thesis. This is followed by a 
consideration of the possible physiological role and therapeutic 
potential of this factor. The final section outlines suggestions for 
further work using the A/J model. 
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Fig 8.1 Scheme of haemopoiesis (adapted from Clark and Kamen, 1987). The 
sites of action of the different growth factors are deduced from analysis of mature 
cells found in co lon ies grown in the presence of the factors. In the presence of other 
factors M-CSF and G-CSF will also act on re lative ly early progenitor cells (see 
text). RBC , red blood ce ll ; N, neutrophil; Eos, eosinophil; B, basophil; MK, 
megakaryocyte. 
Genetic variation 1n the proliferative response to IL-3 
The broad range of target cells responsive to IL-3 suggests that the 
proliferative activity of this factor may be of central importance 
for haemopoietic growth and development. However, as revealed in 
Chapter 2, the proliferative response of mouse bone marrow cells · 
to IL-3 varies according to the strain of the donor mouse. A recent 
report by Breen and associates (1988) has provided independent 
confirmation of this inter-strain variation in IL-3 responsiveness. 
Some inbred strains including A/J (Chapter 2; Breen et al., 1988), 
AKR (Chapter 2), RF (Harland et al., 1980), and NZB (Kincade et 
al., 1979) are particularly hyporesponsive to the proliferative 
stimulus of IL-3. Presently, there is insufficient data available to 
assess whether a similar degree of variation exists in human 
populations although a study by Paquette et al.(1988) on the 
proliferative response of human progenitor cells to various growth 
factors including gibbon IL-3 did reveal considerable variation 
from experiment to experiment. Such variation may reflect 
differences in the responsiveness of cells from different 
individuals. 
Further investigation of bone marrow cells from the IL-3-
hyporesponsive A/J mice revealed that IL-3 has no direct 
proliferative activity on these cells but nevertheless acts 
synergistically with M-CSF, maintains the viability of growth 
factor responsive cells and induces growth factor expression in 
A/J bone marrow cell cultures. Since IL-3 does not induce the 
proliferation of bone marrow cells from some strains, the direct 
mitogenic activity of IL-3 is probably not essential for maintaining 
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normal haemopo ies is. Nevertheless, the synerg istic , maintenance, 
and growth factor-induc ing activities of IL-3 may play an 
important role in contro lling blood ce ll growth and development. 
Synergistic activities of IL-3 
Mouse IL-3 acts synergistically with M-CSF to stimulate the 
production of distinctively large colonies from a unique population 
of haemopoietic progenitors termed high pro liferative potential 
colony forming cells (HPP-CFC). Properties of HPP-CFC, including 
their relative resistance to 5-FU in vivo, suggest that they 
comprise a developmentally early cell population in the 
haemopoietic system (Bradley and Hodgson, 1979; McNiece et 
al., 1986). In addition, the predominant growth factor responsive 
CFC found in the yolk sac blood islets of 8 day mouse embryos, 
responds synergistically to the combination of IL-3 plus M-CSF 
(Townsend et al., unpublished observations). These data emphasise 
that the activities of M-CSF are not restricted to late progenitor 
cells. As yet it is not known whether the interaction between IL-3 
and M-CSF also occurs in the human system. Both human and mouse 
IL-3 also act synerg ist ically with erythropo ietin to enhance 
erythroid colony formation (Sonada et al. , 1988; lscove et al., 1982). 
To explain these synergistic interactions, lscove proposed that IL-
3 acts as a multilineage factor which supports the proliferation 
and maturation of early haemopoietic precursors, whereas lineage 
restricted factors such as M-CSF or erythropoietin act only on cells 
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which have acquired the appropriate receptors as part of their 
differentiation programme. As a corollary, the synergistic activity 
of IL-3 is dependent on its proliferative activity on an early 
haemopo·ietic precursor population. 
However, bone marrow cells from the IL-3-hyporesponsive strains 
produce distinctively large colonies in response to IL-3 plus M-CSF, 
indicating that the proliferative activity of IL-3 is not an essential 
requirement for this synergistic interaction (Chapter 4). The 
results of experiments reported in Chapter 5 suggest that IL-3 
synerg1ses with M-CSF primarily by enhancing M-CSF receptor 
expression although other mechanisms may also be involved. 
The synergistic interaction between IL-3 and M-CSF also occurs in 
vivo. Thus, although relatively large concentrations of IL-3 or M-
CSF must be administered to produce a detectable effect in vivo, 
these concentrations can be vastly reduced by administering the 
factors together (Broxmeyer et al., 1987). The effects of the 
administration of low concentrations of IL-3 plus M-CSF include an 
increase in the proliferation of HPP-CFC in vivo (Williams et 
al.,1987b). 
In agreement with lscove's model, the synergism between IL-3 and 
Epo is apparently correlated to the proliferative activity of IL-3 
(Chapter 6). Since IL-3 and Epo do not enhance erythroid colony 
formation from A/J bone marrow cells, alternative pathways must 
exist for the regulation of erythropoiesis (discussed in Chapter 6). 
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The synergistic activities of IL-3 extend beyond its interactions 
with M-CSF and erythropoietin. Mouse IL-3 and human G-CSF act 
synergistically to support the proliferation of mouse 
multi potential stem cells (lkebuchi et al., 1988) indicating that the 
action of G-CSF is not restricted to commited precursors of the 
granulocyte lineage. The combination of gibbon IL-3 with human G-
CSF or GM-CSF results in synergistic stimulation of colony 
formation from human myeloid precursor cells (Paquette et 
al., 1988). In humans and mice, the combination of IL-6 and IL-3 
accelerates the appearance of blast cell colonies in culture 
(reviewed in Wong and Clark, 1988). IL-3, GM-CSF and M-CSF all act 
synergistically with a growth factor found in the medium 
conditioned by a mouse adherant cell line, TC-1 (Quesenberry et 
al.,1987). The mechanisms involved in these synergistic activities 
of IL-3 are as yet unknown. 
IL-1 (formerly known as haemopoietin-1) and IL-4 belong to a 
separate class of haemopoietic factors which have no intrinsic 
colony stimulating activity but enhance the response of 
haemopoietic cells to various growth factors including IL-3 
(reviewed in Chapters 1 and 6). The relevance of the synerg istic 
interaction between IL-3 and IL-4 is questionable however, since 
IL-4 does not enhance IL-3-responsiveness in the A/J system. 
Role of IL-3 in haemopoiesis 
Constitutive haemopoiesis 
As discussed 1n Chapter 1, as a prerequisite to ascribing a 
physiological role for IL-3 in the development and maintenance of 
the haemopoietic system, it must be demonstrated that cells 
present at the major sites of constitutive haemopoiesis are 
capable of producing this factor. Recent work indicates that 
endothelial cells which are present in the bone marrow stroma and 
surround blood islets in the yolk sac may, under certain conditions, 
be responsible for IL-3 production. A CSF with the chromatographic 
and biological properties of IL-3 has been isolated from the 
conditioned media produced by cultures of human umbilical vein 
endothelial cells (Elsbury et al., unpublished observations). This 1s 
consistent with a report by Labastie et al (1984) that an IL-3-like 
activity can be detected in yolk sac (reviewed in Chapter 1 ). In 
addition, B cells have been identified as a source of spontaneously 
exfoliated, membrane associated growth factors including an 
erythroid burst stimulatory activity which may be identical to IL-3 
(Dainiak et al., 1987). As numerous B cells reside in the bone 
marrow they too are a potential source of IL-3 for constitutive 
haemopoiesis. However, these data have yet to be confirmed in 
other laboratories 
Does IL-3 regulate the self-renewal and differentiation of 
haemopoietic stem cells? A number of investigators have shown 
that the targets of IL-3 include stem cell populations. For example, 
mouse IL-3 supports the growth of blast cell colonies in vitro and 
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stimulates the proliferation of CFU-S both in vitro and in vivo 
(reviewed in Chapter 1 ). Similarly human IL-3 and gibbon IL-3 
support the proliferation of multipotential stem cells with 
extensive replating capacity in vitro (Kobayashi et al., 1988; 
reviewed in Clark and Kamen, 1987). However, since IL-3 has no 
direct proliferative activity on haemopoietic cells from a number 
of mouse strains (Chapters 2 and 3), it is unlikely that this activity 
plays an essential role in stem cell regulation. This is consistent 
with a recent report by Zipori and Lee (1988) aimed at determining 
the influence of IL-3 gene expression on the ability of a stromal 
cell line, 14F1 .1, to sustain haemopoiesis. 14F1 .1 cells are a line of 
endothelial-adipocytes which produce M-CSF but not IL-3, GM-CSF, 
or G-CSF. This stromal line is capable of maintaining long term 
haemopoiesis when co-cultured with bone marrow cells. Zipori and 
Lee found that IL-3 gene expression, achieved by transfection of 
14F1 .1 cells with a plasmid carrying an IL-3 cDNA, did not modify 
the ability of these cells to maintain stem cell renewal. 
Evidence to date suggests therefore, that IL-3 is not an important 
regulator of stem cell renewal. Other more plausible candidates for 
this role include the endogenous CFU-S cell cycle stimulating and 
inhibitory factors (reviewed in Chapter 1) .and as yet 
uncharacterised factor(s) produced by stromal cell lines, such as 
14F1 .1, which are capable of maintaining long term haemopoiesis. 
On the other hand there is evidence that IL-3 regulates the 
differentiation of stem cells. For example, in the study by Zipori 
and Lee (1988), the expression of IL-3 in the stromal cell/bone 
marrow cell co-cultures resulted in a shift in differentiation 
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towards the myeloid lineages. This effect may be accounted for 
partly by an enhancement of the response of bone marrow cells to 
the endogenous M-CSF present in these cultures. As mentioned 
earlier, IL-3 also appears to enhance the M-CSF-responsiveness of 
stem cells found in the yolk sac blood islets of 8 day mouse 
embryos, suggesting that this differentiative activity is involved 
in early haemopoietic development. Perhaps then, the maJor role of 
IL-3 in constitutive haemopoiesis is to facilitate the 
differentiation of stem cells towards myeloid lineages. In the bone 
marrow microenvironment the final outcome of this effect would 
depend on which other endogenous factors were present. 
Inducible haemopoiesis 
As a product of activated T cells, IL-3 is probably important for 
host defense rections against the invasion of foreign substances. 
However, the role of IL-3 in this process is not clear since GM-CSF, 
which shares many of the activities of IL-3, is produced by the 
same population of activated T cells. 
One of the activities of IL-3 which is apparently unique to th is 
factor is its proliferative and differentiative activity on mucosa! 
mast cells in vitro. Exogenous administration of IL-3 also has a 
striking effect on mast cell numbers in vivo (Metcalf et al., 1986a). 
Therefore, IL-3 production may regulate the mast ce ll hyperplas ia 
involved in parasite and allergic responses. The action of IL-3 on 
IL-4 expression by the mast cell-like 320 cl-23 cells (Chapter 7) 
adds a further dimension to the possible role of IL-3 in such 
responses. IL-4 is capable of increasing lg E production by 
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activated B cells in vitro (Coffman et al., 1986) and probably in vivo 
(Finkelman et al., 1986). In turn, binding of lg E to the high affinity 
receptor expressed on the mast cell mediates the release of 
vasoactive amines. Thus, if IL-3 induces IL-4 expression by 
mucosal mast cells in vivo this could represent an important 
mechanism for the amplification of lg E mediated responses. The 
synergism between IL-3 and IL-4 on the proliferative response of 
mast cells could further enhance these responses. 
The synergistic activities of IL-3 may also play an important role 
in inducible haemopoiesis by amplifying the inflammatory reponse 
induced by other factors. Such an effect would be particularly 
potent on the macrophage lineage since IL-3 not only enhances the 
proliferative response to M-CSF (Chapter 4) but also induces M-CSF 
expression by mature macrophages (Chapter 7). 
Therapeutic potential of IL-3 
Clinical trials are in progress to investigate the potential of 
growth factors, including IL-3, for enhancing the rate of bone 
marrow engraftment and for stimulating hematopoies is in patients 
undergoing radiotherapy or chemotherapy for cancer. Bearing in 
mind the numerous synergistic activities of IL-3, it is likely that 
administration of this factor in combination with others would 
produce the greatest benefit. In this regard, treatment of monkeys 
with both IL-3 and GM-CSF results in an increase in neutrophils as 
well as platelets which is not seen in animals treated with GM-CSF 
alone (reviewed in Klingemann and Eaves, 1988). 
.... 
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The administration of IL-3 may also result in adverse reactions. 
Indeed, in one mouse study, treatment with IL-3 iesulted in 
increased replication of the spleen-focus-forming virus, probably 
by first increasing the cycling rates of the target cells for this 
virus (reviewed in Broxmeyer and Williams, 1987). Unpleasant 
complications could also be caused by the differentiative activity 
of IL-3 on mast cells and macrophages and long term treatment 
with IL-3 may lead to enhanced myeloid differentiation at the 
expense of the lymphoid pathway. 
As a final note of caution, the large intra-species variation in the 
response of mouse bone marrow cells to IL-3 may be reflected 1n 
the human population and should therefore be taken into 
consideration during analyses of clinical trials involving this 
growth factor. 
Future use of the A/J model 
Dissection of the signalling pathways induced by IL-3 
The isolation of the proliferative from the synergistic and growth 
factor-induction responses to IL-3 in A/J bone marrow cells 
suggests that these reponses may be controlled by separate 
signalling pathways, perhaps via functionally different receptors. 
In support of this notion, Palazynski and Ihle (1984) reported the 
identification of IL-3 receptors of two different molecular 
weights, 55,000 and 70,000. Further binding analyses, including 
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Scatchard analysis, are required to determine whether there is any 
significant difference in the numbers, molecular weights, or 
binding affinities of IL-3 receptors on A/J bone marrow cells 
compared with those on bone marrow cells which proliferate in 
response to IL-3. 
There is some evidence for the existence of two separate signall ing 
pathways induced by IL-3. One of these putative signalling 
mechanisms involves the activation of protein kinase C. The 
interaction of IL-3 with its receptor on FDC-P1 cells results 1n the 
trans location and activation of protein kinase C (Farrar et al., 1985) 
and in the phosphorylation of two major cellular substrates with 
molecular weights of 68,000 (pp68) and 20,000 (pp20) (Evans et 
al., 1988). Phosphoaminoacid analysis demonstrated that pp68 was 
phosphorylated on threonine and not tyrosine residues. This 
eliminates the possibility that the phosphorylation observed had 
been affected by a tyrosine kinase and further implicates protein 
kinase C (a serine-threonine kinase) in the transduction of the 
signal induced by IL-3. 
The best defined mechanism of activation of protein kinase C is the 
receptor-mediated hydrolysis of membrane bound phosphatidyl 
inositol 4,5-bisphosphate to generate two second messenger 
molecules: inositol triphosphate and diacylglycerol (Berridge and 
Irvine, 1984). The release of inositol triphosphate causes a 
transient increment in the intracellular Ca2+ concentration , 
whereas the release of diacylglycerol activates protein kinase C. 
These two events act synergistically to elicit physiological 
responses. The combination of a tumor promoting phorbol ester and 
139 
- --
I 
I 
I 
ii 
I 
:r 
I 
a Ca2+ ionophore can m1m1c the effects of phosphoinositide 
breakdown: Phorbol esters directly activate protein kinase C 
(reviewed in Nishizuka, 1984) and Ca2+ ionophores increase 
cytosolic Ca2+ levels. 
Whetten et al. (1986) demonstrated that the IL-3-dependent cell 
line, FDCP-Mix 1, cultured with a phorbol ester, tetradecanoyl 
phorbol 13-acetate (TPA), and a Ca2+ ionophore (A23187) remained 
viable in the absence of IL-3 for 24 hr. At optimal concentrations 
TPA and A23187 also induced a small proliferative response 1n 
these cells although this was less than half the proliferative 
reponse induced by IL-3. From the observation that agents which 
mimic diacylglycerol and inositol triphosphate can partly replace 
IL-3 as a proliferation/survival signal, Whetten et al. inferred that 
IL-3 promotes the survival and proliferation of cells via its ability 
to stimulate phosphatidyl inositol metabolism. However, in recent 
work, Whetten et al. (1988) demonstrated that IL-3 does not 
stimulate an increase in inositol lipid turnover in FDCP-Mix 1 cells. 
Therefore, although activation of protein kinase C and a transient 
increase in cytosolic Ca2+ may be induced by IL-3, it is unlikely 
that these second messengers are generated via the phosphatidyl 
inositol pathway. 
One possible explanation for the failure of IL-3 to induce 
proliferation of A/J bone marrow cells is that these cells are 
deficient in the generation or response to activated protein kinase 
C and/or increases in cytosolic Ca2+. Some preliminary 
experiments were carried out during the course of this thesis to 
ascertain the effect of the phorbol ester, phorbol 12-myristate 13-
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acetate (PMA), and the Ca2+ ionophore, A23187, on the proliferation 
of A/J and BALB/c bone marrow cells. Because the proliferation 
induced by these agents, alone or in combination, was somewhat 
variable and only of very low level in both A/J and BALB/c bone 
marrow cell cultures, the results are not formally presented 
elsewhere in this thesis. However, the general trends observed 1n 
these experiments are summarised below. Even at optimal 
concentrations, PMA (2ng/ml) alone had little effect on the 
proliferation of A/J or BALB/c bone marrow cells. PMA (2ng/ml) 
and ionophore (700ng/ml) acted synergistically to induce a low 
level of bone marrow cell proliferation. The response to this 
combination of agents was similar in both A/J and BALB/c bone 
marrow cell cultures suggesting that A/J cells respond normally to 
activated potein kinase C and cytosolic calcium fluctuations. 
Concentrations of calcium ionophore in the range 1-1,000 ng/ml 
failed to induce proliferation. At the higher concentrations in this 
range, ionophore actually inhibited background proliferation 
(proliferation occurring in the absence of exogenous growth factor) 
and inhibited the proliferation induced by IL-3 in both A/J and 
BALB/c cultures. Interestingly, PMA appeared to enhance the 
proliferation induced by IL-3 in A/J bone marrow cell cultures such 
that optimal concentrations of both PMA (2ng/ml) and IL-3 
(1 OOU/ml) induced a similar level of proliferation to that obtained 
with optimal concentrations of PMA and ionophore. In contrast, PMA 
only enhanced the IL-3-induced proliferation of BALB/c bone 
marrow cells when low concentrations of IL-3 were used (<SU/ml). 
This may indicate that A/J cells fail to generate normal levels of 
activated protein kinase C in response to IL-3. To investigate 
whether it is likely that the deficiency 1n A/J bone marrow cells 
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lies in the activation of protein kinase C, the threonine 
phosphorylation of cellular substrates induced in A/J cells by IL-3 
should be compared with those induced in BALB/c cells. This may 
reveal whether the activation of protein kinase C is a critical event 
in the proliferative response to IL-3. The similarity in the response 
of A/J cells to PMA plus IL-3 and PMA plus ionophore, may indicate 
that IL-3 causes a transient increase in calcium levels (as does 
ionophore). Alternatively, the apparent interaction between IL-3 
and PMA may be indirect because IL-3 induces the endogenous 
production of M-CSF in A/J bone marrow cell cultures (Chapter 7) 
and phorbol esters are known to enhance the proliferation induced 
by low concentrations of M-CSF (Stuart et al., 1981 ). 
The other pathway implicated as the transducing mechanism for the 
proliferative signal of IL-3 involves a tyrosine kinase. IL-3 
specifically induces tyrosine phosphorylation of a 150,000 kd 
membrane glycoprotein (gpp150) in the IL-3 dependent cell lines 
IC2 and DA-1 (Koyasu et al., 1987) This tyrosine phosphorylation 
occurs earlier than the threonine phosphorylation of pp68 and pp20. 
Again, a comparison of the cellular substrates phosphorylated after 
treatment of A/J and BALB/c bone marrow cells with IL-3 may 
reveal whether the tyrosine kinase pathway is critical for IL-3-
i nduced proliferation. 
Further analysis of the interaction between IL-3 and other factors 
The separation of the mitogenic activity of IL-3 from some of its 
synergistic activities in A/J bone marrow cell cultures should 
facilitate further analysis of the interactions between IL-3 and 
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other growth factors. In particular, the A/J model should facilitate 
the isolation and characterision of the HPP-CFC responsive to IL-3 
and M-CSF. 
Analysis of the importance of IL-3-induced proliferation 1n host 
defense reactions 
A/J mice should provide a model for studying the importance of the 
proliferative response to IL-3 in host defense reactions. Previous 
reports have shown that A/J mice are highly susceptible to a 
variety of intracellular parasites such as Schistosoma mansoni 
(James et al.,1983), Rikettsia akari (Meltzer et al.,1982), and 
Legionella pneumophila (Yamamoto et al., 1988). Much of this 
impaired resistance may be accounted for by the observation that 
I FN-y does not efficiently induce cytotoxic activity in macrophages 
from these mice (Hamilton et al., 1986). However, Meltzer and 
colleagues (1982) demonstrated that the defective cytotoxic 
activity displayed by macrophages from A/J mice is not causally 
related to the extreme susceptibility of these mice to Rikettsia 
akari. Further study is required to assess the involvement of the 
direct mitogenic activity of IL-3 in resistance to these bacterial 
infections. In view of the apparent dependency of mucosa! mast 
cells on IL-3 for proliferation it would also be particularly 
interesting to study the susceptiblity of A/J mice to helminth 
parasite infection. 
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